Experimental Colonic Carcinogenesis: The Interaction of Diet, Bile Acids, Colonic Kallikrein Activity and Colonic Prostaglandin Content by McIntyre, Robert
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
EXPERIMENTAL COLONIC CARCINOGENESIS.
THE INTERACTION OF DIET. BILE ACIDS. 
COLONIC KALLIKREIN ACTIVITY 
AND
COLONIC PROSTAGLANDIN CONTENT.
A THESIS PRESENTED IN 
FULFILMENT OF THE REQUIREMENTS FOR THE 
DEGREE OF DOCTOR OF MEDICINE.
BY
ROBERT MCINTYRE, B.Sc. (Hons), M.B. Ch.B.,
F.R.C.S. (Glasg)
DEPARTMENT OF SURGERY,
WESTERN INFIRMARY,
GLASGOW. AUGUST, 1989
(c) Robert McIntyre
ProQuest Number: 11007409
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007409
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
C O N  T E N T S
ACKNOWLEDGEMENTS.................................................................................. page ( iv )
SUMMARY page (v i )
INTRODUCTION............................................................................................ page 1
The Colonic Microenvironment...............................page 4
Experimental Colorectal Carcinogenesis page 11
The K a l l ik re in  - Kinin System.............................page 27
Prostaglandins page 38
AIMS OF THE STUDY................................................................................. page 48
MATERIALS AND METHODS........................................................................ page 51
Animals.............................................................................page 51
D ie ts ................................................................................. page 51
A p ro tin in ........................................................................ page 53
Indomethacin page 53
S a c r i f ic e ........................................................................ page 54
Measurement o f Tissue K a i l ik re in -1 ik e
A c t iv i ty  in the Colon page 56
Graphs 1 - 3 ..................................................................page 61
Measurement of Prostaglandin E« in
Colonic Tissue page 64
Stathmokinetic Analysis ..........................................page 68
Measurement o f Faecal Constituents..................page 69
Histo logical Examination........................................page 69
Measurement of plasma Indomethacin................. page 69
S ta t is t ic a l  Methods.................................................. page 70
( i )
TABLES 1 - 11..........................................................................................page 73
RESULTS.......................................................................................................page 86
Growth and Development of the Animals page 86
D is tr ib u tio n  of K a ll ik re in  A c t iv i ty  in
the Colon..................................... page 90
D is tr ib u tio n  of Prostaglandin E2 in
the Colon..................................... page 96
Crypt Cell Production Rates.................................page 102
Faecal Constituents.................................................. page 104
Tumour Induction.........................................................page 107
Indomethacin measurement....................................... page 110
TABLES 12 - 30 ....................................................................................... page 111
FIGURES 1 - 7 ..........................................................................................page 141
DISCUSSION................................................................................................ page 148
Tissue K a i l ik re in -1 ik e  Amidase A c t iv i t y . ,  page 149
Tissue PGE2   page 154
Crypt Cell Production Rate  page 161
Faecal B ile  Acids  page 169
Diet and Tumour Induction  page 173
General Discussion and Conclusions  page 184
APPENDICES................................................................................................page 188
Appendix 1......................................................................page 188
Appendix 2 ......................................................................page 191
Appendix 3 ......................................................................page 192
APPENDICES (continued)
Appendix 4  page 193
Appendix 5  page 195
Appendix 6  page 196
Appendix 7 ......................................................................page 204
Appendix 8 ......................................................................page 206
Appendix 9 ......................................................................page 207
Appendix 10................................................................... page 208
BIBLIOGRAPHY...........................................................................................page 210
( i i i )
A C K N O W L E D G E M E N T S
I t  is customary in a project such as th is  to spare a few 
words fo r  the many other individuals whose contributions to i t  
are unique, diverse and essentia l.  Such thanks is f a in t  praise  
but I am glad to take the opportunity to record my debt and 
g ratitude  to the following people.
F i r s t ly  I have to thank Professor W.D. George fo r  his 
un tir ing  enthusiasm and steady hand in guiding th is  pro ject from 
i t s  inception. With him I also thank Mr D.J. Galloway whose 
endless patience, gentle encouragement and willingness have 
solved many d i f f i c u l t i e s .  In p a r t ic u la r ,  I am grate fu l to him for  
carrying out the crypt ce ll  counting and bearing the brunt of  
proof-reading the manuscript.
To Dr I . J .  Z e i t l in  I am gratefu l fo r  teaching me much 
about the systems I was to examine and fo r  adding a breadth to my 
education in many long discussions from which only I gained.
I have had a great deal of w i l l in g  and s k i l l f u l  technical 
help from a number of sources. Mr C. Hughes and Miss V. Simpson 
tended the animals, did most of the drug in jec tions  and helped in 
tissue preparation. Mr J. Kennedy processed the stathmokinetic  
m ater ia l.  Mr E. Campbell and Mr C. Muirhead assisted in some of 
the assays as did Mr C. Anderson who also supervised some of my 
early  attempts at pharmacological methods. To a l l  o f these I 
glad ly  acknowledge th e ir  e f fo r ts  and thank them.
The analysis of the faecal b i le  acids was carr ied  out 
e n t i re ly  by Dr. R.W. Owen in the PHLS, Porton Down and fo r  th is  I 
am deeply indebted.
I am gratefu l to Dr. Freda J a r re t t  who carried  out the 
h is to log ica l studies so amiably and rap id ly  and I would also l ik e  
to thank Dr. Susan Coker who demonstrated the prostanoid assay 
and provided m aterials fo r  i t  i n i t i a l l y .
My thanks also go to Dr. G. Murray who carried  the large  
burden of the s ta t is t ic a l  analysis with commendable equanimity.
This study was made possible by the generous funding of 
the Scottish Home and Health department to whom many thanks are 
due. The generosity of Bayer UK Ltd in providing Trasylol and 
Merck, Sharpe & Dohme in providing Indomethacin fo r  the study 
completely free of charge is g ra te fu l ly  acknowleged.
F in a l ly ,  i t  is easy to overlook the contribution made to 
such a study by family and fr iends. My fam ily and friends have 
had a lo t  to endure over a protracted time. Their perseverance, 
tolerance and encouragement have made an invaluable contribution  
to th is  work fo r  which thanks is barely adequate.
(v)
S U M M A R Y
1. Colorectal cancer is currently  the fourth most common k i l l in g  
malignancy. There is good epidemiological and experimental 
evidence that the incidence of th is  tumour re f le c ts  the nature of  
the d ie t  consumed. P r in c ip a lly ,  th is  evidence suggests tha t  a 
d ie t  which is r e la t iv e ly  high in fa t  or low in d ie ta ry  f ib re  
content w i l l  increase the like lihood  of the development of  
colorectal cancer.
2. Epidemiological and experimental evidence have also 
demonstrated that the development of colorectal neoplasia is  
re la ted  to the presence of high concentrations of b i le  acids and 
th e i r  metabolites in the faeces. The concentration of the faecal 
constituents are dependent on the d ie t .
3. At the c e l lu la r  level there are a large number of substances 
which may control growth and d if fe re n ta t io n  - the autacoids. The 
kinins and prostaglandins are autacoids which have been shown to 
have s ig n if ic a n t  e ffects  on the structure and metabolism of the 
colonic epithelium.
4. There is an established animal model fo r  colonic  
carcinogenesis whichgives a f a i r  representation o f the human 
condition.
5. This study has examined such an animal model fo r  colorectal  
carcinogenesis to establish i f  there is any detectable  
re la tionsh ip  between the d ie t ,  the faecal constituents and the 
leve ls  of autacoids in the colonic t issue.
(v i)
6. Furthermore, th is  study has examined i f  there are changes in 
the concentration of autacoids with the development o f tumours in 
the animal model and i f  the tumour incidence can be a lte red  by 
pharmacological manipulation of the autacoid a c t iv i t y .
7. 575 male albino Swiss rats  were entered into the study and 
555 survived u n ti l  completion. These animals were fed one of 
three d iets  which were e ith e r  a) high f a t ,  low f ib re ;  b) low f a t ,  
high f ib re  or c) th e ir  standard laboratory d ie t  from entry into  
the study until  completion.
8. In addition, some animals received the carcinogen azoxymethane 
by weekly, subcutaneous in jec tion  over a period of twelve weeks. 
Selected animals also received d a ily  in jections of aprotin in  
which is a protease in h ib ito r  blocking the formation of kin ins. 
Other animals received indomethacin continuously in th e i r  
drinking water to in h ib it  prostaglandin synthesis. Appropriate 
control treatments were also administered to other animals.
9. Animals were sacrif iced  at 4, 16 and 24 weeks a f te r  entry into  
the experiment. Samples of colonic tissue were taken to measure:
a) the tissue k a i l ik re in -1 ik e  amidase a c t iv i t y  which indicates  
the kinin-forming a c t iv i ty  of the tissue.
b) the tissue prostaglandin content since th is  is the most 
abundant prostanoid in the colon.
c) the crypt ce ll  production ra te .
( v i i )
10. Samples o f a l l  tumours were assessed h is to lo g ic a l ly  and 
samples o f the faeces were taken fo r  b i le  acid analysis.
11. The animals grew and developed normally on a l l  three d iets  
but those receiving the low f a t ,  high f ib re  d ie t  gained leas t  
weight over the experimental period. Administration of the 
carcinogen was associated with a reduction in overa ll weight gain 
but none of the other drug treatments s ig n i f ic a n t ly  affected the 
growth of the animals.
12. Tissue k a i l ik re in -1 ik e  amidase a c t iv i t y  was demonstrated to 
be present in the ra t  colon in a d is t in c t  pattern with the levels  
in the caecum being three to f iv e  times higher than those 
elsewhere in the colon.
13. The colonic tissue k a i l ik re in -1 ik e  amidase a c t iv i t y  was 
unaffected by the d ie t  which the animals consumed and by the use 
of carcinogen.
14. Regular in jections of aprotin in  resulted in a s ig n if ic a n t  
decrease in the colonic tissue k a l i ik r e in -1 ik e  amidase a c t iv i t y  
but none of the other treatments had a s ig n if ic a n t  e f fe c t  on th is  
a c t iv i t y .
15. Prostaglandin E2 was demonstrated to be present in the ra t  
colon in a d is t in c t  pattern with the levels  in the d is ta l  areas 
of the colon being higher than those in the caecum.
( v i i i )
16. The colonic prostaglandin E2 content was unaffected by the 
d ie t  which the animals consumed but animals receiving the 
carcinogen had increased levels  of prostaglandin E2 in the 
colon.
17. The regular administration of indomethacin resulted in a 
s ig n if ic a n t  reduction in the colonic content of prostaglandin E2 
but none of the other treatments had a s ig n if ic a n t  e f fe c t  on the 
Prostaglandin E2 content.
18. Only animals which received the carcinogen developed tumours 
of the colorectum. No re la tionsh ip  was seen between the 
development of tumours and the levels  of e i th e r  tissue
k a i l ik r e in -1 ik e  amidase a c t iv i ty  or prostaglandin E2 .
19. Analysis of the crypt ce ll  production rates by a 
stathmokinetic method fa i le d  to demonstrate any e f fe c t  of d ie t  on 
the crypt ce ll  turnover. Aprotinin and indomethacin were both 
associated with reductions in the crypt ce ll  production ra te  but 
use of the carcinogen and tumour development was without e f fe c t .
20. The faecal b i le  acids, neutral sterols  and free  fa t t y  acids 
were seen to be s ig n if ic a n t ly  re lated  to the d ie t  which the 
animals consumed.
21. Animals on the high f a t ,  low f ib re  d ie t  had raised leve ls  of 
secondary b i le  acids in the faeces, with elevated leve ls  of a l l  
other faecal constituents also. Animals on the th e i r  standard
laboratory d ie t  were noted to have a re la t iv e  excess of faecal 
unsaturated fa t ty  acids.
22. The tumour incidence was higher in the the animals receiving  
the high f a t ,  low f ib re  d ie t  compared to those on the low f a t ,  
high f ib re  d ie t .  The tumour incidence of the animals receiving  
th e i r  standard d ie t  was as great as that of animals on the high 
f a t ,  low f ib re  d ie t .
23. Regular in jection  of aprotinin was found to have a s l ig h t  
protective  e f fe c t  against tumorigenesis in animals on the low 
f a t ,  high f ib re  d ie t .  This was not seen in the other d ie tary  
groups.
24. Indomethacin was not shown to be protective  against tumour 
development. The animals receiving ethanol as a control medium 
did not develop any tumours.
25. These results are taken to confirm the central ro le  o f the 
d ie t  in determining the r is k  fo r  colorectal cancer.
26. The ro le  of the two autacoids examined in th is  study has not 
been c le a r ly  defined but the evidence obtained could be taken as 
suggestive of a promotional ro le  fo r both the kinins and 
prostanoids in colorectal carcinogenesis since pharmacological 
manipulation altered tumour incidence in some instances. The use 
of carcinogen increased colonic prostaglandin E2 content.
(x)
27. Whether the autacoids form a fu rthe r  l in k  in the pathway 
between d ie t ,  b i le  acids and the colonic ce ll  has not been 
established.
28. The lack of a consistent response in the crypt ce ll  
production ra te  is consistent with recent work.
29. The most impressive determinant of colorectal cancer r is k  
was the d ie t .  However i t  is c lear from th is  study that simple 
consideration of one or two d ie tary  elements is  inadequate to 
explain the a lte ra tions  in r is k .
30. I t  is proposed that the re la tionsh ip  between r is k ,  d ie tary  
f a t  content and d ie tary  f ib re  content is non-linear and modified 
by other factors both endogenous and exogenous.
(x i)
I N T R 0 D U C T  I ON
EPIDEMIOLOGY
Each year throughout the World there are around 5.9  
m il l io n  neoplasms diagnosed. (Muir & Parkin, 1985) About 0.5  
m il l io n  of these are cancers of the colorectum making th is ,  on a 
world-wide basis, the fourth most common k i l l in g  malignancy 
( a f t e r  carcinoma of the stomach, bronchus and female breast).  I t  
would seem that in the aetiology of human cancers, environmental 
factors  play the most important ro le . This is c e r ta in ly  true for  
colorectal cancer as epidemiological studies have shown.
In 1971, Burk itt  presented work which highlighted the 
fa m il ia r  facts that there was both a great range in the incidence 
of colorectal cancer throughout the world and that i t  was common 
in the same geographic areas as certa in  non-in fective  bowel 
diseases such as d iv e r t ic u la r  disease and haemorrhoids and as 
certa in  non-bowel diseases such as ischaemic heart disease and 
diabetes. Burk itt  fu rther noted that the Western d ie t  was high 
in refined carbohydrate and low in unabsorbable f ib re  and that  
those who adopted such a d ie t  had an increased r is k  of developing 
colorectal cancer. He postulated that the deficiency in f ib re  was 
important as i t  led to a slow t ra n s i t  time fo r the faecal stream 
and allowed more time for the degradation and ac tiva tion  of 
carcinogens (B u rk it t ,  Walker & Painter 1974)
Contemporaneously Haenszel and Correa (1971) undertook an 
epidemiological review and demonstrated that the incidence of 
colorectal cancer in the population of Colombia depended on the 
social class there being a s ta r t l in g  sevenfold var ia t ion  between
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those in the high r is k  upper class and the low r is k  lower class. 
They also demonstrated that the disease behaved d i f fe re n t ly  in 
the two groups; colonic cancer being more frequent than rectal 
when the r is k  was high and the converse true when the r is k  was 
low. A d d it io n a lly ,  in the high r is k  group a preponderance of 
le f t -s id e d  cancers were seen. In a fu r th e r  paper they (Haenszel, 
Correa & Cuello, 1975) indicated that those at excess r is k  were 
consuming a more "affluent"  d ie t  with more meat, eggs and milk.
Since these early  studies, repeated observations have 
re-asserted the role of d ie tary  f a t ,  f ib re  and protein and other 
"indicators of affluence" in determining the ultim ate r is k  for  
co lrec ta l cancer. The precise contribution of each component was 
unclear and i ts  importance depended to some extent on the 
standpoint of the w r i te r .  (Drasar & Irv ing , 1973; Berg and Howell 
1974; B u rk it t ,  1975; Hegsted, 1975)) By v ir tue  of large  
c o rr la t io n  studies the roles of d ie ta ry  fa t  and protein as 
pos it ive  r is k  factors for colonic cancer became dominant 
(Armstrong & D o ll,  1975) and despite the enthusiasm with which 
the protective  role of d ie tary  f ib re  was promulgated, the 
evidence for i t  was the least rigorous of a l l .  (Stubbs, 1983) Not 
a l l  the data were consistent. (Enstrom, 1975; Graham, Dayal, 
Swanson, et a l . ,  1978) Zaridze (1983) expanded on th is  observing 
th a t  while geographic pathology had given r is e  to the theories on 
large bowel cancer aetiology the subsequent epidemiological 
studies did not uniformly support the theories. Other components 
of the d ie t  came in fo r  scrutiny also. The ro le  of alcohol was
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questioned when beer drinking and rectal cancer were found to be 
associated (Breslow & Enstrom, 1974; Enstrom 1977). Jansson 
(1982) described an apparently protective  e f fe c t  of potassium 
sa lts  in the d ie t  and the possible protective powers of the 
antioxidant selenium have been discussed on several occasions. 
(Shamberger, 1970; W i l le t t  & MacMahon, 1984; Salonen, Salonen, 
Lappetelainen et a l . ,  1985)
Despite the varied opinions, i t  seems c lear from the 
combined body of work that the r is k  to an individual of 
developing colorectal cancer is la rg e ly  determined by his or her 
d ie t  and by two components in p a r t ic u la r .  These observations on 
d ie ta ry  fa t  and d ie tary  f ib re  have la id  the foundations of 
current thinking on the ae tio log ica l mechanisms of th is  disease.
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THE COLONIC MICROENVIRONMENT
Wynder (1975) had come to the conclusion from his e a r l ie r  
epidemiological study that the colonic contents contained 
tumorigenic components and other factors , probably related to 
d ie ta ry  f a t ,  that d ire c t ly  and in d ire c t ly  affected the 
composition of the faeces and consequently the tumorigenic 
components. He suggested that the d ie t  determined the 
in traco lo n ic  contents and the colonic m icroflora produced 
metabolites which may have carcinogenic or cocarcinogenic 
a c t iv i t y  (Wynder & Reddy, 1975). This idea was not new.
The carcinogenic potential of metabolites of b i le  acids 
and stero ls  was known. (Lacassagne, Buu-Hoi & Zajdela, 1966) In 
1968 H i l l  and Drasar showed experimentally th a t ,  in v i t r o , 
b acteria  could deconjugate b i le  salts and could perform the 
dehydroxyl ation of the b i le  acid nucleus which converted a 
primary b i le  acid into a secondary b i le  acid. Thus, cholic acid 
was metabolised to deoxycholate acid and chenodeoxycholic acid to 
l i th o c h o lic  acid. Many anaerobes had the capacity to perform th is  
reaction  but i t  became clear that Bacteroides and Clost r id ia  were 
the most active species. Some organisms could metabolise b i le  
acids without p r io r  deconjugation. (Aries, Crowther, Drasar et 
a l . ,  1969a; Aries & H i l l ,  1969a & b) In short, in the in tes tina l  
metabolism of b i le  salts  i t  was the s t r ic t  anaerobes which were 
most important. Examination of the faecal f lo ra  of two 
populations at grea tly  d i f fe r in g  risks of developing colorectal 
cancer - the English and Ugandans - found that the dominant type
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of bacteria  in both instances was the non-sporing anaerobe. This 
organism was present in the English population in t h i r t y  times 
the numbers seen in the Ugandans. Both sets of bacteria were 
equally  active  in degrading b i le  salts  but the quantities of 
bacter ia  in the English faeces resulted in greater degradation 
occurring. (Aries , et a l . ,  1969b)
From these observations i t  was proposed that the 
in te s t in a l  f lo ra  and the d ie t  were in te r - re la te d  and that  
bacteria  could form carcinogens from d ie tary  substrates. Further 
studies consistently showed that groups at a high r is k  of 
developing colorectal cancer had more bacteria capable of 
metabolizing b i le  acids. The faeces of these groups contained 
raised amounts of b i le  acid and cholesterol metabolites, 
p r in c ip a l ly  from nuclear-dehydrogenating C lo s tr id ia .  (H i l l  & 
A ries , 1971; H i l l ,  Crowther, Drasar et a l . ,  1971; Goddard, 
Fernandez, West et a l . ,  1975; Reddy & Wynder, 1973; Wynder & 
Reddy, 1974) S im ila r ly  other studies showed that d ie t  had 
profound e ffec ts  on the faecal composition of b i le  acid 
m etabolites. (Mastromarino, Reddy & Wynder, 1976; Nair, Turjman, 
Goodman et a l . ,  1984; Turjman, Goodman, Jaegar et a l . ,  1984) 
While i t  was generally agreed that d ie t  was a major 
fa c to r  in the aetiology of colonic cancer there was s t i l l  
considerable debate as to which component was responsible - 
pro te in ,  f a t ,  f ib re  or refined carbohydrate. There was l i t t l e  
evidence to suggest a d ie tary  carcinogen but i t  was feasib le  for  
one or more components of the d ie t  to form carcinogens in vivo.
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( H i l l ,  1974) Thus, proteins could form phenols, N-nitrosamines or 
eth ion ine . Fat metabolism could produce s im ilar  compounds. More 
a t t r a c t iv e  was the concept that i t  was the b i le  acids which were 
converted into  the carcinogen since f u l l  aromatization of the 
b i le  acid nucleus would form a cyclopentanophenanthrene with 
carcinogenic p o te n t ia l .  This would require only four types of 
nuclear dehydrogenation which could a l l  be carried out by gut 
bacteria  - almost exclusively Cl. paraputr i f icum.  I t  was further  
suggested that the gut bacteria may a ffe c t  the enterohepatic 
c irc u la t io n  of carcinogens, hepatic d e to x if ica tio n  or immune 
defence mechanisms. Thus the d ie tary  fa t  could control both the 
colonic f lo ra  and the flow of substrate to i t .  An examination of 
the b i le  acids and f lo ra  in patients with large bowel cancer 
showed them to have the expected high levels of faecal b i le  acids 
and also to have a high proportion of Cl. paraputr i f icum present 
capable of performing the nuclear dehydrogenation required.
( H i l l ,  Drasar, Williams et a l . ,  1975)
Several other experimental studies gave fu rthe r  support 
to the re la tionsh ip  of d ie tary  f a t ,  b i le  acids, colonic bacteria  
and colonic cancer. (Antonis & Bersohn, 1962; Aries, Crowther, 
Drasar et a l . ,  1971; Crowther, Drasar, H i l l  et a l . ,  1976) These 
studies demonstrated in various ways that consuming higher 
amounts of d ie tary  fa t  resulted in higher amounts of secondary 
b i le  acids in the faeces due to a ltered m icroflora a c t iv i ty .  
Faecal f a t t y  acids were also increased (Cummings, Wiggins, 
Jenkins et a l . ,  1978) but in te re s tin g ly  the faecal fa t ty  acids
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were not those of the d ie t .  Meat protein was not a major 
determinant of faecal b i le  acid excretion. (Cummings, H i l l ,
J iv r a j  et a l . ,  1979; Cummings, H i l l ,  Bone et a l . ,  1979)
Not a l l  evidence was clear cut. A study in the West of 
Scotland - an area of exceptionally high incidence of colonic 
cancer - showed patients with colorectal cancer to have a lower 
concentration of faecal b i le  acids but a higher concentration of 
nuclear-dehydrogenating c lo s tr id ia .  (Murray, Blackwood, T ro tte r,  
et a l . ,  1980) I t  was suggested that the very high levels of 
indigenous bacteria l a c t iv i ty  may have led to very extensive 
metabolism of the b i le  acids to a paradoxically low le v e l .  A
s im ila r  study at the same time (Mudd, McKelvey, Norwood, et a l . ,
1980) could find no difference in faecal b i le  acid concentrations 
between patients with large bowel cancer and those with a varie ty  
of conditions which exposed them to an increased r is k  of 
carcinoma. A more recent study from Japan (Hikasa, Tanida, Ohno 
et a l . ,  1984) compared the faecal b i le  acid p ro f i les  in 14
patien ts  with colorectal cancer and 14 age-sex matched controls.
They could not demonstrate any s ig n if ican t a l te ra t io n  in the 
faecal b i le  acid p ro f iles  between patients and contro l. However 
they did demonstrate the excretion of a unique product - 
5B -chol-3-en-24-oic  acid - by a high proportion of the patients  
in amounts. The significance of th is  was not c lear .
While the in te r -re la t io n s h ip  of d ie tary  fa t  and b i le  
acids with colonic cancer was becoming c leare r ,  the interaction  
of d ie ta ry  f ib re  remained ambiguous. Bran could apparently a l te r
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the composition of b i le  acids in b i le  by influencing the 
b ac te r ia l  metabolism or colonic environment. (Pomare and Heaton,
1973) However, d ie ta ry  f ib re  did not appear to modify the faecal 
m icro flo ra  to any detectable extent. (Drasar & Jenkins, 1976; 
Drasar, Jenkins & Cummings, 1976; Fuchs, Dorfman & Floch, 1976) 
The addition of bran to the d ie t  had a variable e ffec t on 
the d a i ly  excretion of sterols and b i le  acids but th e ir  
concentration in the faeces seemed to be universally  reduced. 
(S tan ley , Paul, Gacke et a l . ,  1973; H i l l ,  1975; Cummings, H i l l ,  
Jenkins et a l . ,  1976 & Cummings, Branch, Jenkins et a l . ,  1978) 
These e f fe c ts  were dependent on the type of f ib re  - bran reduced 
the faecal concentrations of acid and neutral sterols but bagasse 
increased the excretion of acid sterols only without affecting  
the concentrations of acid or neutral sterols . (Walters, Baird, 
Davies e t a l . ,  1975) Large concentrations of bran may bind 
steroids leading to an increased faecal concentration and 
increased excretion . This is unusual but is seen with agents 
such as pectin and guar where the d i lu t ing  e ffec t  of increased 
bulk is  o f fs e t  by a 'washout' e ffe c t  leading to increased faecal 
excretion and concentration. A d irec t study of the binding 
capacity o f b i le  acids and b i le  salts by several types of f ib re  
showed tha t  there were considerable variations between the 
d i f fe r e n t  f ib r e  types and bran had only a th ird  of the binding 
capacity o f l ig n in .  (Story & Kritchevsky, 1976). The mechanism 
of binding was seen to be complex and varied depending on the 
type o f f ib r e .  The t ra n s i t  time increases with the increased
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faecal bulk but th is  does not a ffe c t  the amount of bacterial 
m etabolite formed. ( H i l l ,  1978) The precise e ffec t of f ib re  
depends on each o f i t s  components and the amounts present. Fibre 
may in fluence b ac te r ia l  enzyme a c t iv i ty  by modifying the f lo ra  
i t s e l f  or by a l te r in g  the milieu e.g. lowering the pH of the 
faeces. ( H i l l ,  1982).
The bulk o f the evidence supports the hypothesis la id  
down by Wynder and by H i l l .  Thompson (1982) summarised the 
s itu a t io n  : there is a positive  correlation between the incidence 
of colon cancer and the consumption of animal protein and fa t  and 
an inverse re la t io n s h ip  with d ietary  f ib re .  There is also a 
p o s it iv e  c o rre la t io n  with faecal b i le  acid concentration and the 
concentration of nuclear dehydrogenating c lo s tr id ia  in the 
faeces. Increasing the consumption of fa t  and protein leads to an 
increase in the faecal b i le  acids; f ib re  has a variable effect  
depending on the source. All of the dietary components are 
in te r l in k e d  - a l te r in g  one invariab ly  a lters  another.
Using th is  evidence H i l l ,  Morson and Bussey (1978) 
proposed th a t  "Adenomas are i n i t i a l l y  caused by an environmental 
agent which acts on the colorectal ce lls  of adenoma prone 
persons, a fu r th e r  agent causes small adenomas to grow and a 
carcinogen causes malignancy in a high proportion of large 
adenomas". I t  was w e ll -  recognised that the malignant potential 
of large adenomas was greater than small ones but was equally 
great whether the individual was at high or low r isk  of 
developing colorecta l cancer. The incidence and subsite
- 9 -
d is t r ib u t io n  of large adenomas follows that of carcinoma and i t  
followed tha t  the fac to r  determining carcinoma incidence also 
determined growth of adenomas. They proposed that th is  factor was 
a b a c te r ia l  metabolite of b i le  acids. A study of the 
in trac o lo n ic  environment and the presence of colonic adenomas in 
man (Van der Werf, Nagengast, Van Berge Henegouwen et a l . 1983) 
has shown that patients with adenomas have increased b ile  acid 
turnover and increased absorption of deoxycholic acid indicating  
increased exposure of the colonic mucosa to secondary b ile  acids. 
A d d it io n a lly  these patients have a higher proportion of anaerobic 
bacter ia  present and the combination of these two observations 
favours a l in k  between a colonic environment w ell-su ited  to the 
growth of anaerobic bacteria  and exposure of the mucosa to 
tumour-promoting b i le  acids.
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FXPERIMENTAL COLORECTAL CARCINOfiFNFSTS
Within the rodent kingdom the spontaneous development of 
tumours is  uncommon and especially  so for colonic lesions. Miwa, 
Takenaka, I to  et a l .(1976) describe a spontaneous occurrence of 
colonic tumours (not necessarily carcinomas) of less than 1%. The 
discovery and use of the hydrazine derivatives of cycasin to 
induce tumour formation has passed into laboratory fo lk lore  and 
been adequately reviewed elsewhere. (LaMont and O'Gorman, 1978) 
The animal models fo r  colonic carcinogenesis based on these 
agents have been u t i l is e d  extensively in the laboratory and have 
confirmed much of the epidemiological studies described above.
Studies using other carcinogens have also been described 
with in te re s t in g  resu lts . Early experiments demonstrated the 
s im i la r i t y  o f induced colon tumours in rats to human lesions. 
(Spjut & N oa ll ,  1971) The s e le c t iv i ty  of some carcinogens for the 
colon was demonstrated in transposition experiments (Gennaro, 
Villanueva , Sukonthaman et a l . ,  1973) and the necessity of a 
faecal stream fo r  tumours to develop was also rapidly  
appreciated. (Spjut & Noall, 1971) Direct in s t i l la t io n  of the 
powerful mutagen N-Methyl-N'-Nitro-N-Nitrosoguanidine (MNNG) into 
the rectum also resulted in tumour formation wwhich was augmented 
by the concurrent use of a secondary b ile  acid whether free or 
conjugated. (So, Magadia & Wynder, 1973; Narisawa, Magadia, 
Weisburger et a l . ,  1974)
While assessing the experimental potential of 
dimethylhydrazine and azoxymethane, Nigro, Bhadrachari & Chomchai
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(1973) found that administering cholestyramine resulted in an 
increased y ie ld  of colonic tumours presumably due to the 
increased local concentration of b i le  acids. They gave th e ir  work 
fu r th e r  support in a la te r  study (Chomchai, Bhadrachari & Nigro,
1974) in which they demonstrated that reimplanting the b ile  duct 
to the mid small bowel also resulted in a greatly  increased 
number o f colonic tumours developing for the same reason.
D ie tary  f a t  and b i le  acids
Reddy, Weisburger & Wynder (1974) used a rat model with 
1,2-dim ethylhydrazine (DMH) as the carcinogen to examine the 
e ffe c ts  of d ie ta ry  fa t  on faecal sterol excretion and 
carcinogenesis. They found that the faecal excretion of neutral 
ste ro ls  and b i le  acids increased when the animals were given a 
high (20%) fa t  d ie t .  Tumour induction was greatest in animals on 
the high f a t  d ie t .  DMH caused a r ise  in the excretion of b ile  
acids and neutral sterols in a l l  groups regardless of d ie t .  
Paradoxically , animals on th e ir  standard laboratory d ie t  (Purina 
lab chow) had the highest levels  of neutral sterol and b ile  acid 
excretion but a level of tumour induction which was the lowest of 
any the groups. There was no obvious explanation for th is .  
Subsequently, d ie ta ry  fa t  from various sources has been 
u n iv e rs a lly  shown to increase the y ie ld  of tumours regardless of 
the carcinogen used. (Nigro, Singh, Campbell et a l . ,  1975; Reddy, 
Narisawa & Weisburger, 1976; Reddy, Narisawa, Vukusich et a l . ,  
1976; Reddy, Watanabe & Weisburger, 1977)
Reddy, Narisawa, Weisburger and Wynder (1976) used MNNG
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in germ-free rats to examine the role of deoxycholic acid in 
tumour formation. While the to ta l number of tumours induced was 
about the same, the animals which received deoxycholic acid a f te r  
MNNG administration developed more adenocarcinomas than the group 
receiving MNNG alone. Those receiving deoxycholic acid alone did 
not develop tumours and i t  was deduced that deoxycholic acid was 
behaving as a promoter of carcinogenesis in th is  model. The 
primary b i le  acids cholic and chenodeoxycholic acid, and another 
secondary b i le  acid, l ith o ch o lic  acid, were s im ila r ly  shown to 
promote MNNG-carcinogenesis. (Reddy, Watanabe, Weisburger et a l . ,  
1977; Reddy and Watanabe, 1979) Another group (Deschner, Cohen & 
Raicht, 1981) examined the e ffec t  of giving cholic acid with the 
d ie t  on N-methyl-N-Nitrosourea (MNNU)-induced rectal  
carcinogenesis. This also increased the number of tumours 
developing.
In an involved series of experiments the p o s s ib i l i ty  that  
die tary  fa t  acted as a promoter was suggested. (B u ll,  S o u ll ie r ,  
Wilson, et a l . ,  1979). Their studies using the azoxymethane 
(AOM)-rat model allowed the animals to have e ith e r  a high or low 
fa t  d ie t  for varying times before, during and a f te r  induction of 
carcinogenesis. Animals on the high fa t  d ie t  developed more 
tumours than those on the low fa t  d ie t .  The highest rate  of 
tumour induction was seen when the high fa t  d ie t  was given for  
four or more weeks a f te r  the carcinogen administration was 
complete. Thus the high fa t  d ie t  exhibited most of the features  
of a promoter - i t  was not carcinogenic by i t s e l f ;  i t  increased
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tumour incidence a f te r  AOM administration; delaying 
administration produced the same e f fe c t .  As well as confirming 
the role  of the high f a t  d ie t  th is  study gave some substance to 
the notion that colonic carcinogenesis was at least  a two-step 
process. A l a te r  study by Reddy and Maruyama (1986) supported 
the role  of d ietary fa t  as a promoting substance.
Several studies have consistently shown that unsaturated 
fats  in the d iet  are more e f f ica t ious  as tumour promoters. Reddy 
and Maeura (1984) found that colonic tumorigenesis depended 
c ru c ia l ly  on the type of fa t  and that polyunsaturated fats  
increased faecal b i le  acid concentrations. Broitman and coworkers 
(Broitman, V i ta le ,  Vavrousek-Jakuba et a l . ,  1977) l inked th e i r  
observations on tumour development to studies on the immune 
system and showed depressed immune re a c t iv i t y  associated with the 
ingestion of unsaturated fa ts .  Sakaguchi and coworkers 
(Sakaguchi, Hiramatsu, Takata et a l . ,  1984) described clear  
changes in cel l  membrane phospholipids associated with 
unsaturated fa t  consumption as well as increased tumour 
formation. They la te r  confirmed that unsaturated fats  increased 
faecal b i le  concentrations more than saturated fats (Sakaguchi, 
Minoura, Hiramatsu, et a l . ,  1986).
Not a l l  studies concurred. An exacting study of the 
e f fec t  of a l tera t ions in the quali ty  and quantity of d ietary fa t  
(Nauss, Locniskar & Newberne, 1983) could f ind no difference  
between the number, s i te  or invasiveness of the tumours developed 
in animals on e i ther  a 5% mixed f a t  d ie t ,  24% beef f a t  d ie t ,  a
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24% corn o i l  d ie t  or a 24% Crisco d ie t  ( p a r t i a l l y  hydrogenated 
f a t ) .  These workers expressed reservations about previous 
studies which had a l l  been based on unbalanced d ie ts .  
In te res t ing ly ,  they administered the carcinogen (DMH) by gavage 
whereas i t  was injected in a l l  other studies, a point which they 
subsequently examined and showed to be of no importance. 
(Locniskar, Nauss, Kaufmann et a l . ,  1985)
Dietary f ib re
While the ef fects of dietary fa t  on experimental colonic 
carcinogenesis seemed to be largely  consistent with the 
epidemiological hypotheses the e f fect  of f ib re  was somewhat less 
predictable.  Two studies on DMH-induced colon cancer (F le iszer ,  
MacFarlane, Murray et a l . ,  1978; Freeman, S p i l l e r  & Kim, 1978) 
suggested that f ib re  protected against colonic cancer 
development. Indeed there seemed to be a "graded" response with 
the tumour incidence increasing as the f ib re  content decreased. A 
simi lar  protective e f fect  of wheat bran was seen by Wilson, 
Hutcheson and Wideman (1977) who found that nei ther  the type nor 
quantity of d ietary fa t  influenced tumour development. The 
protect ive e f fec t  of d ietary f ib re  was confirmed by Reddy, Mori & 
Nicolas (1981) who observed a s ign i f icant  decrease in the number 
of animals developing tumours when diets with wheat bran and 
ci trus  f ib re  supplements were used. There was no difference  
between the two f ib re  groups.
In contrast,  one study (Bauer, Asp, Dahlqvist, et  a l . ,
1981) did not demonstrate any protect ive e f fec t  of pectin,  guar
- 15 -
gum or bran in DMH-induced carcinogenesis. Jacobs (1983 & 1984) 
found that  the e f fec t  of f ib re  depended on the time of  
administration. His experiments, although small in numbers, 
suggested that  feeding a 20% wheatbran supplement to rats during 
carcinogen (DMH) exposure resulted in a marked increase in the 
number of tumours developed. In contrast,  feeding bran a f te r  
carcinogen exposure led to a s ign i f icant  reduction in the y ie ld  
of tumours. I t  was suggested that there was an increase in the 
p r o l i f e r a t iv e  a c t i v i t y  of the colon with the bran d ie t  which had 
an addit ive e f fec t  with the hyperplasia of carcinogen 
administration.
Barnes, Clapp, Scott et al (1983) showed that the e f fec t  
of bran depended on the source with wheat bran being protect ive  
against DMH-induced colonic tumours but r ice  and soybean bran 
being in e f fec t ive .  Corn bran appeared to potent iate the e f fec t  of  
the carcinogen. The protective e f fec t  of wheat bran was only 
apparent i f  given before or shortly a f te r  tumour i n i t i a t i o n .
Trudel,  Senterman & Brown (1983) examined the e f fe c t  of  
fa t  and f ib re  simultaneously using equicalor ic  pair -feeding of  
animals. The usual lab d iet  was supplemented with cel lu lose,  
safflower o i l  or lard. The fats increased the tumour incidence 
( the fa t  type was immaterial) and cel lulose ". .counteracted the 
deleterious e f fec t  of f a t . "
The protective e f fect  of wheat bran was shown to be 
independent of faecal b i le  acid concentration by Calvert,  
K lu r f ie ld ,  Subramaniam et a l . ,  (1987).  These authors argued that
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f ib re  did not work by "dilution"  of b i le  acids but perhaps by 
another mechanism such as al tered t ra n s i t  time, al tered mucins or 
a bulking e f fe c t .  Agents causing faecal d i lu t ion  had already been 
shown not to be protect ive.  (Kar l in ,  O'Donnell & Jensen, 1980) 
Some studies have examined the ef fects  of f ib re  on the 
colonic microenvironment. Dietary f ib re  (bran) does not lead to 
any change in the tota l  faecal b i le  acids (Brydon, Tadesse & 
Eastwood, 1980) but animals on a low f ib re  d ie t  have higher 
levels  of cholic,  chenodeoxycholic and muricholic acid. The 
to ta l  b i le  acid pool does not a l t e r  and the main e f fec t  of bran 
seems to be to a l te r  the physical d is t r ibu t ion  of b i le  acids 
along the intestine since the levels of b i le  acids in the small 
in test ine  r ise .  ( ib id ) .  Shiau and Chang (1983) showed that a 
var ie ty  of f ibres - pectin,  guar gum, carrageenan and cellu lose - 
would reduce the a c t iv i t y  of colonic mucinase and B-glucuronidase 
which may explain th e i r  protective e f fe c t .  (Goldin & Gorbach, 
1976)
Galloway and coworkers (Galloway, Owen, J a r re t t  et  a l . ,  
1986) showed that tumour induction with azoxymethane was 
profoundly influenced by the dietary content of f a t  and f ib re .  
Most tumours developed when the animals received a d ie t  high in 
f a t  and low in f ib re .  The least number of tumours were seen when 
the d ie t  was low in fa t  and high in f ib r e .  Al ter ing th is  to a 
d ie t  which was high in fa t  and high in f ib re  did not a l t e r  tumour 
incidence. This, taken with the faecal b i le  acid p ro f i les  for  
each of the dietary  groups, suggested that the f ib re  content of
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the d ie t  was of primary importance.
B i l ia r y  secretion
The role of b i l i a r y  secretion has been examined by 
diversion of the b i l i a r y  secretions to the mid small bowel via a 
transposed Vaterian segment of duodenum. (Williamson, Bauer,
Ross, et a l . ,  1979) This resulted in an increased y ie ld  of  
colonic tumours no matter whether the diversion was done before 
or a f te r  the administration of carcinogen. Addit iona l ly ,  a f te r  
diversion, most tumours occurred in the caecum and metastases 
were more frequent. Oddly, there was no s ign i f ican t  change in the 
level of  faecal b i le  acids. The diversion led to colonic 
hyperplasia which may have been responsible for  the increase in 
tumour induction but s imilar  hyperplasia occurred in the ileum 
which did not have an increased tumour incidence.
The role of b i le  in carcinogenesis has been examined also 
by establishing a segment of the colon as an isolated loop 
(Th iry -Ve l la  f i s t u la )  in animals receiving a carcinogen. (Rainey, 
Davies, Bristol et a l . ,  1983) Tumour induction in such a f i s t u l a  
was generally reduced but was increased when the f i s t u l a  was 
i r r iga ted  with a solution of faeces. I r r ig a t io n  with saline or 
sodium deoxycholate solution was without e f fe c t .  In th is  instance 
deoxycholic acid was not acting as a cocarcinogen but there is 
l i t t l e  doubt that the TVF microflora must be a ltered as there is 
no faecal stream present.
Williamson and Rainey (1984) also showed that  proximal 
and dis ta l  enterectomy would increase colonic tumorigenesis with
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increased cell  turnover.  Part ia l  colectomy did not great ly  af fect  
tumour development but tumours did c luster  at si tes of  
anastamosis. Defunctioned colon (as in the Th iry -Ve l la  F istu la )  
had a reduced tumour development.
The e f fec t  of small bowel transection, 50% je juno i lea l  
resection or bypass was assessed by Scudamore and Freeman (1983) 
on small and large bowel tumours. They found that  the tota l  
number of  tumours increased in the operated animals as did the 
number of tumours per animal. This was most apparent in the group 
undergoing 50% je juno i lea l  bypass. Colonic tumours tended to 
occur more d is t a l l y .  The observed ef fects  may re la te  to 
hyperplasia or increased exposure to pancreat icobil iary  
secretions. Other workers also found that resection of the 
terminal ileum enhanced DMH tumorigenesis and increased the tota l  
faecal b i le  acids. They also noted that tumours occurred mostly 
in the d ista l  colon. (Koga, Kaibara & Takeda, 1982)
This has been contradicted by a more recent study which 
showed that small bowel resection resulted in a f a l l  in the 
faecal b i le  acids with promotion of tumour development. (Savage, 
Sian, Matthews, et a l . ,  1988)
The b i le  acid pattern in a st ra in  of ra t  with a high 
incidence of spontaneous colonic cancer has been desribed.  
(Hayashi, Amuro, Endo et a l . ,  1986) Animals with colonic tumours 
were found to have a s ign i f ican t ly  raised faecal concentration of  
deoxycholic acid when compared to animals without tumours. This 
was accompanied by a generalised reduction in the other b i le
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acids measured such that the tota l  faecal b i le  acids were no 
d i f fe r e n t  between the tumour-bearing and tumour-free groups. 
Microscopic Detail of Experimental Tumour Development.
One pa r t ic u la r ly  useful facet of the animal model is that  
i t  allows the study of the development of tumours and has made 
possible the study of the mucosal changes associated with 
carcinogenesis.
The gross and microscopic features of human colorectal  
carcinoma are well recognised and are extensively described in 
standard textbooks. The re lat ionship between the colonic adenoma 
and carcinoma has presented an enigma which is of some importance 
c l i n i c a l l y  and is central  to consideration of the role of b i le  
acids and bacteria in colonic carcinogenesis, (page 9)
I t  is established that colonic adenomas have a 
re lationship  in time and d is t r ibut ion  to colonic carcinomas. 
(Grundmann, 1985) There are also certain polyposis syndromes 
which are associated with the premature development of cancer. 
(Neel, 1971; Bulow, 1984) In an extensive review Enterl ine (1976) 
submitted that ,  i f  the true v i l lous adenoma is ignored since i t  
has never been part of the issue, then there is good evidence 
that adenomas mirror the subsite d is t r ibu t ion  of  colonic 
carcinoma and that they exhibit  a range of changes from focal  
atypia to frank carcinoma. The minute carcinoma is ra re ly ,  i f  
ever, discovered independent of an adenoma. In addit ion the peak 
incidence of adenoma predates that of carcinoma by about f ive  
years which would be a feasible  " latent" period for  the
- 20 -
development of c l in ica l  carcinoma. Morson (1984) and Day (1984) 
also support th is  view.
The changes in the mucosa around a neoplasm have received 
some attent ion since they may give some insight into the 
precursor changes in the development of carcinoma. Histochemical 
studies have c lear ly  shown changes in the type of mucin 
production in areas which are neoplastic.  Essent ia l ly  th is  
comprises a r e la t iv e  increase in the amount of sialomucin 
produced. Moreover, th is type of change can be demonstrated in 
what is h is to log ica l ly  normal colonic mucosa. ( F i l ip e  &
Branfoot, 1974 & 1976; Jass, Strudley & Faludy, 1984)
U1trastructural examination of the mucosa adjacent to the 
carcinoma has shown that marked abnormalities of structure and 
organisation exist  in areas of apparently normal epithelium.  
(Riddel & Levin, 1977; Traynor, Costa, Blumgart, et  a l . 1981)
In a l l  studies which have examined the pathological  
anatomy and histology of experimental tumours i t  seems clear  that  
the animal tumours closely r e f le c t  the human s i tua t ion ,  (e .g .  
Ward, Yamamoto & Brown, 1973; Nigro, Sardesai, Chomchai et a l . ,  
1973; Reddy, Narisawa, Weisburger et a l . ,  1976). A detai led  
comparison between human tumours and those induced experimentally  
in animals using DMH, AOM and methylazoxymethanol (MAM) has shown 
s im i la r i t i e s  in the general morphology, patterns of invasion,  
association with adenomas and the greater invasiveness of  
mucinous tumours. Dist inct  differences also ex ist  in the 
experimental s i tuat ion such as the occurrence of multip le
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tumours, an association with Peyer's patches, a lesser  
invasiveness of non-mucinous tumours and the development of  
extra-colonic  tumours. Nonetheless " . . th e  comparison is dominated 
by a s t r ik ing  overall  histological resemblance between the two 
groups." (Ross, 1982)
Cell Kinetics and Neoplastic Change.
The organised structure of the colonic epithelium and the 
rapid turnover of the cel ls  has lent i t s e l f  to extensive studies 
of the cel l  k inet ics.  I t  is well established that  the colonic 
epithelium derives from the p r o l i f e r a t iv e  zone occupying the 
lower one th ird  of the colonic crypt in man (Lipkin,  1971) and 
rodents (Wright, 1978). From here the cel ls  migrate and 
d i f f e r e n t ia te  to become mature, non-dividing enterocytes on the 
e p i th e l ia l  surface. Cell k inet ic  studies using thymidine 
labe l l ing  and stathmokinetic arrest has shown that the cel l  
turnover exhibits a diurnal rhythm and varies along the length of  
the colon. Studies on the p ro l i fe ra t io n  of normal and neoplastic  
ce l ls  in human colon (Lipkin, 1971) have suggested that carcinoma 
ce l ls  p ro l i fe ra te  at rates equal to or slower than normal ce l ls .  
The histological changes occurring in the animal mucosal 
structure have been examined by several authors. (Deschner, 1974; 
Lipkin, 1974; Maskens & Deschner, 1977; Pozharisski, 1975; Barkla 
& Tutton, 1977; Shamsuddin & Trump, 1981; Shamsuddin, 1982; 
Kikkawa & Sasai, 1982; Pan, Hamilton, Hyland et a l . ,  1985) These 
detai led studies have demonstrated in animals (mice and rats)  and 
in some cases, in man, a clear  set of events occurring in the
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colonic mucosa pr ior  to tumour development. Essent ia l ly  there is 
a s h i f t  of the DNA synthetic ce l ls  to occupy the whole colonic 
crypt and the repopulation of the crypt and mucosa by act ive ly  
dividing ce l ls .  Various categories of l ig h t  and electron  
microscopic changes have been depicted which a l l  appear to be 
re lated to abnormal ep i th e l ia l  maturation and div is ion .  Such 
changes have also been seen adjacent to human carcinomas.
However, none of the studies in experimental animals have 
demonstrated an adenoma-carcinoma sequence.
In contrast,  a study using the scanning electron  
microscope (Cooke, Kirkham, Stainthorp, et a l . ,  1984) has shown 
the development of lesions around the mouth of the colonic crypts 
which the authors re fer  to as "microadenomas" and were found as 
early  as f ive  weeks a f te r  start ing carcinogen treatment. They 
take th is  as being supportive evidence for  an adenoma-carcinoma 
sequence.
In an experimental study with a l i t e r a t u r e  review Maskens 
and Dujardin-Loits (1981) concluded that experimental tumours in 
rats arose de novo without a pr ior  adenoma and that  adenomas 
behaved as d is t in c t  e n t i t i e s .  However they did note that the 
mouse model was more akin to the human s i tuation since a range of  
lesions are seen. The changes in the epithelium of the mouse 
colon have been described extensively by Chang (1984) who found 
lesions to arise both de novo and from within adenomas.
The e f fec t  of carcinogen administration on the colonic 
e p i th e l ia l  cel l  kinetics has been described. (Wright, 1983)
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I n i t i a l l y ,  there was inh ib i t ion  of DNA synthesis with necrosis of  
the crypt ce l ls  in the p r o l i f e r a t iv e  region. A compensatory 
p r o l i f e r a t iv e  response followed leading to crypt hyperplasia and 
by one week normality returned. Chronic administration of a 
carcinogen led to a var ie ty  of hyperplastic changes. The 
labe l l ing  index increased associated with an expansion of  the 
p r o l i f e r a t iv e  zone to the top of the crypt.  The growth fraction  
in the hyperplastic crypts f e l l  as did the colonic cel l  cycle 
time. The overall  kinetics remained about the same. The cel l  
b ir th  rate in the p ro l i f e ra t iv e  zone f e l l  but the cel l  cycle time 
tended to remain constant in th is zone and the resultant  f a l l  in 
the growth f ract ion was due to a f a l l i n g  growth f ract ion  within  
the p r o l i f e r a t iv e  compartment.
Deschner (1982) described a s imilar  series of changes and 
divided them into three stages. She and Wright agree that such 
hyperplastic crypts have a selective advantage over others in 
allowing them to express neoplastic transformation and Wright 
proposes that a slowly cycling transformed cel l  evolves which 
gives r ise  to subsequent tumours.
Tutton and Barkla (1976, 1980a, 1981, 1982) have examined 
the ra t  - DMH model kinetics extensively by stathmokinetic  
methodology. They showed that t reat ing rats with DMH led to 
marked enlargement of the crypt cel l  circumference and elongation 
of the p ro l i f e r a t iv e  zone at the base of the crypt.  (1976) They 
went on to show that there was evidence of autonomic control over 
the p ro l i fe ra t io n .  (1980a) In 1981 they demonstrated that
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adrenalectomy almost abolished cel l  div is ion in tumours and that  
i t  was restored by hydrocortisone but normal cel l  d iv is ion seemed 
to be unaffected. They demonstrated a s imilar  dependency of 
tumour div is ion on androgens (1982) and other workers had shown 
the presence of androgen receptors in DMH-induced tumours.
(Mehta, Fricks & Moon, 1980)
Deschner, Cohen and Raicht (1981) showed that feeding 
cholic acid to rats in th e i r  d ie t  s ig n i f ic a n t ly  increased the 
thymidine labe l l ing  of the crypts and subsequently to enlargement 
of the p ro l i f e ra t iv e  zone and elongation of the crypt.  These 
ef fects  were are due to deoxycholic acid since cholic acid is 
metabolised to deoxycholic acid in the colon.
The evidence to date reinforces the concept that the 
experimental animal model of tumour development is broadly 
simi lar  to the human si tuat ion and is under s imi lar  control.  The 
question of the adenoma-carcinoma sequence has not been f u l l y  
resolved but there is a str ik ing lack of supportive evidence for  
i t  in the animal model.
Other features of the experimental model.
The ra t  model has been explored in more diverse ways. Two 
observations are of in terest .
In 1983 Summerton, Flynn, Cooke & Taylor demonstrated the 
presence of specif ic deoxycholic acid receptors in a high 
percentage of human colonic tumours. This was subsequently 
demonstrated to be true in the animal model (Summerton, Goeting, 
Tro t te r ,  et a l . ,  1985) and i t  was shown at the same time that
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tumour incidence increased by administering rectal  deoxycholic 
acid with parenteral carcinogen. The authors speculated that the 
receptor had a role in promotion - in p a r t icu la r  the change from 
adenoma to carcinoma.
Barthold and Jonas (1977) exploited the suscep t ib i l i ty  of  
the mouse to a specif ic variant of Citrobacter  f reundi  which 
causes severe, t ransient  hyperplasia of the d is ta l  colon. 
Administration of th is agent led to a decrease in the la ten t  
period to the development of tumours. There was no e f fec t  on 
established lesions.
As regards the re lationship of f a t ,  f ib r e ,  b i le  acids and 
tumour development an underlying problem has always been the 
mechanism involved. I f  the dietary contents or b i le  acids do not 
d i r e c t ly  act on the colonic mucosal cell  then by what means do 
they influence it?  In part ia l  answer to this i t  is worthwhile 
considering two systems - the ka l1ik re in -k in in  system and the 
prostaglandins. Both of these systems have been shown to have a 
role in c e l lu la r  communication and to be involved with c e l lu la r  
p ro l i fe ra t io n  and the development of the neoplastic state .
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THE KALLIKREIN-KININ SYSTEM
The ka l l ik re ins  (EC 3 .4 .21 .8 )  can be defined as those 
serine proteases which l ibe ra te  kinins from kininogen by l imited  
proteolysis and which have l i t t l e  or no proteoly t ic  a c t i v i t y  on 
other proteins. (Pisano, 1975) All  mammals studied to date have 
two ka l l ik re in s  - glandular (or t issue) and plasma - which d i f f e r  
in physicochemical properties, rates of reaction with kininogens 
and synthetic substrates, the kinins produced and the response to 
a var iety  of natural and synthetic inh ib i tors .
The discovery and characterisation of k a l l i k r e in  and i ts  
product bradykinin have become part of pharmacological history  
and need not be reviewed here as they are covered comprehensively 
elsewhere. (Werle, 1970; E l l i o t ,  1970; Schachter,1980; F r i t z ,  
1983)
The serine proteases are a broad group of enzymes which 
are active at neutral pH and require no cofactors (Barre t t ,
1980). The group includes enzymes such as trypsin, chymotrypsin, 
elastase, thrombin and plasmin. (Schachter, 1980) Not a l l  serine 
proteases are capable of cleaving kininogen - the substrate of  
k a l l ik r e in  - to form a kinin but k a l l i k r e in ,  trypsin and plasmin 
may do so. Kall ik re ins are unique in that they show v i r t u a l l y  no 
proteoly t ic  a c t iv i t y  on any other protein.
Glandular or tissue k a l l ik re in  is an heterogeneous group 
of acidic glycoproteins of MW 24000 - 43600. (Pisano, 1975) I t  
acts on two substrates - High MW Kininogen and Low MW Kininogen - 
to form k a l l id in  ( lys -bradyk in in ) . Plasma k a l l ik r e in  is a basic
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glycoprotein of  MW 100000 acting only on High MW kininogen to 
form bradykinin. Plasma k a l l i k r e i n  ex ists  as an inact ive  
precursor which is act ivated by l im i ted  proteolysis  by act ivated  
Hageman fac to r  or by t ryps in .  ( F r i t z ,  1983)
Bradykinin is a nonapeptide of short h a l f - l i f e  which is 
rap id ly  inact ivated by kininases which are widely d is t r ib u te d .  
(Erdos and Yan, 1970) I t  has been shown to have many propert ies;
- vasodi la tat ion ( E l l i o t ,  1970 , Haddy, Emerson, Scott,  
et a l . ,  1970)
- contract ion of the longitudinal  muscle of  the
jejunum, ileum and taenia c o l i ;  re laxa t ion  of  the
c i r c u la r  muscle of the ileum and colon (Fishlock,
1968)
- vasodi la ta t ion  of  the stomach and gut with an
increase in gas tr ic  secretion due transudation of
e x t r a c e l lu la r  f l u i d .  (Jacobsson, 1970)
- renal a r t e r i o l a r  d i l a t a t i o n  and n a t r iu re s is  
(Jacobsson, 1970)
- increased sa l ivary  secretion and bronchoconstriction.  
(Pisano, 1975)
- st imulat ion of ce l l  p r o l i f e r a t io n  in bone marrow, 
e p i t h e l ia l  basal c e l ls  of  tongue and in the 
gastro in tes t ina l  t r a c t  (Pisano, 1975).
Much work has been done on the d is t r ib u t io n  and 
l o c a l is a t io n  o f  k a l l i k r e i n  w ith in  the t issues.  Kinin-forming  
a c t i v i t y  was shown in a l l  areas of  the g as tro in tes t in a l  t r a c t  by
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Amundsen and Nustad (1965) although this was not sp e c i f ica l ly  
k a l l ik r e in  a c t i v i t y .  In terest ingly  they demonstrated the presence 
of kininase a c t iv i t y  in a l l  the t issues they examined which 
included ones without kinin-forming a c t i v i t y .  The kinin-forming  
a c t iv i t y  was thought to reside in c e l lu la r  granules and was 
fur ther  demonstrated in salivary glands, pancreas and urine 
(Webster, 1970). Orstavik (1978 & 1983) showed the presence of  
k a l l ik re in  in rat  submandibular and sublingual glands and 
pancreas. He subsequently demonstrated that i t  resided in the 
secretory granules of the tubular ce l ls  and the pancreatic acinar  
c e l ls .  This was subsequently shown to be true in the pig and in 
human pancreas. (Amouric, De La Porte, Colomb et a l . ,  1983). In 
the ra t  kidney glandular k a l l ik re in  was found in the d ista l  
tubular ce l ls  (Nustad, Orstavik,  Gautvik, et a l . ,  1978). 
Immunofluorescent local isat ion  of glandular k a l l i k r e in  (Fink,  
D ie t l ,  Se i fe r t ,  et a l . ,  1979) fa i led  to show any d e f in i te  
local isat ion  in the kidney although k a l l ik re in  was present in 
blood and excreted by the kidney. Human tissue k a l l ik re in s  have 
been isolated from duodenal ju ice ,  urine, large in tes t ine ,  blood 
plasma and seminal plasma and have been shown to be ident ical  
with each other and similar to porcine pancreatic k a l l i k r e in .  
(Geiger, Hofman, Franke, et a l . ,  1983)
Following the work of Amundsen & Nustad, Z e i t l i n  (1971) 
investigated the nature of the kinin-forming a c t i v i t y  of ra t  
in test ina l  mucosa and showed that the kinin-forming enzyme was 
d is t in c t  from trypsin, plasmin, plasma k a l l ik r e in  and rat
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pancreatic k a l l ik r e in .  He also showed that the a c t i v i t y  was 
almost completely inhibi ted by the proteinase in h ib i to r  
aprot in in,  s l ig h t ly  inhibi ted by soybean trypsin inh ib i to r  
(unlike plasma k a l l ik re in  which was completely inhib ited)  and was 
unaffected by a specif ic trypsin inh ib i to r .  Other workers showed 
that  normal human colon t issue and that from colon adenocarcinoma 
contained kininogenase a c t iv i t y  which existed at least  in part as 
a p re -k a i l i k re in .  (Seki, Nakajima & Erdos, 1972).
The plasma and tissue enzymes were l a te r  shown to be 
d is t in c t  en t i t ies  with the t issue enzyme having a molecular 
weight (MW) of 33000 and the plasma enzyme a MW of 61500 and 
125000. ( Z e i t l i n ,  Singh, Lembeck, et a l . ,  1976)
Studies in the human ( Z e i t l in  & Smith, 1973) showed that  
in the normal human colon k a l l ik re in  a c t i v i t y  resided in the 
mucosa while the kininogen resided in the muscular layers of the 
bowel wall .  Colonic t issue involved by d iv e r t ic u la r  disease was 
indistinguishable from normal but t issue from pat ients with 
ulcerat ive c o l i t i s  had high levels of k a l l ik r e in  a c t i v i t y  in the 
the colonic muscle while the mucosal levels were r e la t i v e ly  
unchanged. Intervening, unaffected t issue was normal and the 
change was thought to be due to an increase in permeabil i ty of 
the colonic wall due to the inflammatory process which may, in 
part ,  be related to the production of kinins lo c a l ly .
Frankish and Z e i t l i n  (1977a) demonstrated that b i le  salts  
(deoxycholic acid) stimulated the release of k a l l ik r e in  from 
str ips of duodenum in v i t ro .  This was not a simple detergent
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e f fe c t .  The levels of k a l l ik re in  a c t iv i t y ,  as determined by 
bioassay, in the duodenum could be increased by fasting the 
animal (Frankish & Z e i t l i n ,  1977b & 1980). S imi lar ly  the level  
of kinin-forming a c t iv i t y  in the duodenum was increased by giving 
the animal ( ra t )  only water for 24 hours but the levels of 
a c t iv i t y  in the caecum f e l l  while those in the d is ta l  colon rose. 
Giving glucose only for 60 hours resulted in duodenal levels  
s l ig h t ly  greater than normal, caecal levels which were 
considerably lower than normal and dista l  colon levels which were 
r e la t i v e ly  high in comparison to normally fed animals.
Using a glandular k a i l ik re in -s e le c t iv e  chromogenic 
substrate,  Al-Dhahir & Z e i t l i n  (1982 & 1983) showed that d i rect  
i n s t i l l a t i o n  of b i le  salts in physiological concentrations into  
the colonic lumen in v i t r o , led to a large increase in the 
k a l l ik re in  a c t iv i ty  of the i n s t i l l  ate associated with a f a l l  in 
the t issue glandular ka l1ikre in -1 ike  a c t i v i t y .  They also showed 
that  the macroscopic changes of b i le  i n s t i l l a t i o n  - oedematous 
congested mucosa with haemorrhagic discharge - were inhib ited by 
the concurrent administration of aprotinin which t o t a l l y  
inhibited tissue glandular k a l l ik re in  a c t iv i t y .
Aprotinin.  Protease Inhibitors and Tumour Formation.
Aprotinin is a broad-spectrum protease in h ib i to r  which 
was o r ig in a l ly  ident i f ied  in the pancreas of the cow by Kunitz 
and Northrop in 1935 . I t  has been described in several species 
and in a var iety  of organs; an aprot inin-1ike in h ib i to r  has also 
been isolated from human serum. I ts  structure, inh ib i tory
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character is t ics ,  spectrum of a c t iv i t y  and the molecular 
mechanisms have been extensively reviewed ( F r i t z  & Wunderer,
1983). Aprotinin exhibits a c t iv i t y  against several enzymes 
including trypsin, chymotrypsin, plasmin, plasma k a l l ik r e in  and 
t issue k a l l ik r e in .  In biochemical research aprotinin has been 
useful as an aid to protease pur i f ica t ion ,  molecular weight 
estimation and in the estimation of k a l l ik r e in  a c t i v i t y .  I t  has 
also some other properties of interest  in c e l lu la r  systems - in 
par t icu la r  i t  can inh ib i t  the growth of malignant transformed 
ce l ls  and may depress the growth and invasiveness of tumours. I t  
may also improve immunity by acting on lymphocytes.
In cel l  culture normal ce l ls  grow to a monolayer and 
stop. Resting cel ls  can be triggered into mitosis by hormones, 
lect ins or proteases. (Verloes, Atassi,  Dumont, et  a l . ,  1978) 
Tumour cel ls  in culture do not stop growing and i t  has been 
proposed that they carry or can secrete th e i r  own mitot ic  
protease. The f ie ld  of protease inhib itors and malignant cel l  
growth has been a f r u i t f u l  one for researchers and w i l l  be 
b r ie f l y  reviewed with respect to aprot inin.
The interest  in the effects of protease inh ib i tors  on 
carcinogenesis arose from work on skin carcinogenesis in the 
mouse. In the two-stage model of skin carcinogenesis, the 
application of the tumour promoter 12-0-tetradecanoyl-phorbol-13 
acetate resulted in the appearance of a t ry p s in - l i k e  protease. A 
var ie ty  of protease inhib itors were e f fe c t ive  anti-tumour agents. 
The development of th is research has been reviewed by Rossman and
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Trol l  (1980).
In 1970, Burger reported that adding small amounts of  
trypsin to mouse f ibrob las t  ce l ls  in culture lead to th e i r  escape 
from contact inh ib i t ion  with renewed division and cel l  
overgrowth. Adding a trypsin inh ib i to r  (ovomucoid) prevented the 
escape phenomenon. He observed that the changes at the cel l  
surface resembled those occurring in chemical or v i ra l  
transformation of normal cel ls  to malignant ones. A s imilar  
phenomenon was seen in embryonic chick cel l  cul ture (Sefton & 
Rubin, 1970).
Schnebli and Burger (1972) subsequently examined a range 
of compounds whose only common feature was th e i r  
proteinase- inhib itory a c t iv i t y .  These were
1. Tosyl-arginine methyl ester (TAME)
2. Tosyl-phenylalanyl-chioromethyl ketone (TPCK)
3. Tosyl- lysyl-chioromethylketone (TLCK)
4. Soybean trypsin inh ib i to r  (SBTI)
5. Ovomucoid
6. Aprotinin.
Using transformed mouse f ibrob las t  and baby hamster 
kidney cel ls  i t  became clear  that the growth of transformed ce l ls  
was inhibi ted in a dose-dependent fashion by a l l  the inh ib itors  
except SBTI. Untransformed cel ls  were unaffected by the 
inh ib i tors .  They concluded that the transformed ce l ls  required a 
protease-l ike a c t iv i t y  to exhibit  unrestrained growth. Another 
group using the same inhib itors with transformed hamster ce l ls  in
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culture made the same observations (Goetz, Weinstein & Roberts, 
1972).
SBTI was shown to promote the adhesion of Ehrl ich ascites 
ce l ls  to the host peritoneum in a way not usually encountered 
(Whur, Robson & Payne 1973). This was considered to be due to 
inh ib i t ion  of in t r in s ic  proteolyt ic  a c t iv i t y  and that the 
abnormal growth rates and adhesive properties of tumour cel ls  are 
related to modifications of the cell  surface binding si tes by the 
a c t iv i t y  of in t r in s ic  proteases.
In contrast to the above, Mcllhinney & Hogan (1974) found 
variable  and contradictory effects of TPCK and aprotinin on the 
growth of normal and transformed baby hamster kidney ce l ls  in 
vivo , such that they could not support the hypothesis that  
transformed cel ls  maintain th e i r  higher growth rate by increased 
proteolyt ic  a c t iv i ty .
Latner, Longstaff & Pradhan, (1973) took a more d irect  
approach to show that aprotinin could inh ib i t  invasion of  
subsequent kidney explants by transformed c e l ls .  They further  
showed (Latner,  Longstaff & Turner, 1974) that aprotinin could 
decrease the invasiveness of tumours implanted into test  animals 
but the e f fect  depended on the route of administration with the 
intraperitoneal  route apparently stopping invasion while the 
local administration led to reduced invasion and increased 
necrosis.
Latner and Turner (1976) demonstrated that aprotinin  
slowed the development of a second implanted tumour in hamsters
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and decreased the number of metastases. In terest ing ly ,  pr ior  
inoculation with cortisone abolished the effectiveness of  
aprot inin .  A role for  the immune system was proposed.
The other side of the problem was addressed by Bosmann & 
Hall (1974) when they examined the enzymic a c t i v i t y  of malignant 
human breast and colon tumours compared with control t issue.  
Malignant tumours had increased a c t i v i t y  of several enzymes 
including proteases. The increased enzymic a c t i v i t y  represented 
increased degradative capacity which could be responsible for  
tumour character is t ics.
LeBlanc & Back (1975a & b) made an extensive study of  
proteases during the growth of Ehrlich ascites tumour. They 
confirmed the production of plasminogen act ivators by tumour 
ce l ls  and went on to demonstrate the presence of prekal1ikre in  in 
asc i t ic  f lu id  from the tumours. Kininogen was also present in 
levels  which increased with tumour growth. The asc i t ic  f lu id  had 
kinin-forming a c t iv i t y  which was eightfold that of plasma and 
th is  a c t iv i t y  was inhibited by aprotinin,  SBTI and heparin.  
Kininase a c t iv i t y  was i n i t i a l l y  high, f e l l  o f f  and then rose 
again suggesting that kinin a c t iv i t y  acted only at cer tain phases 
of tumour growth - perhaps a l ter ing  cap i l la ry  permeabil i ty.  Other 
workers showed that SBTI inhibited the growth of the ascites  
tumour in a dose dependent fashion. (Verloes & Kanarek, 1976)
With the knowledge that specif ic kinin-forming enzymes 
could be isolated from solid rodent tumours, ascites tumours and 
rodent f ibroblasts Back & Steger (1976) examined the ef fects  of
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three protease inhibitors - aprotinin,  e-aminocaproic acid (EACA) 
and heparin - on tumour growth. Aprotinin and heparin were 
ef fec t ive  in reducing tumour growth. Changes in the kinin-forming 
system were documented which suggested that the tumour-inhibitory  
a c t iv i t y  of aprotinin was related to " ef fects  on the 
kinin-forming enzyme system. . . .  aprotinin apparently interfered  
with the a b i l i t y  of the tumour to u t i l i s e  prekal1ik re in  and 
kininogen"
The effects of aprotinin in vivo were not always so 
str ik ing .  Thomson and coworkers (Thomson, Pugh-Humphreys, Horne 
et a l . ,  1977) injected aprotinin into the peritoneal cav ity  of  
rats inoculated with tumour cells from a var iety  of routes and 
found no increase in survival but a part ia l  attenuation of the 
effects  of the tumour. Turner and Weiss (1981) reported that  
aprotinin could enhance the metastatic capacity of a lung 
tumour.
Koppelman, Moore and Porter (1978) assessed the e f fec t  of  
direct  injection of bradykinin into a hamster sarcoma on the 
plasma ka l l ik re in  a c t iv i t y .  Bradykinin reduced the tumour growth 
and produced a marked mononuclear i n f i l t r a t e  into the tumour. 
Animals which were inoculated with the tumour but which did not 
develop lesions had higher levels of plasma k a l l ik r e in  than those 
which did develop the tumour. Contrariwise the level of 
k a l l ik re in  inh ib i to r  in those not developing tumours was lower 
than those which did. Injection of bradykinin produced an 
increase in the plasma ka l l ik re in  a c t iv i t y .  Thus the plasma
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k a l l ik re in  was reduced by tumour progression and growth of  
established tumours was slowed by bradykinin.
Human and experimental colonic tumours have been 
part ly  examined. An early study (Goldberg, McAll ister  & Roy,
1969) found decreased proteolyt ic  a c t iv i t y  in human colonic 
tumours. The capacity of colonic carcinoma tissue to produce 
plasminogen activators has been found to be both increased 
(Corasanti, Celik,  Camiolo, et a l . ,  1980; Tissot,  Hauert & 
Bachmann, 1984) and decreased (Gel is ter ,  Mahmoud, Lewin, et a l . ,  
1986) when compared to normal colonic t issue. The l a t t e r  group 
found the carcinomas had a raised level of urokinase. Plasminogen 
activators are of interest  since plasmin is a prekal1ikre in  
act ivator  and therefore activat ion of plasminogen may ul t imate ly  
r e f le c t  activation of ka l l ik re in  and kinin formation. Corasanti,  
Hobika & Markus (1982) reported that giving e-aminocaproic acid 
(EACA) to mice in drinking water conferred s ign i f icant  protection 
for  colonic carcinoma induced by dimethyl-hydrazine (DMH).
In summary i t  may be said that there is a considerable 
body of evidence to implicate protease enzymes in tumour 
development and metastasis and k a l l ik re in  may be involved in th is  
process e i ther  d i rec t ly  as a protease or through i ts  specif ic  
product bradykinin.
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PROSTAGLANDINS
The prostaglandins are an extensive family of compounds 
derived from 20-carbon polyunsaturated fa t ty  acids - p r inc ipa l ly  
arachidonic acid. They are present in some form in every t issue  
of the body examined to date. The history of the discovery and 
understanding of this diverse and important group of substances 
has been reviewed. (Moncada & Vane, 1983; Crawford, 1983). The 
i n i t i a l  descriptions of these substances came from von Euler and 
Goldblatt  in the 1930's but i t  was to be over three decades 
before the relationship between the prostaglandins and the 
essential  fa t ty  acids from which they were derived was 
established. Of a l l  the at tr ibuted effects of prostaglandins 
three part icu la r  areas have come to be p a r t ic u la r ly  well-studied:  
the role of the prostanoids in mediating the inflammatory 
process, the role of the prostaglandin endoperoxides in p la te le t  
aggregation and vessel wall protection, and the description of  
the lipoxygenase products and th e i r  role in chronic inflammation 
and asthma.
In vivo and in vi t ro  the prostanoids (= eicosanoids = 
cyclo-oxygenase products (COP) ) are synthesised and catabolised  
within the same tissue and probably within the same group of  
cel ls  and as such are correctly  c lass i f ied  as local hormones 
(Bakhle, 1983). The pivotal  point in the metabolic cascade of the 
eicosanoids is the enzyme cyclo-oxygenase which mediates the 
conversion of the fa t ty  acid into the cyc lic  endoperoxide 
precursors of the common prostaglandins. The overall scheme of
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the reactions is shown as Fig 1. In essence arachidonic acid is 
l ibera ted from cell  membranes by the action of phospholipase and 
converted by cyclo-oxygenase into i ts  respective products. A 
proportion is converted by the lipoxygenase pathway into a 
separate group of products - the leukotrienes.
Cyclo-oxygenase a c t iv i ty  is widely d istr ibuted but the 
mixture of products formed shows marked sp e c i f ic i ty  for  c e l l ,  
t issue and species. In the gastrointest inal t ra c t  E and F 
prostaglandins have been found in a l l  tissues examined. (Bennett 
& Fleshier,  1970) L i t t l e  is known about the d is t r ibu t ion  within  
the gut wall nor the c e l lu la r  location. The main ef fects  of  
prostaglandins are to contract the longitudinal muscle and relax  
the c i rcu lar  muscle coats although the effects were not e n t i re ly  
constant. In the human i t  was shown that PGE£ was the main type 
of prostaglandin present in the stomach and colon and that  
mucosal levels were lower than those in muscle of the colon but 
the converse was true in the stomach. (Bennett, Stamford & 
Stockley, 1977). Exposing gastrointest inal homogenates to a 
hypertonic environment results in an increase in prostanoid 
production from stomach, jejunum or colon (Knapp, Oelz, Sweetman 
et a l . ,  1978). Again, PGE^  was the main prostanoid recovered 
although PGF2a and PGD^  were also detectable.
In a remarkable and comprehensive series of experiments 
Craven and DeRubertis examined the relat ionship between colonic 
mucosal cel l  turnover, cyclic monophosphates and the 
prostaglandins. They showed (DeRubertis, Craven & Saito,  1980)
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that  administering the colonic carcinogen MNNG to isolated  
colonic ep i the l ia l  str ips produced an increase in the production 
of cGMP but did not a f fect  cAMP. The b i le  sa l t ,  sodium 
deoxycholate, could stimulate cAMP production by the ep i th e l ia l  
str ips when present in high concentration but in low 
concentration only potentiated the e f fect  of MNNG on cGMP. In the 
colonic epithelium neoplastic change was associated with a f a l l  
in the levels of cAMP and raised or normal levels of cGMP.
(Craven & DeRubertis, 1981) They examined the cyclic  nucleotide 
metabolism of rat colonic ep i the l ia l  ce l ls  by sequential ly  
scraping the mucosa. Incorporation of t r i t i a t e d  thymidine was 
greatest in the cells from the scrapings from the deeper regions 
of the p i ts .  cAMP and cGMP levels were lower in the deep 
scrapings when compared with superficial  scrapings; basal 
adenylate cyclase a c t iv i ty  was higher than the superfic ia l  ce l ls  
and could be stimulated by sodium f luoride,  PGE^  and VIP. 
Guanylate cyclase a c t iv i ty  was highest in the superfic ia l  
scrapings. cAMP, PGE^  and VIP produced a reduction in the uptake 
of t r i t i a t e d  thymidine by colonic segments; cGMP was without 
e f fe c t .  The authors noted that the lower cyc lic  AMP levels of  
rapidly  pro l i fe ra t ing  ep i the l ia l  cel ls  was " . .  analogous to the 
change observed in human and experimental colonic tumours" and 
that  the reduction in cell p ro l i fe ra t ion  induced by dibutyryl  
cyclic  AMP and prostaglandin E2 was consistent with an 
inh ib itory  influence of cAMP on p ro l i fe ra t io n ."
In further  experiments on the colon they examined the
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prostanoid production by the intact  colon, by colon devoid of  
epithelium and of the ep i the l ia l  cel ls  alone. (Craven & 
DeRubertis, 1983). This showed that while PGE^  was the most 
abundant prostanoid formed in tota l  i t  was v i r t u a l l y  a l l  formed 
in the submucosa. In contrast, the mucosal ep i th e l ia l  ce l ls  
contained 71% of the total  degradative capacity and the 
superfic ia l  cel ls  were sixfold more active in degrading PGE2 than 
the deep ce l ls .  In te restingly ,  adding exogenous arachidonic acid 
led to increased PGF2a in the ep i the l ia l  ce l ls  and adding 
deoxycholate - which stimulates prostanoid synthesis by enhancing 
arachidonate release - produced a similar e f fe c t .  This l a t t e r  
result  was followed up in 1984 (DeRubertis, Craven and Saito,
1984) when they examined the ef fect  of b i le  sa l t  st imulation of 
colonic pro l i fera t ion  and the role of arachidonic acid 
metabolites. Their results showed that b i le  salts (deoxycholic 
acid, chenodeoxycholic acid and cholic acid) increased the 
release of arachidonic acid by the colon in v i t ro .  I n s t i l l a t i o n  
of deoxycholic acid into the rat  colon produced an increased 
uptake of t r i t i a t e d  thymidine in vivo and when the colon was 
incubated thereafter  in vi t ro  prostanoid production was elevated 
as was the production of 12-HETE, a lipoxygenase product ( f ig  1).  
Indomethacin reduced the prostanoid production and enhanced the 
the thymidine uptake increase produced by the b i le  acid. Thus i t  
seems possible that the lipoxygenase products have a role to play 
in modulating the turnover of the colonic epithelium.
An examination of the human colon (Boughton-Smith, Hawkey
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& Whitt le,  1983) showed that i t  could synthesise cyclo-oxygenase 
products from added radiolabelled arachidonic acid with PGE^  
being the principal product. In addition lipoxygenase products 
were also formed and inflammed mucosa from c o l i t i c  patients  
produced more of a l l  products. The chemotactic and chemokinetic 
properties of the lipoxygenase products could well be responsible 
for  the inflammatory manifestations of the disease and could 
explain why inhibitors of cyclo-oxygenase are ine f fec t ive  in the 
disease in spite of the raised levels of prostaglandin 
production. (Sharon, Ligumsky, Rachmilewitz et a l . ,  1978; Harris,  
Smith & Swan, 1978; Rampton & Sladen, 1981) Indeed, inh ib i tors  of  
cyclo-oxygenase may aggravate the disease. (Hawkey and Truelove,  
1983)
Prostaglandins and Tumours.
The evidence l inking the prostaglandins and tumours was 
i n i t i a l l y  sketchy. Jaffe reviewed the knowledge in 1974. The 
essence was that neoplastic cel ls  were known to synthesise 
prostaglandins in vivo and in vi t ro  and malignant ce l ls  produced 
more prostaglandin than normal ce l ls ,  the dominant prostanoid 
being PGE2 - Effects of prostanoids on cell  p ro l i fe ra t io n  were 
recognised (but were not to be elucidated for  some years as 
detai led above) and J a f fe 7s own work had shown that colonic 
tumours in organ culture produced eight times as much PGE2 as 
normal ce l ls .  Addit ional ly,  indomethacin, an inh ib i to r  of 
prostaglandin production delayed the establishment of inoculated 
tumours in mice.
- 42 -
The increased formation of prostanoid material  by tumours 
was also seen in human breast cancers (Bennet, Simpson, McDonald 
et a l . ,  1975) and i t  was also noted that those with bony 
metastases had par t icu la r ly  high leve ls .  (Bennett, Charl ier  & 
McDonald, 1976) Similar ly ,  elevated levels of prostanoid were 
seen in some human colonic tumours when compared with normal 
mucosa from the same individual (Bennett & DelTacca, 1975; 
Bennett, DelTacca, Stamford, et a l . ,  1977) but the pattern was 
not consistent.  Rolland and coworkers (Rolland, Martin,  
Jacquemier, et a l . ,  1980) showed that there was an inverse 
relationship between tumour size and the levels of prostanoid 
produced; metastatic lesions appeared to produce more prostanoid 
than the primary tumour. A relationship with the oestrogen and 
progesterone receptor status of the tumour was suggested. 
(Karmali, Welt, Thaler et a l . ,  1983)
Prostanoid production was not just  the preserve of breast 
and colon tumours: i t  was also demonstrated in thyroid cancer, 
neuroblastoma, phaeochromocytoma, i s le t  cell  tumours, bronchial 
carcinoma and renal cell carcinoma and several experimental 
tumours. (Levine, 1981; Smith, Wills & Savory, 1983) Moreover, in 
the fam il ia r  tetraphorbol acetate(TPA)-croton oi l  mouse skin 
cancer model i t  was recognised that TPA could stimulate several 
cel l  types to produce prostaglandins by stimulating the release  
of arachidonic acid from membrane phospholipids. Addit ional ly ,  
indomethacin could block the promoting e f fect  of TPA and th is  
could be over come by adding PGE2 (Levine, 1981; Honn, Bockmann
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& Marnett, 1981) Increased production of prostaglandins has been 
shown for  other tumour promoters. (Snoek & Levine, 1983) The 
inh ib i t ion  of tumour growth by indomethacin (and other inhib itors  
of cyclo-oxygenase) has been demonstrated on several occasions.
In 1973 aspirin and indomethacin were shown to in h ib i t  the 
development of osteolytic  tumour deposits and the development of  
hypercalcaemia in rats inoculated with Walker tumour. (Powles, 
Clark, Easty et a l . ,  1973). Humes, Cupo and Strausser (1974) 
showed that indomethacin delayed the onset of Moloney Sarcoma 
virus-induced tumours inoculated into mice and also suppressed 
the tumour growth. This was correlated with tumour prostaglandin 
production. Transplantable fibrosarcoma growth was inhib ited by 
aspirin and indomethacin (Lynch, Castens, Astoin et a l . ,  1978; 
Lynch & Salomon 1979). I t  was suggested that the role of  
indomethacin may be to unmask the tumour and allow fu l l  
expression of "anaphylactic reactions". Pollard and Luckart 
(1981a & b) demonstrated a general reduction in DMH-induced 
colonic tumorigenesis in rats by the coadministration of  
indomethacin. Bennett, Berstock & Carroll (1982) showed that the 
survival time a f te r  excision of a transplantable mammary tumour 
in mice was prolonged by both indomethacin and f lurb iprofen.  The 
tumour prostaglandins were also reduced by the treatment.
An antitumour ef fect  of indomethacin on DMH and MAM - 
induced colonic tumours in rats was shown by Pollard & Luckert 
(1983).  They showed that the inhib itory e f fec t  of indomethacin 
was demonstrable even i f  i ts  use was in i t ia te d  long a f te r  the
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inoculation of carcinogen. Indomethacin was shown to block the 
promotion of rat  colonic tumours induced by N-nitrosomethylurea 
but curiously the addition of PGE^  to the regime by in jection did 
not reverse this e f fec t .  (Narisawa, Hermanek, Habs et a l . ,  1984) 
Indomethacin inhibited the growth of transplanted experimental 
breast tumour in rats and completely abrogated the promotional 
ef fec t  of increased dietary fa t .  (Kollmorgan, King, Kosanke et 
a l . ,  1983) A high fa t  d iet  increased the incidence and size of  
7 , 12-Dimethylbenz(a)anthracene induced mammary tumours in mice. 
This ef fect  of fa t  was blocked by the coadministration of  
indomethacin. (Carter,  Mi 1 hoi 1 and, Shea et a l . ,  1983) Serum 
cortisone levels in the rats receiving indomethacin and a normal 
fa t  d ie t  were elevated but were normal in the animals on the high 
fa t  group. Cortisone would block the action of phospholipase and 
prevent the release of arachidonic acid from the cel l  membrane. 
This would lead to depressed levels of prostaglandin. High 
levels of prostaglandin are known to inh ib i t  cel l-mediated  
immunity and would be the result  of the high fa t  d ie t .  
Prostaglandins have been shown to be capable of an inh ib i tory  
influence on natural k i l l e r  cel ls  (Brunda, Heberman & Holden 
1980) and this e f fect  may be mediated by th e i r  stimulating the 
accumulation of cAMP which is associated with depression of 
lymphocyte stimulation and production, cell-mediated immunity and 
antibody formation. (Lewis, 1983). Immunosuppression in cancer 
patients is well recognised and has been documented in those with 
colorectal  cancer. (Wanebo, Baskar, Attiyeh et a l . 1980) The
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immunosuppression may be mediated by prostaglandins (PGE^) but 
not necessari ly derived from the tumour cel ls  but from the 
monocyte response. (Balch, Dougherty, Cloud et a l . ,  1984; 
A tta l lah ,  Lee, Ambrus et a l . 1984) Not surprisingly,  a possible 
role for  the potent lipoxygenase products has been proposed in 
immunoregulation. (Valone, 1983)
As regards tumorigenesis, i t  has been repeatedly 
suggested that the metabolic activat ion of the primary carcinogen 
may be linked to prostaglandin formation. This has been best 
demonstrated for  benz(a)pyrene (Sivarajah, Anderson & Eling,
1978; Sivarajah, Lasker & Eling, 1981; Craven, DeRubertis & Fox, 
1983; Krauss & Eling, 1984). The colonic mucosa microsomes have 
been shown to possess an inducible mixed function oxidase system 
capable of hydroxylation of carcinogens to mutagenic products. 
This system can be stimulated by PGE .^ (Strobel,  Fang & Oshinsky, 
1980)
I t  would not be unreasonable to presuppose a re la tionship  
between the ka i l ik re in -k in in  system and the prostanoids since 
both are involved in inflammatory processes. (Wil liams, 1983) I t  
has been shown that protease treatment of peritoneal macrophages 
w i l l  cause release of PGE^  but not in a fashion related to 
proteolyt ic  strength (Chang, Wigley & Newcombe, 1980). This 
prostanoid release can be inhibited by proteinase inh ib i tors  
( including aprot inin) .  In terest ingly ,  aprotinin w i l l  also in h ib i t  
the prostanoid release stimulated by tetradecanoyl phorbol 
acetate (TPA) - a tumour promoter.
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A relationship between the kinins and prostaglandin 
synthesis has been demonstrated in the kidney (Vio, Bednal & 
McGiff, 1983) and i t  has been proposed that bradykinin may 
control the a c t iv i t y  of phospholipase C which is essential  to the 
release of arachidonic acid from the cell  membrane. Studies in 
v i t ro  have shown that bradykinin can release arachidonic acid 
from ce l ls  in a dose-dependent fashion with accompanying 
increases in prostaglandin formation. (Juan & Sametz, 1983) Some 
of the most important interactions of the prostaglandins and 
kinins are involved in regulating the micro-c ircu lat ion to the 
metabolic demands of the t issue.
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A I M S
Existing evidence suggests that the development of  
experimental colonic cancer may depend upon a number of  
variables.  Important among these are the d ie t ,  the faecal b i le  
acids, the colonic crypt cell  p ro l i fe ra t ion  rate and the presence 
of a carcinogen. There is ample evidence to implicate also other  
agents which may interact  with these var iables. In par t icu la r  the 
k a l i ik re in -k in in  system and the prostaglandins have established 
roles in c e l lu la r  growth and in some experimental tumour systems. 
In addition, dietary constituents, b i le  acids and carcinogens may 
influence the a c t iv i ty  of these two endogenous mediators - the 
kinins and the prostaglandins. Therefore i t  may be proposed that  
these substances provide an important l in k  in the overall  
relationship between diet  and the development of experimental 
colorectal  cancer.
The pr inciple aim of this study is to examinethe e f fec t  
of d ie t  on experimental colorectal  carcinogenesis and to attempt 
to simultaneously examine the mechanisms whereby d ie t  may produce 
i ts  e f fects .  The hypothesis outlined above indicates that there 
are six variables to be studied:
1. the d iet
2. the ka l l ik re in  - kinin system
3. the prostanoids
4. the faecal b i le  acids
5. the crypt cell  p ro l i fe ra t ion  rates
6. the presence of carcinogen.
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The aims of the study can be formulated as a series of  
questions as follows:
1. What is the e f fect  of high and low r isk  diets for  
colorectal cancer on the following factors in normal experimental 
animals: the colonic k a l l ik re in  a c t i v i t y ,  the colonic prostanoid 
content, the faecal b i le  acids and the colonic crypt cell  
production rates?
2. In animals receiving high and low r isk  diets what is the 
e f fec t  of pharmacological inhib i t ion  of k a l l ik r e in  a c t i v i t y  on 
the colonic ka l l ik re in  a c t iv i t y ,  the colonic prostanoid content 
and the colonic crypt cell  production rates?
3. In animals receiving high and low r isk  diets what is the 
e f fec t  of pharmacological inh ib i t ion  of prostaglandin synthesis 
on the colonic ka l l ik re in  a c t iv i t y ,  the colonic prostanoid 
content and the colonic crypt cel l  production rates?
Once these "baseline" measurements are established then 
the same questions can be addressed for animals receiving a 
carcinogen:
4. What is the ef fect  of high and low r isk  diets for  
colorectal cancer on the following factors in animals exposed to 
the carcinogen: the colonic k a l l ik re in  a c t i v i t y ,  the colonic 
prostanoid content, the faecal b i le  acids, the colonic crypt cell  
production rates and the tumour induction?
5. In animals receiving high and low r isk  diets and the 
carcinogen what is the e f fect  of pharmacological inh ib i t ion  of  
k a l l ik r e in  a c t iv i t y  on the colonic k a l l ik re in  a c t i v i t y ,  the
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colonic prostanoid content,the colonic crypt cell  production 
rates and tumour induction?
6. In animals receiving high and low r isk  diets and the 
carcinogen what is the e f fect  of pharmacological inh ib i t ion  of  
prostaglandin synthesis on the colonic k a l l ik re in  a c t i v i t y ,  the 
colonic prostanoid content,the colonic crypt cel l  production 
rates and tumour induction?
In addition to these central questions one other aspect 
needs evaluation:
7. In what way do animals receiving defined high and low 
r is k  diets d i f f e r  from those on th e i r  usual laboratory d ie t  in 
terms of the the colonic ka l l ik re in  a c t iv i t y ,  the colonic 
prostanoid content, the faecal b i le  acids, the colonic crypt cel l  
production rates and ul t imately the tumour induction?
The study f a l l s  therefore into two phases - f i r s t l y  
studying animals which have not received carcinogen and secondly 
studying those which have had carcinogen treatment to induce 
tumours. While the data w i l l  be presented for each variable  
ind iv idual ly ,  this basic division w i l l  always be observed.
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M A T E R I A L S  A N D  M E T H O D S  
( G R A P H S  1 . - 3 )
ANIMALS
The animals used in this study were male Swiss albino 
rats bred from a closed colony in the animal unit of the 
Department of Surgery, Western Infirmary, Glasgow. They were 
recrui ted into the experiment at about 250gm body weight (10 
weeks of age). They l ived in controlled quarters with a 12 hour 
l igh t -dark  cycle in cages of up to 5 animals. Diet and water were 
supplied ad l ibitum and the animals were weighed weekly during 
the course of the experiment.
DIETS
Three diets were given during the course of the 
experiment. All animals were raised on Oxoid breeding d ie t .  When 
recruited into the experiment some animals continued on th is ;  
others received one of two special diets designed to be e i ther  
high in fa t  and low in f ib re  content or low in fa t  and high in 
f ib re  content. These were prepared by a commercial f irm to bulk 
order (Special Diet Services, Witham, Essex). The composition of  
the diets is shown in Appendix 1. The special diets d i f f e r  only 
in th e i r  fa t  and f ib re  content and consequently t h e i r  ca lor ic  
value. Detai ls of the fa t ty  acid composition are presented in the 
appendix for the high fa t ,  low f ib re  d ie t .  The main saturated 
f a t t y  acids are palmitic acid (5.2%) and stear ic  acid (3.6%). The 
main unsaturated fa t ty  acids are oleic acid (7.5%) and l in o le ic  
acid (2.6%). The fa t ty  acid composition of the low f a t ,  high 
f ib re  d iet  is a similar mix of essential and non-essential f a t t y
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acids. The f ib re  present in the d iet  (crude f ib re )  is essent ia l ly  
cellulose and l ig n in .  The Oxoid diet has a fa t  and f ib re  content 
between the two special diets but also d i f fe rs  in calor ic  value, 
vitamin and micronutrient content. The precise fa t t y  acid and 
f ib re  composition is not available.
The consumption of d iet  and water during the experiment 
was assessed by weighing the amount of d iet  consumed by the 
animals every week and by measuring the volume of water consumed 
over two 24 hour periods (09.00 Monday - 09.00 Tuesday and 09.00
Thursday - 09.00 Friday).  When calculated, the d ie t  and water
consumption was expressed per animal day. Whilst th is  method 
provides no data on the individual v a r i a b i l i t y  of the consumption 
per animal i t  was considered j u s t i f i a b le  since a l l  animals in a
cage belonged to one experimental group.
During the course of the experimental period the animals 
received some combination of d iet  and drug treatment with or 
without a carcinogen for one of three time periods. The various 
combinations used are shown in Table 1 with the numbers of the 
animals and the code numbers for each group. The experimental 
plan is i l lus t ra te d  in f igure 2.
AZOXYMETHANE
Approximately ha l f  of the animals received azoxymethane 
as a tumour-inducing agent. This was given by weekly subcutaneous 
injections over twelve weeks beginning on the fourth week of the 
experiment. The dose was lOmg/kg or a tota l  dose of 120mg/kg for
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each animal. Administration of the carcinogen required several 
precautions to be taken which are detai led in Appendix 2.
APROTININ
This drug was given by dai ly  subcutaneous in jection in a 
dose of 20000 KlU/kg every day during the course of the 
experiment to animals due to receive i t .  Control animals received 
an in jection of 0.9% saline which was the vehicle.  This drug was 
g i f ted  by Bayer UK Ltd.
INDOMETHACIN
Indomethacin was given to the animals in th e i r  drinking  
water in a dose of 2mg/kg. As indomethacin is insoluble in water 
ethanol was added to a concentration of 0.25%. A stock solution  
of indomethacin in ethanol was made at a concentration of 8mg/ml 
and th is  was added to the drinking water of the animals using
0.25ml in 99.75ml of water. The method of administration does 
not provide an exact dosing regime but on the assumption that a l l  
animals drink about the same (which was established pr ior  to the 
experiment) and that this method has been successfully used 
elsewhere then i t  was considered reasonable so to do. Control 
animals for  th is group received 0.25% ethanol in t h e i r  drinking 
water.
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SACRIFICE
Animals were sacrif iced at e i ther  4, 16 or 24 weeks a f te r  
entering the experiment. Immediately pr ior  to sacr i f ice  some 
animals received v incr is t ine  (0.25mg) as a stathmokinetic agent 
by a single intraperitoneal in ject ion.
Animals were k i l led  by ether anaesthesia and cervical  
dislocat ion. Where stathmokinetic studies were to be undertaken 
the animals were sacrif iced at intervals of 15 minutes.
On opening the body cavity a small p last ic  cannula was 
placed in the thoracic aorta and the in fe r io r  vena cava divided.  
The lower body viscera including the colon were then perfused 
free of blood using heparinized Kreb's solution i n i t i a l l y  and 
then plain Kreb's solution. Simple in ject ion with a small volume 
syringe performed this adequately and an animal of 300g would be 
adequately perfused with about 75ml of solution.
Following this the colon was removed from rectum to 
caecum, the terminal ileum being cut o f f  flush with the caecum. 
The ent ire  colon and rectum was opened longitud ina lly  and faecal 
material  collected for analysis of faecal b i le  acids. The ent i re  
faecal content of the colon was collected and samples from any 
one group pooled for analysis.
The colon was then washed with Kreb's solution and pinned 
out under minimal tension and the length measured. I t  was cut 
into f ive  equal segments label led A,B,C,D & E. These corresponded 
to the caecum, proximal colon, mid colon, d ista l  colon and rectum 
respect ively.  Each segment was s p l i t  longitudina lly  and samples
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taken for histological and stathmokinetic analysis.  Tumours were 
recorded as occurring at a part icu la r  s i te  by length from the 
caecum and were removed ent ire  for histological study. The 
remaining t issue was snap frozen in l iqu id  nitrogen and stored 
deep frozen (-40°C) unti l  analysis
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MEASUREMENT OF TISSUE KALLIKREIN-LIKE ACTIVITY IN COLON.
Tissue kal1ikre in -1 ike  a c t iv i ty  was estimated by a 
semi-micro, quant itat ive spectrophotometric assay which 
essent ia l ly  follows the descriptions of Amundsen, Putter,  
Friberger et a l . ,  (1979) and Al-Dhahir and Z e i t l i n  (1982).  
Preparation of the t issue
Colonic tissue was stored at -40°C unti l  used. I t  was 
thawed at room temperature and washed b r ie f ly  with fresh 
d i s t i l l e d  water, blotted dry and weighed. To the t issue was added 
fresh d i s t i l l e d  water in a volume 40 times the weight of the 
t issue in grams. [Thus O.lg of tissue had 4ml of water added].
The tissue was homogenised in an Ul tra turrax blender at the 
temperature of melting ice for three minutes. This homogenate was 
then allowed to stand at room temperature under toluene vacuum 
overnight to allow activation of the c e l lu la r  debris.  After  th is  
the homogenate was centrifuged at 2000g and 4°C for  30minutes and 
the clear  supernatant containing the k a l l ik re in  a c t i v i t y  
aspirated. This was then stored deep frozen in al iquots unt i l  
used. Once thawed no sample was refrozen ( Z e i t l in  et a l . ,1976)  
Assay
At the time of the assay each al iquot of homogenate 
supernatant was thawed at 37°C in a water bath. A sample from 
each al iquot was incubated with synthetic chromogenic 
k a l l ik re in -se lec t iv e  substrate S-2266 (KabiVitrium, Stockholm, 
Sweden). Appendix 3 shows the individual steps of the assay and 
the calculation of the ka l i i  krei n-1ike amidase a c t iv i t y  is shown
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in Appendix 4. All results of the ka l l ik re in  studies are 
expressed as micromoles of substrate cleaved, g wet weight of  
t issue *.min The pr inciple of the assay and data on the 
substrate,  S-2266, are given in Appendix 5.
Calibration of spectrophotometer
The cleavage of S-2266 produces the coloured product 
p -n i t roan i l ine .  This shows maximal absorbance at 405nm. The 
spectrophotometer was calibrated at this wavelength for  solutions 
of d i f fe r ing  concentrations of p-n i troanil  ine when read against 
d i s t i l l e d  water. This allows the extinction coe f f ic ien t  for  the 
assay to be calculated. Table 2 (Graph 1) shows the results of 
the cal ibration curve and the calculation of the extinction  
coeff ic ien t  for these experiments.
Characterisation of the assay.
I t  was necessary to understand the behaviour of the assay 
pr ior  to undertaking any de f in i t iv e  analyses. To th is  end several 
experiments were carried out to assess:
1. the l in e a r i t y  of the assay with concentration of homogenate 
extract
2. the course of the reaction with time
3. the optimal pH for the reaction
4. the coeff ic ient  of variat ion for the experimenter
5. that the a c t iv i ty  being measured was t issue k a i l ik r e in -1 ik e
amidase
1. Lineari ty  of the assay with concentration of extract .
Tissue extract of rat  colon was di luted i n i t i a l l y  to 1/10
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and from this stock further  di lutions were made to 1/20, 1/40,  
1/50 and 1/100. These samples were assayed in standard fashion 
with repl icates.  The results are shown in Table 3. These data 
show that there is a l inear  relationship between the 
concentration of the extract and the a c t iv i t y  produced.
2. Course of the reaction with time.
Rat colon extract was prepared in the usual fashion and 
dilu ted to 1/10 and 1/20 strength. The samples were assayed in 
standard fashion with repl icates and the reaction stopped at 5, 
15, 30, 60 and 120 minutes a f te r  the addition of the substrate by 
ac id i f ica t ion .
The results are shown in Table 4 and Graph 2. This shows 
that the reaction is l inear  with time for the 1/20 d i lu t ion  up to 
120 minutes and for the 1/10 d i lu t ion  up to 60 minutes. In the 
l a t t e r  case the reaction then goes onto a plateau due to 
exhaustion of the substrate.
3. Optimal pH for the reaction.
The buffer for the incubation was made up to various pH 
values in the range of pH 7 to pH 11. Colonic t issue was assayed 
in standard fashion. The results are shown in Table 5 and Graph
3.
I t  proved impossible to establish an optimal pH for  the 
reaction despite several repeti t ions of the experiment. This is 
in contradistinction to other workers who were able to 
demonstrate an optimal pH for the i r  reaction. While th is  was 
unexpected the reaction occurred in a predictable fashion and
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appeared to be reproducible (see coeff ic ient  of var ia t ion ,  
below). In view of this i t  was decided to carry out the assay at 
a pH of 8.2 as was used by Amundsen et a l . (1979).  This w i l l  be 
discussed again, (page 97)
4. Coefficient  of var iat ion.
A single sample of tissue extract was assayed in standard 
fashion on 9 separate occasions and the results recorded. The 
coeff ic ien t  of variat ion was calculated to be 2.8%. (Table 6)
5. Speci f ic i ty  of the assay.
While the substrate S-2266 is select ive for  t issue  
k a l l ik re in  i t  does give some reaction with similar  proteases, 
namely plasma k a l l ik re in ,  trypsin and plasmin. Soybean trypsin  
inh ib i to r  is known to inh ib i t  a l l  three of these proteases while 
leaving tissue ka l l ik re in  unaffected. Aprotinin is a 
broad-spectrum protease inh ib i tor  which w i l l  block the a c t i v i t y  
of t issue ka l l ik re in  as well as other ' in te r fe r in g '  proteases. By 
using these inhibitors in the assay system i t  is possible to 
deduce i f  a l l  the a c t iv i ty  present is due to t issue k a l l i k r e in .
A sample of colon extract was incubated in standard 
fashion with buffer which contained soybean trypsin in h ib i to r  in 
three concentrations and without inh ib i to r .  In a fur ther  
experiment aprotinin was substituted for soybean trypsin  
inh ib i to r .  The results are shown in Table 7.
Addition of soybean trypsin inh ib i tor  produced a small, 
s igni f icant  f a l l  in the a c t iv i ty  of the extract  indicating the 
presence of some other protease a c t iv i ty .  Aprotinin completely
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abolished a l l  a c t iv i t y  in the assay system.
In view of this a l l  future assays were undertaken using 
soybean trypsin inh ib i to r  in the buffer solution at a 
concentration of 250mcg/ml.
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GRAPH 1
CALIBRATION CURVE for SPECTROPHOTOMETER 
Graph of Absorbance against concentration 
of p-nitroaniline
2
1
0
2502001501000 50
Concentration p-nitroaniline (mcmol/l)
Solid l ine  has r = 0.999
Broken l ine  indicates loss of l i n e a r i t y  with 
concentrations of pNA greater than 100 micromol/1 and 
absorbance greater than 1.
Extinction coeff ic ient  = 10343.367
Data: Table 2
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GRAPH 2
LINEARITY of KALLIKREIN ASSAY with TIME
Graph of Absorbance against Time
1
0.5
0
1209060300
TIME (mins)
Standard incubation conditions.
y l  = colonic extract at 1/10 d i lu t ion .  
y2 = colonic extract at 1/20 d i lu t ion .
The 1/10 d i lu t ion  extract shows l in e a r i t y  up to 60 
minutes. After  th is time point the rate of reaction 
decreases and l in e a r i t y  f a i l s ,  (broken l in e ) .
The 1/20 d i lu t ion  extract shows l in e a r i t y  up to 
120minutes.
Data: Table 4
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GRAPH 3
pH OPTIMUM for KALLIKREIN ASSAY 
Graph of Absorbance against Buffer pH
0.5
0.4 -
0.3 -
0.2 -
0.1
Animal No. 1 Animal No. 2
1110987
pH of Buffer
Colonic extracts for 2 animals assayed. 
Standard incubation conditions.
Data: Table 5
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MEASUREMENT OF PROSTAGLANDIN E£ IN COLONIC TISSUE.
The content of PGE2 in colonic t issue was estimated by 
performing radioimmunoassay on an extract  of colon t issue.  
Preparation of the Tissue
Tissue was stored deep frozen unti l  used. I t  was then 
thawed at room temperature and weighed. To i t  was added a volume 
of phosphosaline buffer (PSB) containing indomethacin (lOmcg/ml). 
The volume added was 25 times the weight of the t issue in grams. 
[Thus O.lg of tissue had 2.5ml of buffer added.] The mixture was 
homogenised in an Ul tra turrax blender for  3 minutes at the 
temperature of melting ice. The homogenate was then centrifuged 
for  20 minutes at 2000g and 4°C and the supernatant decanted into 
a volume of PSB to provide a 1:10 d i lu t ion .  This d i lu ted extract  
was then stored at -40°C unti l  assay.
Assay of PGE^
Samples of the diluted colonic extract were thawed at the 
time of assay. A suitable al iquot was dispensed into glass tubes 
in duplicate and an assay for  PGE^  carried out using a method 
already established and validated in th is  laboratory. (Coker, 
Clark and Z e i t l i n ,  1982). Detai ls of the methodology and the 
source and characterist ics of the reagents are given separately 
as appendices 6 & 7.
Since t issue damage w i l l  activate prostanoid production 
the e f fec t  of homogenisation on the measured levels of PGE2 was 
assessed. Samples of colonic tissue were homogenised using the 
Ultra turrax blender as described. Samples of the homogenate were
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taken a f te r  3, 5 and 10 minutes of homogenising and assayed for 
PGE2 using the radioimmunoassay as described. The results are 
shown in Table 8. The levels of PGE2 measured did not d i f fe r  
between the time periods and did not increase with prolonged 
homogenising. (823±36pg for 3 minute values vs 824+112pg and 904+ 
72 fo r  5 and 10 minute values respectively)
To ensure that the concentration of indomethacin used in 
the phosphosaline buffer (PSB) produced maximal inhibit ion of 
prostanoid production during homogenisation the ef fect  of 
increasing the concentration was examined. Samples of colonic
tissue from the same area of the colon were homogenised in PSB
containing indomethacin in concentrations of 10, 20 and 50mcg/ml 
and the homogenates assayed for PGE2 . The results are presented 
in Table 9. Increasing the concentration of indomethacin in the 
buffer  did not a f fect  the levels of PGE2 measured. (732+25pg.mg~* 
fo r  lOmcg.ml"*, 714+81pg.ml~1 for 20mcg.ml_1, 688±65pg.ml 1 for 
50mcg.ml~*, NSD)
The e f fe c t  of delaying separation of the homogenate was 
assessed by divid ing samples of colonic homogenate into three 
separate specimens which were then either:
a) separated immediately by centrifugation
b) l e f t  at 4°C overnight in a refr igerator  prior to
separation
or c) l e f t  at  room temperature under toluene overnight prior
to separation 
These samples were then assayed for PGE2 content in
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standard fashion. The results are shown in Table 10. Delaying 
separation of the homogenate resulted in some increase in the 
measured prostaglandin content (392+82pg vs 537±108pg, p<0.05)
For th is  study, a l l  colon samples were homogenised in 
phosphosaline buffer  containing indomethacin in a concentration 
of lOmcg.ml * for  three minutes and were separated by 
centr i fugation immediately a f te r  homogenisation.
The coe f f ic ien t  of var iation of the prostanoid assay was 
estimated by analysis of a sample of colonic homogenate which was 
aliquoted into several separate vials and kept at -40°C. One vial  
( s u f f i c ie n t  for  a rep l icate  assay) was assayed periodical ly  with 
the main assay. The results of the individual analysis are shown 
in Table 11. The interassay coeff ic ient  of variat ion is 
calculated to be 24%. The intra-assay coeff ic ient  of variat ion  
was estimated by the multiple analysis of one specimen in the 
course of one assay. This was shown to be 9.5%
I t  was impossible to assay al l  samples simultaneously. In 
view of  the high interassay var iation and to avoid "batch" 
ef fec ts  on the results of the prostaglandin assay, the samples 
were assayed in a random fashion. This ensured that any 
differences observed between groups was not simply a ref lect ion  
of d i f f e r e n t  assay conditions. Each batch of samples which was 
assayed had a set of known prostaglandin standards included. This 
set of  standards provided the necessary data to calculate the 
standard curve for  the assay and, by derivation, the absolute 
prostaglandin content of the sample. The prostaglandin standards
- 66 -
were a l l  made from a single standard solution of prostaglandin 
E2 . This ensured that a l l  measured levels of prostaglandin 
re la ted  to a single,  known standard. All samples were assayed in 
duplicate.  (Appendix 6)
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STATHMOKINETIC ANALYSIS
The preparation of specimens for stathmokinetic analysis 
followed established methods for  crypt microdissection, staining 
and evaluation of crypt cel l  production rates. (Ferguson, 
Sutherland, MacDonald et a l . ,  1977; Cooke et a l . ,  1984)
Specimens from each of the f ive  areas of the colon were 
taken from the animals which had received v incr is t ine  (E l i  L i l l y  
& Co., Basingstoke) pr ior  to sacr i f ice .  These were f ixed in 
Carnoy's solution and dehydrated through alcohols for  storage. 
Following rehydration they were stained with Schif f  reagent for  
DNA (Feulgen react ion) .  (Appendix 8 . )  After  staining the intact  
specimen the mucosa was dissected from the muscularis and the 
crypts teased from this using f ine knife,  needles and forceps.
A squash preparation of the crypts was made onto a microscope 
sl ide  and in a modification to the method a covers!ip was bonded 
to th is  under pressure with an epoxy resin (A ra ld i te ) .
By l ig h t  microscopy at xlOO or x400 magnif ication, crypts 
were assessed and the d is t inc t  metaphase f igures counted for  each 
crypt .  (Figure 3) For each specimen a minimum of 10 crypts were 
counted. The subsequent crypt cel l  metaphase counts were 
converted into the crypt cell  production rate (CCPR) by p lott ing  
the regression l ine  through the metaphase count versus time. This 
provides a measure of the e f f lux  of ce l ls  from the p r o l i fe ra t iv e  
compartment to the functional compartment of the crypt. The CCPR 
was measured for  each animal at each segment of colon studied.
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MEASUREMENT OF FAECAL CONSTITUENTS.
Samples of faeces were taken from the colons of animals 
at s a c r i f ic e .  These samples comprised the ent i re  colonic content. 
The samples were then freeze-dried to constant weight and stored 
at -40oC unt i l  assay. The faecal specimens from one group of  
animals were pooled and the subsequent measurements made on this  
sample.
These samples were then assayed by the method of Owen, 
Thompson and H i l l  (1984) as described in Appendix 9.
HISTOLOGICAL EXAMINATION
All  specimens for histological assessment were f ixed in 
formol saline solution and processed through routine histological  
methods using alcohol dehydration, chloroform and xylene clearing  
p r io r  to paraf f in  wax embedding. Sections (4mcm) were stained 
with haematoxylin and eosin for examination. All  specimens were 
examined by one indiv idual .
MEASUREMENT OF PLASMA INDOMETHACIN
The plasma indomethacin was assayed in a number of  
animals receiving the drug at the time of sac r i f ice .  Blood was 
obtained by cardiac puncture and placed in heparinised tubes. The 
samples were centrifuged at 4°C to separate the plasma which was 
then stored at -40°C unti l  assay.
At the time of assay the plasma samples were thawed and 
the indomethacin concentration measured by the method of Hucker, 
Zacchei, Cox et a l . (1966) as described in Appendix 10.
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STATISTICAL METHODS.
Several s t a t is t i c a l  methods were used in the analysis of  
the d i f f e r e n t  sets of data.
1. Tissue k a i l ik r e in -1 ik e  amidase a c t iv i t y  and tissue  
prostaglandin Eo content.
The design of the study was such that data were obtained 
under a to ta l  of 300 d i f fe ren t  experimental conditions. [2 diets 
(high f a t ,  low f ib re  & low fa t ,  high f ib re )  by 5 treatments (no 
drug, sal ine control,  ethanol control,  aprotinin,  indomethacin) 
by 3 times (4, 16 & 24 weeks) by 2 levels of carcinogen (present 
or absent) by 5 colon segments (A, B, C, D & E) ] .  This gives rise  
to 38850 (300x299/2) possible pairwise comparisons. Clearly i t  
is ne i ther  feasible  nor sensible to compare the findings over 
each pa ir  of  experimental conditions. Either i t  would be 
necessary to ignore the multiple comparisons and thereby generate 
a large number of false posit ive f indings (Type I e r ro r ) ,  or by 
correcting for  the multiple comparisons, so reduce the 
s t a t i s t i c a l  power of the study such that a large number of fa lse  
negatives would resu l t .  (Type I I  e r ror ) .
Fortunately s ta t is t ic a l  methods for the analysis of data 
from such complex but carefu l ly  structured experiments are 
well-developed and are based upon the analysis of variance.  
(Scheffe,  1959) In essence a very general s ta t is t ic a l  model is 
f i t t e d  to the data and then terms which do not contribute 
s ig n i f ic a n t ly  to the v a r i a b i l i t y  of the data (hence "analysis of  
variance") are successively removed by dropping variables and/or
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pooling categories. The end result  should be a simple model which 
adequately describes the observed v a r ia b i l i t y  of the data and 
i m p l i c i t l y ,  by pooling over i rre levant  factors, greatly increases 
the precision with which the key comparisons may be made. The 
crux of  the approach is that one regards the data as a coherent 
whole which has arisen from a single,  care fu l ly  designed and 
structured experiment rather than an unstructured mass of 300 
sets of  data.
The data for the ka l l ik re in  a c t iv i ty  and prostaglandin 
content were analysed using repeated measures analysis of  
variance, taking colon segment as the within-animal factor and 
taking carcinogen, d ie t ,  drug and time as grouping factors. A 
square root transformation was used throughout the formal 
analysis to s tab i l ise  the v a r ia b i l i t y  which tended to increase 
with increasing levels of ka l l ik re in  a c t iv i ty  and prostaglandin 
content.  Wherever possible, and as set out in detai l  in the 
results  section, categories were pooled and/or factors were 
dropped from the analysis to give clear answers to the primary 
questions of in terest .
The calculations were performed on an ICL 3980 mainframe 
computer, using the BMDP program P2V. (Dixon, Brown, Engelman et 
a l . ,  1985)
2. Crvpt cel l  production rates.
These data were i n i t i a l l y  plotted so that clear out l iers  
could be rejected v isual ly .  Points were rejected i f  they lay more 
than 50% from a v isual ly  plotted l ine  on the graphs. In practice
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th is  only involved a tota l  of less than 50 points in a l l  the 
metaphase counts made and such points were very obviously at 
variance with the trend of the plotted l ine .
The crypt cell  production rates were then estimated by 
f i t t i n g  l in e a r  regression l ines to the data. This was done using 
weighted least  squares, with the weighting according to the 
v a r i a b i l i t y  of the 10 replicated counts. The calculations were 
performed using the MINITAB s ta t is t ica l  package running on an ICL 
3980 mainframe computer. (MINITAB Inc. ,  3081 Enterprise Drive,  
State College, PA 16801, USA.)
The crypt cel l  production rates were simply tabulated 
along with t h e i r  standard errors, as the sparse structure of the 
data precluded any more formal analysis of the ef fects of the 
factors such as colon segment or d iet .
3. Animal growth, d iet  consumption, faecal b i le  acids and tumour 
induction.
Where numbers permitted, mean values were compared using 
Student's t - t e s t .  Where numbers were small (<10) the data were 
analysed by using the Mann-Whitney U-test.  Analysis of tumour 
induction was done using the Chi-square test .
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T A B L E S  1 - 1 1
TABLE 1
DESCRIPTION OF THE GROUPS OF ANIMALS. 
GROUP ANIMAL
NO. NUMBERS DIET DURATION DRUGS
9 83/42 - 83/51 normal 4 none
10 83/52 - 83/61 normal 16 none
11 83/62 - 83/71 normal 24 none
12 84/01 - 84/10 normal 4 aprotinin
13 84/11 - 84/20 normal 16 aprotinin
14 84/21 - 84/30 normal 24 aprotinin
15 84/31 - 84/40 normal 4 indomethacin
16 84/41 - 84/50 normal 16 indomethacin
17 84/51 - 84/60 normal 24 indomethacin
18 84/61 - 84/64
vehicle85/100 - 85/104 normal 4
19 84/65 - 84/68 normal 24 vehicle
20 84/69 - 84/72 normal 4 ethanol
21 84/73 - 84/76 normal 24 ethanol
22 84/77 - 84/80 high fa t , low f ibre 4 none
23 84/81 - 84/84
f ibre 1684/921 - 84/924 high fa t , low none
24 84/85 - 84/88
f ibre 2484/801 - 84/804 high fa t , low none
25 84/90 - 84/99 high fa t , low f ibre 4 aprotinin
26 84/100 - 84/109 high fa t , low f ibre 16 aprotinin
27 84/110 - 84/119 high fa t , low f ibre 24 aprotinin
28 84/120 - 84/129 high fa t , low f ibre 4 indomethacin
29 84/130 - 84/139 high fa t , low f ibre 16 indomethacin
30 84/140 - 84/149 high fa t , low f ibre 24 indomethacin
31 84/150 - 84/153 high fa t , low f ibre 4 vehicle
32 84/154 - 84/157 high fa t , low f ibre 24 vehicle
33 84/158 - 84/161 high fa t , low f ibre 4 ethanol
34 84/162 - 84/165 high fa t , low f ibre 24 ethanol
35 84/166 - 84/169 low fa t , high f ibre 4 none
36 84/170 - 84/173
f ibre 1685/21 - 85/24 low fa t , high none
37 84/174 - 84/177 low fa t , high f ibre 24 none
38 84/178 - 84/187 low fa t , high f ibre 4 aprotinin
39 84/188 - 84/197 low fa t , high f ibre 16 aprotinin
40 84/198 - 84/207 low fa t , high f ibre 24 aprotinin
41 84/208 - 84/217 low fa t , high f ibre 4 indomethacin
42 84/218 - 84/227 low fa t , high f ibre 16 indomethacin
43 84/228 - 84/237 low fa t , high f ib re 24 indomethacini • *i
44 84/238 - 84/241 low fa t , high f ibre 4 vehiclei • i
45 84/242 - 84/245 low fa t , high f ib re 24 vehicle
46 84/246 - 84/249 low fa t , high f ibre 4 ethanol. ■ i
47 84/250 - 84/253 low fa t , high f ib re 24 ethanol
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TABLE 1 (con tinued )
DESCRIPTION OF THE GROUPS OF ANIMALS.
GROUP 
HO.__
48 *
49 *
50 *
51 *
52 *
53 *
54 *
55 *
56 *
57 *
58 *
59 *
60 *  
61 *  
62 *
63 *
64 *
65 *
66 *
67 *
68 *
69 *
70 *
71 *
72 *
73 *
74 *
75 *
76 *
77 *
78 *
79 *
80 *  
81 *  
82 *
83
84 *
85 *
86 *
ANIMAL
NUMBERS DIET DURATION DRUG
84/264 - 84/273 
84/274 - 84/285
84/296 - 84/305 
84/306 - 84/317
84/328 - 84/337 
84/338 - 84/349
84/354 - 84/358
84/363 - 84/367
84/372 - 84/376 
85/01
84/377 - 84/382 
84/901 - 84/904
84/393 - 84/402 
84/403 - 84/414
84/425 - 84/434 
84/435 - 84/446
84/451 - 84/455
84/460 - 84/464
84/469 - 84/473 
85/11
84/474 - 84/479 
84/911 - 84/914
84/490 - 84/499 
84/500 - 84/511
84/522 - 84/531 
84/532 - 84/543
84/548 - 84/552
84/557 - 84/561
normal 4 none
normal 16 none
normal 24 none
normal 4 aprotinin
normal 16 aprotinin
normal 24 aprotinin
normal 4 indomethacin
normal 16 indomethacin
normal 24 indomethacin
normal 4 vehicle
normal 24 vehicle
normal 4 ethanol
normal 24 ethanol
high fa t , low f ibre 4 none
high fa t , low f ibre 16 none
high fa t low f ibre 24 none
high fa t low f ibre 4 aprotinin
high fa t low f ibre 16 aprotinin
high fa t low f ibre 24 aprotinin
high fa t low f ibre 4 indomethacin
high fa t low f ibre 16 indomethacin
high fa t low f ibre 24 indomethacin
high fa t low f ibre 4 vehicle
high fa t low f ibre 24 vehicle
high fa t low f ibre 4 ethanol
high fa t low fibre 24 ethanol
low fa t , high f ib re 4 none
low fa t , high f ibre 16 none
low fa t , high f ibre 24 none
low fa t , high f ibre 4 aprotinin
low fa t , high f ibre 16 aprotinin
low fa t , high f ib re 24 aprotinin
low fa t . high f ibre 4 indomethacin
low fa t ,  high f ibre 16 indomethacin
low fa t , high f ibre 24 indomethacin
low fa t , high f ib re 4 vehicle
low fa t . high f ib re 24 vehicle
low fa t ,  high f ib re 4 ethanol
low fa t , high f ib re 24 ethanol
= carcinogen given
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TABLE 1 (con tinued )
DESCRIPTION OF THE GROUPS OF ANIMALS.
GROUP ANIMAL
NO._______ NUMBERS_________ DIEI____________ DURATION DRUG
87 85/201 - 85/205 normal 16 vehicle
88 85/105 - 85/109 normal 16 ethanol
89 85/110 - 85/114 high fa t ,  low f ib re 16 vehicle
90 85/115 - 85/119 high fa t ,  low f ib re 16 ethanol
91 85/120 - 85/124 low f a t ,  high f ibre 16 vehicle
92 85/125 - 85/129 low f a t ,  high f ibre 16 ethanol
93 * 85/130 - 85/134 normal 16 vehicle
94 * 85/135 - 85/139 normal 16 ethanol
95 * 85/140 - 85/144 high fa t ,  low f ibre 16 vehicle
96 * 85/145 - 85/149 high f a t ,  low f ibre 16 ethanol
97 * 85/150 - 85/154 low fa t ,  high f ibre 16 vehicle
98 * 85/155 - 85/159 low f a t ,  high f ibre 16 ethanol
*  = carcinogen given
GROUP
NO.
ANIMAL
NUMBERS DIET DURATION DRUGS
1 83/10 - 83/13 normal
2 83/14 - 83/17 normal
3 83/18 - 83/21 normal
4 83/22 - 83/25 normal
5 83/26 - 83/29 normal
6 83/30 - 83/33 normal
7 83/34 - 83/37 normal
8 83/38 - 83/41 normal
2 none
2 aprotinin
2 aprotinin
2 aprotinin
2 indomethacin
2 indomethacin
2 indomethacin
2 indomethacin
These animals were used for a 2 week p i lo t  study and are included 
fo r  completeness for  the group numbering.
- 75 -
TABLE 2
CALIBRATION OF SPECTROPHOTOMETER FOR p-NITRQANILINE fp-NA)
ABSORBANCE
p-NA (uM) I I I I I I Mean + / -  SEM
10 0.106 0.107 0.108 0.107 ± 0.000
20 0.211 0.213 0.213 0.212 ± 0.001
40 0.448 0.449 0.448 0.448 ± 0.000
50 0.500 0.500 0.501 0.500 ± 0.000
100 1.036 1.039 1.042 1.039 ± 0.001
200 1.800 1.812 1.818 1.810 ± 0.004
By l in e a r  regression, the slope of the l ine  for values 
from 0 - lOOmcM p-NA is 10343.367 . This is equivalent to 
the ext inct ion coe f f ic ien t ,  
r  = 0.999
The graph of these values (Graph 1) shows that beyond 100 
mcM the re lat ionship ceases to be l inear .
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TABLE 3
LINEARITY OF ASSAY FOR TISSUE KALLIKRFTN 
WITH EXTRACT CONCENTRATION.
Concentration of extract________ Absorbance (450nm)
1/10 0.910 ± 0.047
1/20 0.528 ± 0.036
1/40 0.298 ± 0.007
1/50 0.200 ± 0.026
1/100 0.155 ± 0.020
By l in e a r  regression : r  = 0.996
slope = 8.557
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TABLE 4
LINEARITY OF THE ASSAY FOR TKLA WITH TIME. 
Time of Reaction Absorbance
(mins) 1/10 d i l 'n 1/20
5 0.075 ± 0.003 0.044 ±
15 0.163 ± 0.001 0.102 ±
30 0.301 ± 0.002 0.165 ±
60 0.506 ± 0.007 0.290 ±
120 0.787 ± 0.005 0.567 ±
For 1/20 d i lu t io n  : r  = 0.998
For 1/10 d i lu t io n  : r  = 0.994 for  values up to 60 mins
r  = 0.986 for  values up to 120 mins.
These resul ts are shown in Graph 2.
di l  'n 
0.001 
0.003 
0.002  
0.001 
0.009
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TABLE 5
EFFECT OF pH ON THE ASSAY FOR TISSUF KAII TKRFTN
pH A B S O R B A N C E
(TRIS buffer)  Colon 1 Colon 2 Small Int.Bst.inp
7.0 0.043 0.016
7.5 0.069 0.072
8.0 0.119 0.112 0.379
8.25 0.164 0.156
8.5 0.188 0.176 0.408
8.75 0.215 0.216
9.0 0.264 0.260 0.485
9.25 0.316
9.5 0.440 0.331 0.513
9.75 0.382
10.0 0.417 0.638
10.5 0.481
11.0 0.516 0.683
Notes: 1. The colon samples came from two animals.
2. The small intestine sample was included since the 
a c t i v i t y  from i t  is higher and i t  has also been shown 
to have an optimum pH.
3. None of the samples examined here by the standard 
assay method showed a d is t inc t  optimal pH for the 
reaction (although the reaction was pH-dependent). The 
results  are shown graphically in Graph 3.
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TABLE 6
COEFFICIENT OF VARIATION OF THE ASSAY FOR TISSUE KALLIKRFIN.
A single sample of colon extract was aliquoted and the 
a c t i v i t y  assessed on several separate occasions. The results of 
each individual  assay are shown below.
Al iauot___________________Absorbance
1 0.167
2 0.160
3 0.154
4 0.156
5 0.165
6 0.159
7 0.155
8 0.160
9 0.161
Mean 0.160
S.D. 0.004
Coeff ic ient  of  var iation 2.8%
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TABLE 7
SPECIFICITY OF THE ASSAY FOR 
TISSUE KALLIKREIN-LIKE AMIDASE ACTTVTTY
Assay Conditions Absorbance (Mean + / -  S.D.)
No SBTI 0.303 ± 0.009
SBTI 250ug/ml 0.276 ± 0.001
SBTI 500ug/ml 0.278 ± 0.001
SBTI lOOOug/ml 0.273 ± 0.002
No APROTININ 0.129 ± 0.002
APROTININ 3000KIU/ml 0.000
Notes : 1. SBTI = Soybean trypsin inh ib itor .
2. SBTI and Aprotinin experiments carried out on 
d i f fe re n t  samples.
3. SBTI causes a reduction in measured TKLA by 
8.9% which is signif icant  at the 5% level
4. Aprotinin abolishes a l l  a c t iv i ty  in the 
sample.
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TABLE 8
EFFECT OF HOMOGENISATION ON TISSUE PGEZ MEASURED 
Time o f  homogenising (mins) 3________ 5_______ 10
1 880 906 854
2 762 868 1018
3 830 865 942
4 824 658 801
MEAN±SD 823±36 824±112 904±72
Values are ng PGE2-g * t issue
Samples were made from a pool of colonic tissue homogenate.
-  82 -
TABLE 9
FFFECT OF INCREASING INDOMETHACIN CONCENTRATION OF BUFFFR
IN ASSAY OF PGEZ.
Indomethacin concentration (mcg/ml) 10_______ 20______ 50
1 614 542 618
2 606 693 690
3 818 727 706
4 801 759 692
5 820 837 600
6 737 730 821
MEAN±SD 732±25 714±81 688±65
Values are ng PGE2-g * t issue
Samples were made from a pool of colonic tissue homogenate.
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TABLE 10
EFFECT OF DELAYING SEPARATION OF HQMOGENATF. 
ON LEVELS OF PGE^  MEASURED.
4°C Room temp.
SEPARATION: Immediate overnight________overnight
Sampl e 1 614 918 919
2 606 801 737
3 542 730 759
4 693 727 937
5 334 706 456
6_______390___________ 693______________439
MEAN+SD 530+116 762±71 708±181
Values are ng PGE2-g * t issue
'Immediate'  group less than other two groups by U-test (p<0.05) 
Samples were made from a pool o f  colonic t issue homogenate.
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TABLE 11
INTERASSAY COEFFICIENT OF VARIATION FOR ASSAY OF PRF
SAMPLE PGE2(pq)
1 107
2 84
3 138
4 67
5 67
6 73
7 112
8 102
9 87
MEAN 93 
SD 22 
CV 24%
The sample was made from a pooled sample of homogenate 
which was ind iv idu a l ly  aliquoted and assayed in duplicate in the 
course of  the routine assay.
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RE  S U L T S
GROWTH AND DEVELOPMENT OF THE ANIMAIS
In to ta l  575 animals were introduced into the study and 
a l l  but 20 survived unt i l  sacr i f ice .  The 20 premature deaths 
occurred in a var ie ty  of groups with no part icular  pattern except 
that  three of  the deaths occurred in the group receiving standard 
d ie t  and indomethacin but no carcinogen. There was no obvious 
cause fo r  any of the deaths and in part icular none of the deaths 
could be a t t r ibu ted  to carcinomatosis.
The growth of the animals is shown in summarised form in 
Tables 12a & b. This table shows the weights of the animals at 
the s ta r t  of  the experiment and at two la te r  time periods - 16 
weeks and 24 weeks the l a t t e r  being the endpoint for the 
experiment. Groups of animals were sacrif iced at 4, 16 and 24 
weeks a f t e r  the s ta r t  of the experiment.
There were no s igni f icant  differences in the weights of 
the animals at the s ta r t  of the experimental period. The mean 
star t ing  weight was 250g with a range for the means of 231g to 
279g fo r  each of the groups. The animals receiving the high fat,  
low f ib r e  d ie t  gained most weight over the experimental period 
(129g in 24 weeks) and those on the low fa t ,  high f ibre diet  
gained leas t .  (77g in 24 weeks) Administration of the carcinogen 
s ig n i f i c a n t ly  reduced the weight gain in a l l  groups of animals 
(73g in high f a t ,  low f ib re  group, 56g in low fa t ,  high f ibre  
group) and was characterised by a sharp f a l l  in the weight of the 
animals a f t e r  the s ta r t  of carcinogen treatment followed by a 
slow recovery period. The animals receiving the ir  standard diet
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gained 118g during the 24 week experimental period and 105g when 
the carcinogen was administered.
The d a i ly  in ject ions of aprotinin were well-tolerated by 
the animals but those on the low fa t ,  high f ibre diet did not 
gain as much weight as th e i r  contemporaries on other treatment, 
(non-carcinogen group: 66g vs 77g; carcinogen-treated group: 39g 
vs 56g) I t  was found from a p i lo t  experiment that injection of 
aprot in in in a dose higher than that used in this study (50000 
and 100000 Kill.kg * vs 20000 KlU.kg was poorly tolerated. On 
the higher doses animals rapidly lost weight and fai led to 
th r iv e .  None of the other drugs affected the growth of the 
animal s.
The d ie t  which the animals consumed was measured for each 
of the groups as described. (Table 13) Over a 24 week period the 
animals on the high fa t  d ie t  consumed an average of 13.6g of diet 
per day while those on the low fa t  diet consumed 29.2g per day. 
With the knowledge of the energy content of the diet this means 
that the animals on the high fa t  diet consumed 218KJ per day and 
those on the low f a t  d ie t  consumed 216KJ per day. Those on the 
standard laboratory d ie t  ate 19.6g of the ir  diet per day (= 
235KJ). Administering the experimental drugs did not 
s ig n i f ic a n t ly  a l t e r  the dietary intake although there was an 
apparent s ig n i f ic a n t  increase in the consumption of the high fat  
d ie t  by the animals receiving the control injection of saline and 
ethanol in drinking water. In the animals receiving the 
carcinogen there was a b ipa r t i te  e f fect .  Those on the high fat
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d ie t  showed a s ign i f ican t  increase in the dietary intake 
(+9.2g/day) while those on the low fa t  diet showed a reduction in 
the intake ( -9 .0g /d ay ) .  This was also seen in the animals 
receiving aprot in in  and indomethacin. There was an apparent 
decrease in the d ie tary  intake in the groups receiving a high 
f a t ,  low f ib r e  d ie t  and saline or ethanol when given carcinogen 
compared with the untreated controls but the values in the 
carcinogen group do not d i f f e r  from those on the other 
t reatments.
These changes necessari ly produce a change in caloric 
intake which is increased to 367KJ/day for the animals on the 
high f a t ,  low f ib r e  d ie t  and decreased to 149KJ/day for the 
animals on the low f a t ,  high f ibre  diet  when the carcinogen was 
administered.
The animals on th e i r  standard diet showed both increases 
and decreases between the carcinogen and non-carcinogen group.
The untreated controls showed a net increase in dietary 
consumption (+3.7g/day) when given carcinogen leading to an 
increased ca lor ic  intake of 279KJ/day.
The water intake was broadly similar across al l  the 
groups but did tend to be higher in the low fa t ,  high f ibre  
group. In the animals receiving indomethacin there were no 
s ig n i f ican t  differences between any of the groups and the animals 
drank an average of 25.3 ml of water/indomethacin solution per 
day. This provided a dose of 0.51mg of indomethacin per rat.day 
(=2.02mg/kg fo r  a 250 g ra t ;  target dose = 2mg/kg for 250 gram
r a t . )  This implies that at the end of the 24 week period the rats  
were receiving a dose of about 1.3 - 1.6mg/kg.day . I t  was noted 
that  the animals consumed more d iet  and water at a younger age 
than at l a t e r  stages.
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DISTRIBUTION OF KALLIKREIN ACTIVITY IN THE COLON
The t issue ka i l ik re in -1 ik e  amidase a c t iv i t y  (TKLA) was 
measured by the method described at f ive  levels in the colon 
corresponding to the caecum, proximal colon, mid colon, distal  
colon and rectum. These are referred to as segments A, B, C, D, 
and E respect ively.  The results are shown in Tables 14a - c which 
i l l u s t r a t e  the mean values of the colonic TKLA for each colon 
segment at each time period for the d i f fe ren t  drug treatments. 
Each d ie t  is considered separately. The results from the 
special ised diets w i l l  be presented f i r s t  and then comment on the 
animals receiving the standard diet  w i l l  be made.
In the animals receiving the two specialised diets - 
namely the high f a t ,  low f ib re  and low fa t ,  high f ib re  d iet  - i t  
is c lear  that the tissue kail  ikrein-1 ike amidase a c t i v i t y  is 
distr ibuted in a unique pattern along the colon with the level of 
a c t i v i t y  in the caecum being s ign i f icant ly  higher than elsewhere 
in the colon, (tables 14a & b) Values in the caecum are in the 
order of three to f ive  times greater than anywhere else in the 
colon. The values tend to decrease from the proximal colon to 
rectum but there is no consistent pattern present and no 
s ign i f ican t  differences are present between any of the segments B 
to E. The pattern described above is also seen in animals 
receiving th e i r  standard laboratory d ie t ,  ( table 14c)
Analysis of the multiple subgroups and comparison with 
t h e i r  respective controls and with each other suggests that  
differences may exist  between the groups but these do not occur
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in any regular ,  predictable fashion. For example, in the animals 
on the high f a t  d ie t ,  i f  the group receiving aprot in in  is 
compared with the sa l ine control group then i t  is possible to 
demonstrate in colon segments A, B, D & E tha t  there is an 
apparent reduction in the k a l l i k r e i n  a c t i v i t y  at 4 weeks.
However, th is  is not read i ly  demonstrated at the 16 week period  
but there is a suggestion that  i t  is present again at the 24 week 
period in segments C, D & E. A s im i la r  set of  resu l ts  is possible 
fo r  the low f a t  d ie t  group.
In an attempt to bring some form to these resu l ts  i t  was 
necessary to reduce the number of comparisons to the ones which 
were of  greatest importance. These comparisons examined:
1. I f  there were any systematic d i f ferences between the 
"control" groups?
2. I f  there were any systematic e f fec ts  of  d ie t  on the 
leve ls  of  k a l l i k r e i n  a c t i v i t y  measured?
3. I f  there were any e f fec ts  of drug treatment on the 
leve ls  of  k a l l i k r e i n  a c t i v i t y  measured.
4. I f  there were any other in teract ions which af fected  
the levels  of  k a l l i k r e i n  a c t i v i t y  measured?
Since i t  was apparent that  there were no constant  
dif ferences between the colonic segments B, C, D & E then 
comparisons were made between segment A and a pooled f igu re  fo r  
segments B - E which was average of  a l l  the B - E values.  
A d d i t io n a l ly  since there were no c lear  demonstrable d i f ferences  
between the time periods examined then the values at 4 and 16
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weeks were merged and compared with the 24 week values. This is 
of some use in examining the group receiving carcinogen treatment 
since th is  covers the period during tumour induction or 
i n i t i a t i o n  and then the period of tumour growth or promotion.
The values generated by this are shown in Table 15.
1. THE CONTROL GROUPS. A comparison of the saline and ethanol
control groups with the group of animals 
receiving no drug treatment at a l l  has shown that they do not 
d i f f e r  s ign i f ican t ly  from each other in the i r  levels of 
k a l l ik r e in  a c t iv i t y .  The probabi l i ty values for each of the 
comparisons is shown in the Table 16. These values have been 
derived by the s ta t is t ic a l  methods described. The only 
sign i f ican t  e f fect  demonstrated is that of segment (segment A 
higher than the rest)  as has been previously noted. With this  
knowledge the control groups were merged into one large group for  
fur ther  comparisons. Each of these placebo groups remained 
d is t in c t  for the time period, use of carcinogen and colon segment 
under study.
2. THE EFFECT OF DIET. These results are shown in Table 17.
Direct comparison of the TKLA between the 
animals receiving the high fa t ,  low f ib re  d iet  and the TKLA of 
the animals receiving the low fa t ,  high f ib re  d iet  has shown that  
for  any given group ( controls,  aprotinin,  indomethacin or 
carcinogen) there is no appreciable e f fect  of d iet  on any 
differences observed, (p = 0.1250) In other words, segment for  
segment and treatment for treatment there is no systematic ef fect
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of d ie t  on the levels of TKLA measured. This is apparent from 
the f igures in table 17 which shows a broad s im i la r i ty  of the 
resul ts in each of the two specialised dietary groups. A single 
discrepancy is seen in the case of the low fa t ,  high f ibre  diet  
receiving indomethacin at 4 & 16 weeks where the caecal TKLA is 
lower in the group receiving carcinogen than in e i ther  the 
non-carcinogen control or the levels in the high fa t ,  low f ibre  
group. (34+20 vs 106+66 & 189+59 n m o l p N A .g .m in r e s p e c t i v e l y ;  
p < 0 .005) .
The animals receiving the i r  standard d iet  have not been 
demonstrated as being s ign i f icant ly  d i f fe ren t  from those on the 
special ised d iets.
I t  would therefore appear that there is l i t t l e  i f  any 
e f fe c t  of the diet  on the colonic TKLA and therefore for fur ther  
analysis the two specialised dietary groups w i l l  be considered as 
one but the animals on the i r  standard diet w i l l  be considered 
separately.
3 . THE EFFECT OF DRUG TREATMENT. The results for this analysis
are shown in table 18. The 
animals receiving the drug treatment (aprotinin or indomethacin) 
are compared against the pooled control groups for  each of the 
two time periods ( 4 & 16 weeks versus 24 weeks).
In the group which did not receive carcinogen the mean 
TKLA in the caecum was higher than the other segments at both 
time periods and in a l l  groups, (p < 0.0001) In the group 
receiving aprotinin the mean TKLA was s ign i f ican t ly  lower than
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the placebo in a l l  segments of the colon at 4 & 16 weeks (116+58 
vs 152+38 nmolpNA.g ^.min  ^ for caecum; 25+6 vs 39+20 
nmolpNA.g'1 .min"1 for  d istal  colon; p < 0.0001) and in the distal  
colon segments at 24 weeks. (30+5 vs 58+21 nmol.pNA.g- 1 .min- 1 ; p 
< 0.0001) The TKLA in the animals receiving indomethacin did not 
d i f f e r  s ign i f ican t ly  from the i r  controls,  (p > 0.05) In the group 
which received the carcinogen treatment as well as the drugs 
there were no differences between the treated (aprotinin or 
indomethacin) and control groups. The s ignif icant  reduction (p 
<0.005) in the TKLA of the A (caecal) segment in the low fa t ,  
high f ib re  group receiving indomethacin for 4 or 16 weeks was 
noted above. This was not seen at 24 weeks and in the pooled 
analysis there was no signif icant  e f fect  of indomethacin on the 
TKLA (table  18) The carcinogen treated placebo group did not 
d i f f e r  from the one which did not receive carcinogen treatment.
In the animals receiving the i r  standard d iet  (table 17) 
the TKLA was reduced in the groups receiving aprotinin at both 
time periods when compared with the placebo group. (Caecum: 
136+27 vs 161+64 & 119+21 vs 150+57; Distal  segments: 26+17 vs 
37+22 & 24+12 vs 33+18; p<0.05 for each pairing) The carcinogen
groups also showed a reduced TKLA in comparison with the 
placebo.
Administering indomethacin also resulted in a reduced 
TKLA in the 4 & 16 week group on standard d iet  (caecum: 122±50 vs 
161+64; d ista l  colon 27±15 vs 37±22, p<0.05) but th is was not 
seen at the 24 weeks stage or in the carcinogen treated animals.
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4. OTHER EFFECTS The analysis showed that there was a
s ignif icant  interaction between the segment of 
colon and the time (p < 0 .01) .  This emphasises that the ef fect  
of aprotinin is not seen at 24 weeks in the caecum but is seen 
pr io r  to th is  and is seen in the distal  colon at both time 
in te rva ls .  This has been described above. None of the other 
variables - d ie t ,  drug or carcinogen treatment - interact nor do 
any permutations of these with colon segment or time.
In summary, i t  has been shown that the regular,  daily  
in ject ion  of aprotinin s igni f icant ly  reduces the detectable 
t issue kai l  ik re in -1 ike  amidase ac t iv i ty  of the rat colon at al l  
the levels  examined. With the possible exception of one group of 
animals receiving indomethacin for 4 to 16 weeks no other agent 
al tered the levels of t issue ka i l ik re in-1  ike amidase a c t iv i ty  to 
a s ign i f ican t  degree. This ef fect  was more marked in the e a r l ie r  
stages of the experiment. Dietary change was without e f fec t .  The 
animals on t h e i r  standard diet demonstrated the same changes.
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DISTRIBUTION OF PROSTAGLANDIN IN THE COLON
The t issue levels of prostaglandin were measured as 
prostaglandin E2 (PGE2) by the methods described at the same five  
levels  of the colon - A to E - as for the tissue kai l ik re in-1  ike 
amidase a c t i v i t y .  (The segment of colon was s p l i t  longitudinally  
and one ha l f  used for tissue ka l1ikrein -1 ike amidase ac t iv i ty  
estimation, the other for PGE2 estimation). The results are shown 
in Tables 19a - c which i l l u s t r a te  the mean values of the colonic 
PGE2 concentration for each colon segment at each time period for  
the d i f f e r e n t  drug treatments. Each diet  is considered 
separately.  As before, the results for the specialised diets wil l  
be presented f i r s t  and then the results from the standard d iet .
In the animals receiving the two specialised diets - the 
high f a t ,  low f ib re  and low fa t ,  high f ibre diet  - the colonic 
content of PGE2 varies along the colon such that the lowest 
levels  are found in the caecum (segment A) and the highest levels 
in the more d ista l  segments (B to E). ( tables 19a & b) The PGE2 
content of the d ista l  segments does not vary in any predictable 
fashion and none of these segments d i f f e r  s igni f icant ly  from each 
other.  While there are values which appear to be d i f ferent  from 
each other the spread of results is very great encompassing a 
tenfold difference within one group. On average the values for  
the d is ta l  colon are twice those of the caecum. Animals receiving 
t h e i r  standard d iet  demonstrated a similar gradient of PGE2 
content along the colon with the highest levels being in the 
dis ta l  colon, ( table 19c)
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As with the results of the t issue kal1ikrein-1ike amidase 
a c t i v i t y ,  analysis of the multiple subgroups and comparison with 
t h e i r  respective controls for the tissue prostaglandin content 
produces a set of s ta t is t ic s  suggestive of differences which may 
be present but not in any readi ly  ident i f iab le  fashion. For 
example, in the animals receiving the high fa t ,  low fibre diet ,  
those receiving indomethacin may have reduced levels of PGE2 
a f te r  24 weeks treatment but not at 4 or 16 weeks and not 
necessari ly in every segment examined. In the same way as for the 
results  of the analysis of the t issue kal1ikre in -1 ike amidase 
a c t i v i t y  i t  was necessary to reduce the comparisons made to those 
which were of greatest importance and which corresponded to those 
made fo r  the t issue ka l1ikre in -1 ike  amidase ac t iv i ty  analysis.
These comparisons examined:
1. I f  there were any systematic differences between the 
"control" groups?
2. I f  there were any systematic effects of diet on the 
levels  of PGE2 measured?
3. I f  there were any effects of drug treatment on the 
levels  of PGE2 measured.
4. I f  there were any other interactions which affected 
the levels  of PGE2 measured?
Since i t  was again apparent that there were no detectable 
differences between the colonic segments B - E then comparisons 
were made between segment A and a pooled f igure for segments B - 
E which was the average of a l l  the B - E values. As before the
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values fo r  the 4 and 16 week periods were pooled and compared 
against the 24 week value. These values are shown in Table 20
1. THE CONTROL GROUPS. A comparison of the ethanol and saline
control groups with the group of animals 
receiving no drug treatment has shown that they do not d i f f e r  
from each other as fa r  as the treatments or diets are concerned 
but d i f f e r  between the time periods examined and the use of 
carcinogen. The probabil i ty  values for these comparisons are 
shown in table  21 and are derived by the s ta t is t ica l  methods 
described. The animals treated with carcinogen have s ignif icant ly  
higher levels  of prostaglandin than do the non-carcinogen control 
animals (p < 0.0001) .  There is a s igni f icant e f fect  of segment 
also as noted above (segment A lower than the res t ) .  While these 
differences do exist  i t  is s t i l l  possible to pool the control 
groups as before to form one control group for each time stage 
and fo r  the carcinogen treatment as was done for the analysis of 
TKLA.
2. THE EFFECT OF DIET Comparison between the PGE2 content of the
colon in the animals on the high fa t ,  low 
f ib r e  d ie t  and the PGE2 content of the colon of the animals on 
the low f a t ,  high f ib re  diet  shows that there is no no 
appreciable e f fec t  of d iet  on any differences observed for any 
given group (control ,  indomethacin, aprotinin or carcinogen; 
table  22, p = 0.1575) In other words, segment for segment and 
treatment fo r  treatment there is no systematic ef fect  of diet  on 
the levels  of  PGE2 measured. This is apparent from the figures in
- 98 -
table  22 which shows a broad s im i la r i ty  of the results in each of 
the two special ised dietary groups. For example, in the placebo 
groups at 4 & 16 weeks the caecal colonic PGE2 is 93±35ng.g_1 in 
the high f a t ,  low f ib re  group and is 93±26ng.g_1 in the low fa t ,  
high f ib r e  group; the d istal  segments have corresponding values 
of 179+119 and 170+90ng.g This ref lects  the re la t ive ly  higher 
levels  in the d is ta l  colon. The range of values obtained for some 
of the colonic PGE2 analysis was wide and is reflected in the 
large standard deviations for some groups. Consequently, the 
range of  mean values is great but i t  is impossible to separate 
the groups s t a t i s t i c a l l y .  The animals receiving the ir  standard 
d ie t  have not been shown to be s ignif icant ly  d i f ferent  from those 
on the special ised d iets .
For fur ther  analysis the two specialised dietary groups 
w i l l  be considered together but the animals on the i r  standard 
d ie t  w i l l  be considered separately.
3. THE EFFECT OF DRUG TREATMENT. The results for this analysis
are shown in table 23. The 
animals receiving the drug treatment (indomethacin or aprotinin)  
are compared against the pooled control groups for each of the 
two time periods (4 & 16 weeks and 24 weeks).
In the group which did not receive the carcinogen the 
mean prostaglandin content expressed as PGE2 was lower in the 
caecum than in the other segments at both time periods and in al l  
groups, (p < 0.0001) In the group receiving indomethacin a 
s ign i f ican t  (p < 0.005) reduction was seen in the colonic PGE2 in
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the d is ta l  colonic segments but not in the caecum. (83+36 vs 
94+32 ng.g"1 fo r  caecum; 141+57 vs 176±88 ng.g"1 for d ista l colon 
at 4 & 16 week stage; 56±23 vs 52+20 ng.g-1 for caecum; 87+36 vs 
121+30 ng.g"1 fo r  d is ta l colon at 24 weeks) In the group 
receiving aprotinin there was no difference in the measured 
leve ls  of PGE2 from those in the control group.
In the group receiving the carcinogen as well as 
indomethacin a s ign ifican t reduction in the content of PGE2 was 
seen when compared with the control groups receiving carcinogen 
at the combined 4 & 16 week stage (caecum: 95+31 vs 191+125 
ng.g"1; d is ta l colon 145+31 vs 259+117ng.g_1, p < 0 .025). This 
was also evident at 24 weeks in the d ista l colon (144+46 vs 
191+66 ng.g"1, p < 0.025) but was not detectable in the caecum. 
(87+59 vs 105+44ng.g_1, N.S.D.) In the group receiving aprotinin  
and carcinogen treatment there was a s ignificant difference  
between the treated group and the placebo at the 4 & 16 week 
stage with the aprotinin group having a s ig n if ican tly  lower PGE2 
content. ( p < 0 .05 ) .
Comparison between the two drug-treated groups overall 
showed that the levels of PGE2 were s ig n if ican tly  lower in the 
indomethacin group (p < 0.0006) although in individual 
drug-segment-time combinations they may not appear so: e.g. 
aprotin in  + carcinogen at 4 and 16 weeks compared to indomethacin 
+ carcinogen at the same stage. (Caecum: 92+24 vs 95+31; dista l 
colon: 113±19 vs 145+31ng.g-1; aprotinin vs indomethacin.)
4. OTHER EFFECTS Analysis of the interactions between the
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various experimental components shows that the 
other major variable to determine the PGE2 levels is the use of 
carcinogen, ( tab le  23) The use of carcinogen was associated with 
higher leve ls  of PGE2 in the colon than in the untreated 
(non-carcinogen) groups, (e .g . placebo group, caecum: 191+125 vs 
94+32ng.g_1 (4 & 16 wks); 105+44 vs 52±20ng.g_1 (24 wks); d istal 
colon: 259+117 vs 176+88ng.g_1 (4 & 16 wks); 191+66 vs 
121+30ng.g 1 (24 wks); carcinogen vs non-carcinogen, p < 0.0005)
There was also a s ign ifican t in teractive  e ffect between 
the use of drug and the length of time i t  was used but this  
e f fe c t  was rather more obscure than i t  appeared s ta t is t ic a l ly .
I f  animals not receiving carcinogen are considered then prolonged 
drug treatment (aprotin in  & indomethacin) seemed to result in 
r e la t iv e ly  lower levels of PGE2 at 24 weeks than at 4 & 16 weeks. 
However, a s im ila r  f a l l  in the PGE2 levels was also seen in the 
placebo groups. This was not evident in the animals receiving 
carcinogen treatment.
In summary, i t  has been shown that the levels of colonic 
PGE2 were s ig n if ic a n t ly  reduced by the use of indomethacin when 
compared with untreated controls. The weekly in jection of a 
carcinogen produced a r ise in the colonic PGE2 when compared with 
animals which did not receive carcinogen treatment. The absolute 
leve ls  of PGE2 seemed to f a l l  with increasing age of the animals 
- an e f fe c t  which was abolished by carcinogen treatment.
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CRYPT CELL PRODUCTION RATES
The crypt ce ll  production rates for the various groups 
were calculated by the stathmokinetic method as described. From 
the individual metaphase counts the regression l in e  has been 
calculated and th is  is presented in tables 24a - c for each of 
the time periods and drug combinations. Each d ie t has been 
presented separately.
I t  became clear during the counting of the crypt cell 
dissections that the preparations made from the region of the 
colon labe lled  B (proximal colon) never produced satisfactory  
specimens fo r  counting despite repeated attempts. The reason for 
th is  is not c lear but has been recognised by other workers and 
presumably re la tes  to the structure of the mucosa which does not 
lend i t s e l f  to microdissection. Consequently i t  has been omitted 
from a l l  fu rthe r  analysis.
The results  have been examined both ind iv idually  and in 
the groupings previously described for the k a l l ik re in  and 
prostaglandin studies.
Unlike the pattern seen in the autacoid studies no 
s ig n if ic a n t  differences were seen between the segments (segment A 
versus segments C, D & E ; p = 0 .87). There was no discernible  
e f fe c t  of d ie t  on the crypt cell production rate (high fa t ,  low 
f ib re  vs low f a t ,  high f ib re ;  p = 0.30) S im ilarly  no differences  
between the groups was seen with time of the experiment (4 & 16 
weeks vs 24 weeks; p = 0.76) Administration of the carcinogen did 
not a f fe c t  the crypt cell turnover ( p = 0 .36). However the
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administration of aprotinin and indomethacin did appear to reduce 
the crypt ce l l  turnover when compared with the control (p < 0.05) 
but both drugs seemed to produce the e ffect to the same extent (p 
= 0 .4 3 ) .
Thus i t  has proved impossible to demonstrate any effect  
of d ie t  on the crypt ce ll  production rates (CCPR) in the colon 
nor to demonstrate any variation  in the CCPR along the colon. 
However the administration of the drugs is associated with a 
s ig n if ic a n t  reduction in the CCPR.
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FAECAL CONSTITUENTS.
The resu lts  of the analysis of the faecal b ile  acids, 
faecal neutral sterols  and fa t ty  acids are presented in tables 
25a and 25b. The data are presented under three broad headings - 
neutral steroids, long chain fa t ty  acids and free b ile  acids.
Each value is the mean of several samples of faeces taken from 
the colon o f the rats at the time of sac r if ice . The samples were 
only distinguished by the d ie t  the animals consumed and whether 
the animal received the carcinogen. This analysis takes no 
account of any other drug treatment they may have received.
Figure 4 i l lu s t r a te s  diagramatically the re la t iv e  proportions of 
the various components for each of the dietary groups. The data 
used fo r  th is  included both the non-carcinogen and 
carcinogen-treated groups.
I t  is c lear from Tables 25a & b that d is t in c t  differences 
ex is t  between the faecal compositions of the d iffe ren t dietary  
groups. The animals receiving the high fa t ,  low f ib re  d iet have 
the highest levels  of s tero ls , fa t ty  acids and b ile  acids of any 
of the groups. The animals receiving the low fa t ,  high f ib re  diet  
have the lowest levels  of these substances of the three groups. 
This d ifference is seen whether or not the animal had received 
the carcinogen. The most emphatic difference is seen in the total 
faecal f a t ty  acid content which is between 14 and 20 times 
greater in the high f a t ,  low f ib re  group than in the low fa t ,  
high f ib re  group. The sterol and b ile  acid concentrations of the 
high fa t  group are three times those of the low fa t  d ie t .
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In the animals which did not receive the carcinogen 
(Table 25a) the to ta l sterol concentration of animals on the high 
f a t ,  low f ib r e  d ie t  was 9.85+2.65mg.g"1. This was s ign ificantly  
higher than e ith e r  of the other two dietary groups (p<0.005). The 
to ta l  faecal b i le  acid concentration of the high fa t ,  low fibre  
d ie ta ry  group was 4.59+2.62mg.g'1 which was s ign ifican tly  greater 
than the low f a t ,  high f ib re  group (1.58+1.12mg.g~1, p<0.005) but 
not d i f fe re n t  from animals on th e ir  standard d ie t .
In the animals which received carcinogen the total sterol 
concentration was s ig n if ic a n t ly  higher in the high fa t ,  low fibre  
group than in e ith e r  of the other two d iet groups.
(9 .00+1.65mg.g~* vs 2.28+0.73mg.g~* & 4.33+2.64mg.g’ * ; high fat  
vs low fa t  & standard d ie t  respectively, p<0.005) Sim ilarly , the 
to ta l  faecal b i le  acid concentration of the high fa t ,  low fibre  
d ie ta ry  group (4.77+2.45mg.g *) was s ign ifican tly  higher than 
e ith e r  of the other two d ietary  groups, (low fa t ,  high fib re  
d ie t  = 1 .39+0.36mg.g~*; standard d ie t = 1.72±2.05mg.g 
p<0.005)
In the animals which did not receive carcinogen (Table 
25a) the leve ls  of to ta l sterols and tota l b ile  acids were 
greater in the animals on th e ir  standard d iet than those on the 
the low f a t ,  high f ib re  d ie t .  (Sterols: 6.02+1.39 vs 
3 .6 1 + 3 .0 2 m g .g ; b i le  acids: 4.09+2.35 vs 1.58+1.12mg.g ; 
p<0.005 fo r  both comparisons) However, the faecal fa t ty  acid 
composition of animals on th e ir  standard d iet was no d iffe ren t to 
that o f animals on a low fa t ,  high f ib re  d ie t .  (Table 25a) When
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the animals received carcinogen (Table 25b) the faecal sterols 
and f a t t y  acids of the animals on th e ir  standard diet were 
s ig n i f ic a n t ly  greater than those of animals on the low fa t ,  high 
f ib r e  d ie t .  (S tero ls : 4.33+2.64mg.g_1 vs 2.28+0.73mg.g-1; fa tty  
acids: 4.74±2.29mg.g_1 vs 1.93+1.48mg.g"1; standard diet vs low 
f a t ,  high f ib re  d ie t ,  p<0.05) The tota l b ile  acid concentration 
of the animals on th e ir  standard d ie t and receiving carcinogen 
was lower than those not receiving carcinogen (1.72+2.05 vs 
4.09+2.35 mg.g p<0.025) and was no d iffe ren t from animals on 
the low f a t ,  high f ib re  d ie t .
Study of the individual sterols, fa t ty  acids and bile  
acids reveals that the differences between the diets were due to 
a lte ra t io n s  in a l l  components of the to ta ls .  However the elevated 
to ta l  b i le  acids of the high fa t ,  low f ib re  group were largely  
due to an increase in the concentrations of deoxycholic acid and 
muricholic acids, ( f ig  4) The animals on th e ir  standard diet  
seemed to have a re la t iv e  excess of unsaturated fa t ty  acids in 
comparison to the other d ietary groups, ( f ig  4)
Reviewing the raw data for these results i t  was clear  
tha t the e f fe c t  of the d ie t  on the faecal constituents was so 
dominant tha t i t  was impossible to distinguish i f  any of the 
other treatments produced an e ffec t on the faecal composition.
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TUMOUR INDUCTION
Histological assessment of the colonic mucosa was carried 
out ro u tin e ly  in a l l  animals under study. Additional samples of 
any macroscopic mucosal abnormality seen at the time of sacrifice  
were taken. A ll the histological examination was carried out by 
one in d iv id u a l .
In the animals not receiving carcinogen treatment there 
were no h is to log ica l effects  of any of the drug treatments at any 
of the time periods examined. In part icu la r,  no evidence of 
tumour formation was seen.
In the animals receiving the carcinogen treatment no 
tumours were seen at the 16 weeks stage (the end of the course of 
carcinogen in je c t io n s .)  Tumours were seen in a ll  dietary groups 
at 24 weeks and these are detailed in table 26. This table l is ts  
a l l  the h is to lo g ic a l ly  confirmed lesions and th e ir  nature. 
Colonic lesions were recorded at a distance from the ileocaecal 
valve. Table 27 shows the number of animals with a tumour in 
each group . A ll neoplastic lesions are counted as representing 
tumour formation since colonic lesions are essentially  never seen 
in the untreated ra t  colon. The subsequent table (Table 28) l is ts  
the numbers of tumours developed by each group. The typical 
appearance of the tumours is shown in figure 5.
Documented colonic lesions included tubular adenomas 
(17 ) ,  tubulovillous adenomas (3 ) ,  v illous adenomas (2) and 
adenocarcinomas (32 ).  Fifteen of the adenocarcinomas were 
c la s s if ie d  as being signet-ring cell type. All degrees of
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invasion o f  carcinomas were seen from dysplastic foci with 
carcinom a-in-s itu  to carcinomatosis peritonei. (Figure 6) 
Adenocarcinomas were seen arising in adenomas. Primary tumours of 
the small bowel and duodenum were also seen - 6 adenocarcinomas 
and 1 tubu lov illous  adenoma.
In to ta l  62 primary neoplastic lesions were documented. 
These lesions occurred in 46 rats . Tumours developed more 
commonly in the the animals receiving the high fa t ,  low fibre
p
d ie t  than in the animals on the low fa t ,  high f ib re  d ie t.  (X = 
4.140, p < 0 .0 5 ) .  The animals receiving th e ir  standard diet  
developed most tumours with a marginally raised frequency over 
those on the high fa t  d ie t .  (44% vs 41%, N.S.)
As regards the d if fe re n t  treatment subgroups three 
differences emerged. F i r s t ly ,  no tumours developed in the animals 
receiving the ethanol vehicle which is s ign ifican tly  d ifferent  
from the untreated controls or saline vehicle controls in any of 
the d ie ta ry  groups. (X^ = 10.91, p < 0.05) (Table 27)
Secondly, in the group receiving the low fa t ,  high fibre  
d ie t  and aprotin in  only 2 out of 12 animals developed tumours 
which is less than the frequency of tumour development in the 
saline controls taken as a group (X^ = 3.84, p < 0 .05). I f  the 
untreated controls are included in this analysis then the 
diffe rence  is s t i l l  apparent (X^ = 5.74 , p < 0 .05).
T h ird ly , also in the low fa t ,  high f ib re  group, none of 
the animals receiving indomethacin developed tumours. This is 
not d i f fe re n t  from the ethanol control group but does d i f fe r  from
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the other controls (X = 5.31, p < 0 .05).
Apart from the absence of tumours in the previously noted
groups there were no s ign ifican t differences in the number of 
tumours developing per animal. (Table 28)
The s itua tion  of the tumours was examined by measuring 
th e i r  distance from the ileocaecal valve. (Table 26; f ig  7) 
Tumours in the animals on the high fa t ,  low f ib re  diet occurred 
more frequently  in the proximal colon (at 9. 3+4.8cm from
ileocaecal valve) than did tumours in the animals on either of
the other d ie ts .  (Low f a t ,  high f ib re  d iet 12.6+6. 7cm; standard 
d ie t  14 .8+5 .2cm ; high fa t  vs low fa t  and standard d ie t, p< 0.05, 
U - t e s t . )
In summary, tumour development was only seen in the 
animals receiving carcinogen treatment and a fte r  24 weeks of the 
experiment. A ll va r ie t ie s  of neoplasm were encountered. There was 
a d is t in c t  d ie ta ry  e f fe c t  on tumour incidence which was reduced 
in the low f a t ,  high f ib re  d ie t groups. There was also a 
suggestion that some of the drug treatments reduced the tumour 
incidence. Aprotinin reduced tumour incidence in the low fa t ,  
high f ib r e  d ie t  group and no animal receiving ethanol developed a 
tumour. The e f fe c t  of indomethacin was therefore not apparent.
The d is tr ib u t io n  of the tumours in the colon was affected by the 
d ie t  being more proximal in the high fa t ,  low f ib re  group.
F in a l ly ,  in an e f fo r t  to re la te  the studies on the 
autacoid measurements and the occurrence of tumours the tissue 
k a l i i k r e i n - 1ike amidase a c t iv i ty  and the PGE£ content of the
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colon was compared between the animals which actually  developed 
tumours and those which did not. This was only done fo r the 24 
week period since tumours were only seen at th is  stage and Table 
29 shows the resu lts . Since the numbers in each subgroup become 
small a l l  the d ietary  groups and treatment groups are considered 
together. There is no s ign ifican t difference between the measured 
levels  of colonic TKLA or PGE2 when the tumour-bearing animals 
are compared with the non-tumour bearing animals in e ith er  the 
caecum or d is ta l colonic segments.
INDOMETHACIN MEASUREMENT
Indomethacin was measured by the method described in a 
random selection of plasma samples taken from the 14 d if fe re n t  
rats  at the time of sac r if ice . By th is  method indomethacin was 
shown to be present in the plasma of the animals at the time of 
sac r if ic e  in a concentration of between 0.5 and 4 meg.ml . (mean 
indomethacin concentration 1.00+0.9mcg.ml Table 30).
-  1 1 0  -
T A B L E S 1 2  - 3 0
TABLE 12a
GROWTH OF THE ANIMALS ON THE VARIOUS DIET AND DRUG COMBINATIONS 
NO CARCINOGEN ADMINISTERED
DRUG TREATMENT
DIET TIME NONE APROTININ INDOMETHACIN SALINE ETHANOL MEAN
0 279+37 249+23 273+37 262+21 241+17 263+32
n = 20 30 30 13 13 106
HIGH FAT
16 364+16 351+24 362+41 368+26 371+11 360+28
LOU FIBRE
3 II £ 20 19 9 4 68
DIET
24 382+31 390+22 391+27 400+23 401+13 392+23
n = 4 10 10 4 4 32
0 240+23 240+29 231+30 242+18 249+19 239+26
n = 16 30 30 13 13 102
LOW FAT
16 323+19 315+13 305+24 321+13 314+13 314+18
HIGH FIBRE
n = 12 20 19 9 9 69
DIET
24 352+ 7 304+11 306+20 334+15 312+11 316+22
n = 4 10 9 4 4 31
0 244+20 247+12 266+31 242+11 239+ 8 247+30
n = 30 30 30 18 13 121
STANDARD 16 338+34 351+15 357+30 345+14 345+18 348+26
DIET n = 20 20 18 9 9 96
24 341+19 365+13 391+54 370+23 377+29 365+34
n = 10 9 7 4 4 34
Values are mean weights (g)+SD; Time in weeks;
Column headed "Mean" shows mean weight regardless of treatment
TABLE 12b
GROWTH OF THE ANIMALS ON THE VARIOUS DIET AND DRUG COMBINATIONS 
CARCINOGEN ADMINISTERED
DRUG TREATMENT
DIET TIME NONE APROTININ INDOMETHACIN SALINE ETHANOL MEAN
0 252+29 265+12 280+15 294+22 234+18 261+24
n = 16 22 22 10 10 80
HIGH FAT
16 320+26 323+14 328+35 323+10 315+20 323+25
LOU FIBRE
n = 15 11 21 10 10 67
DIET
24 329+32 351+18 353+24 347+ 6 333+18 344+24
n = 9 10 12 5 5 41
0 243+ 9 269+30 252+37 251+37 248+30 255+31
n = 16 22 22 10 10 80
LOW FAT 
HIGH FIBRE
16
n
284+26 
= 15
292+19
20
293+26
20
288+39
10
287+21
10
289+26
75
DIET
24 288+18 308+20 328+18 300+20 326+20 311+24
n = 9 12 12 5 5 43
0 243+26 234+24 232+32 247+25 225+26 236+27
n = 22 22 22 10 10 86
STANDARD 16 318+32 304+24 306+20 319+ 8 296+24 309+26
DIET n = 22 21 22 9 10 84
24 348+21 335+ 9 328+17 358+12 349+24 341+20
n = 12 11 12 5 5 45
Values are mean weights (g)+SD; Time in  weeks;
Column headed "Mean" shows mean weight regardless of treatment
-  1 1 2  -
TABLE 13
CONSUMPTION OF DIET AND WATER BY THE ANIMALS
DIET DRUG TREATMENT
NONE APROTININ INDOMETHACIN SALINE ETHANOL
HIGH FAT, LOW FIBRE DIET
DIET
13.6±1.5 
22.8±1.0
13.2±2.4 
23 . 6±1.1
11.8+1.4 
21.6±0.9
22.9±1.0 
19.5±0.9
21,4±0.9  
18.8±0.7
WATER
26.9±5.1 
26.7±8.6
22. 7±7.1 
24 .2±4.1
24 .1±7.1 
21.4±4.7
24.2+4.0
19.0±4.9
22.5±2.8  
21 . 1±3.1
LOW FAT, HIGH FIBRE DIET
DIET
29 .2±2.0 
20.2±1.2
27 .6±1.6 
19.9±1.1
29.8+1.2 
22 .8±1.0
27.5±1.9 
17.8±1.7
27.4±1.6 
18.7±1.3
WATER
31.4±4.2 
21 .9±4.2
26 .5±3.5 
27.0±3.4
26.8±1.9 
27.4±3.0
30.8+4.9
23.2±3.8
30.9±3.6
23.5±3.0
STANDARD DIET
DIET
19.6±1.9 
23 .3±1.1
19.9±0.9
23.9±0.6
21.4±2 .1 
22.7±1.4
23.8±0.6  
19 .8±2 .1
2 3 .1±0.7 
2 2 .0± 2 .1
WATER
32.0+3.8  
25 .5+3.2
25 .1±4.9 
24.4±2.9
28.9±5.4 
23.3±2.8
30.0+5.6
18.1±1.0
30.0±5.6
21.2±2.7
Values in  i t a l i c s  are fo r  animals re c e iv in g  carcinogen
trea tm en t.
Diet consumption is in g.animal day * 
Water consumption is in ml.animal day 
Values are mean ± SD
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TABLE 14a
KALLIKREIN ACTIVITY IN THE RAT COLON
DIET: High F at, Lou F ibre d ie t
COLON SEGMENT: CAECUM PROX. COLON MID COLON DIST. COLON RECTUM n
CARCINOGEN : NO YES NO YES NO YES NO YES NO YES NO YES
DRUG_________HME
NIL 4 118+34 ................ 46+22........... 33+13 .......... 56+27 .......... 32+ 7 ............  4 -
16 164+41 210+48 81+32 98+38 50+15 46+16 63+20 67+25 32+ 7 34+ 5 8 6
24 38+23 167+46 34+ 7 65+27 23+6 48+30 57+25 52+17 19+ 7 29+10 4 9
APROTININ 4 78+48   35+15   32+11   31+14.... .......... 12+ 5   7 -
16 119+32 141+102 26+ 7 72+67 21+ 4 57+50 25+ 8 69+60 16+ 7 51+38 6 6
24 104+72 170+39 48+31 58+35 25+ 8 23+ 9 27+ 6 40+12 20+12 24+ 9 6 5
INDOMETHACIN 4 132+36 36+18 30+10 42+13 19+ 7 8 -
16 190+66 176+56 74+41 111+82 43+15 61+67 45+14 72+52 23+ 7 39+35 6 5
24 145+46 181+45 46+17 57+41 41+ 5 26+12 37+12 28+12 31+16 33+ 9 6 6
SALINE 4 172+55 64+28 50+14 63+24 26+ 4 4 -
VEHICLE 16 139+20 182+38 24+ 5 35+14 22+ 3 34+ 6 24+ 6 49+ 8 10+ 4 21+ 7 5 5
24 125+69 217+66 66+44 54+19 60+15 31+11 66+25 37+21 50+26 26+12 4 5
ETHANOL 4 161+29 50+20 22+ 8 57+ 7 23+ 6 4 -
VEHICLE 16 158+18 180+30 22+ 5 38+16 24+ 4 36+11 26+ 9 48+20 12+ 3 21+ 4 5 5
24 222+15 202+87 98+40 46+28 75+15 32+ 9 90+26 56+13 67+34 29+15 4 6
Values shown are  mean + standard devia tion
. '1
K a ll ik re in  a c t iv i t y  expressed as nmolpNA.min .g 
Time expressed as weeks
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TABLE 14b
KALLIKREIN ACTIVITY IN THE RAT COLON
DIET: Lou F at, High F ibre d ie t .
COLON SEGMENT: CAECUM PROX. COLON MID COLON DIST. COLON RECTUM n
CARCINOGEN : NO YES NO YES NO YES NO YES NO YES NO YES
DRUG_________TIME
NIL 4 135+17 57+21 40+14 45+22 24+ 9 3 -
16 132+50 185+47 51+33 48+18 45+32 37+ 6 63+55 36+ 8 28+26 33+ 5 8 6
24 152+53 160+24 101+26 35+14 56+12 33+ 9 47+17 42+ 8 32+15 23+10 4 6
APROTININ 4 114+75 30+17 18+ 4 23+10 24+10 8 -
16 162+32 136+53 24+ 9 44+17 25+ 2 26+10 36+11 31+13 19+10 30+18 6 6
24 173+47 164+80 34+11 54+41 31+13 55+51 30+10 48+37 22+ 7 36+23 6 6
INDOMETHACIN 4 146+65 48+30 30+12 48+16 24+ 6 4 -
16 63+28 34+20 31+ 4 28+ 9 26+ 7 24+ 5 27+ 8 26+ 9 20+ 7 12+ 4 6 4
24 149+36 148+31 44+12 42+12 48+15 28+10 42+19 50+27 21+ 7 29+22 6 6
SALINE 4 130+20 32+13 21+10 57+35 18+ 6 4 -
VEHICLE 16 198+18 125+27 70+20 24+ 6 33+10 33+12 42+16 26+ 6 24+ 9 11+ 3 5 5
24 160+20 211+15 72+26 87+40 54+14 60+45 49+18 94+67 67+ 3 62+44 4 5
ETHANOL 4 152+29 54+26 27+10 65+38 22+ 8 4 -
VEHICLE 16 154+33 148+60 27+ 9 29+ 7 22+ 2 25+ 7 25+ 3 37+10 14+ 4 19+ 6 5 5
24 146+65 193+78 82+45 42+13 61+22 37+10 62+25 56+32 32+17 32+21 4 5
Values shown are mean + standard devia tion
-1
K a ll ik re in  a c t iv i t y  expressed as nmolpNA.min .g 
Time expressed as weeks
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TABLE 14c
KALLIKREIN ACTIVITY IN THE RAT COLON
DIET: Standard Laboratory d ie t .
COLON SEGMENT: CAECUM PROX. COLON MID COLON DIST. COLON RECTUM n
CARCINOGEN : NO YES NO YES NO YES NO YES NO YES NO YES
DRUG_________TIME
NIL 4 182+53 54+26 54+10 60+25 42+24 9 -
16 217+94 212+33 52+12 39+13 42+11 38+15 62+27 39+ 4 34+12 24+ 6 6 6
24 115+61 146+51 36+11 95+39 34+10 47+10 34+16 56+11 22+15 41+13 6 6
APROTININ 4 134+38 43+36 34+21 24+10 10+ 5 5 -
16 137+22 145+41 30+15 36+15 26+ 7 20+ 7 22+ 6 32+22 17+ 5 17+10 6 6
24 119+21 105+41 32+22 41+35 19+ 3 19+ 5 28+ 8 32+12 19+ 5 21+10 4 5
INDOMETHACIN 4 152+68 29+10 40+36 32+ 6 20+ 7 6 -
16 93+34 146+35 30+ 9 36+11 26+ 9 31+ 9 22+ 7 38+20 16+ 6 14+ 3 6 6
24 141+50 163+65 43+27 58+21 32+ 9 34+ 6 42+26 40+12 23+ 7 43+14 5 6
SALINE 4 125+60 48+36 23+ 9 24+ 3 17+ 4 8 -
VEHICLE 16 174+38 199+56 33+11 41+25 33+ 5 29+ 6 30+ 4 39+14 25+14 21+12 5 4
24 207+56 156+52 40+23 44+13 24+12 44+16 40+17 48+15 23+14 30+12 4 5
ETHANOL 4 94+43 42+19 14+ 2 20+ 4 14+ 4 4 -
VEHICLE 16 164+32 177+44 43+43 39+ 6 27+ 6 31+ 9 29+ 8 47+20 21+ 7 22+ 5 5 5
24 160+39 142+39 76+25 47+11 20+ 5 38+12 29+14 56+37 18+ 6 30+ 7 2 5
Values shown are mean + standard devia tion
-1
K a ll ik r e in  a c t iv i t y  expressed as nmolpNA.min .g 
Time expressed as weeks
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TABLE 15
KALLIKREIN ACTIVITY IN RAT COLON
The e ffe c ts  of d ie t  and drug treatm ent by segment of colon.
NO DRUG SALINE VEHICLE ETHANOL VEHICLE APROTININ INDOMETHACIN
CARCINOGEN_______ NO______ YES______ NO______ YES______ NO______ YES______ NO______ YES______ NO YES
DIET TIME SEGMENT
4 & 16 A 149+43 210+48 154+40 182+39 160+22 180+30 105+53 141+102 157+57 189+59
HIGH FAT 4 & 16 B-E 52+15 61+15 33+19 35+ 7 30+12 36+ 6 24+12 62+52 38+23 75+65
LOU FIBRE n 12 6 9 5 9 5 13 6 14 5
DIET 24 A 38+23 167+46 125+69 217+66 222+15 202+87 123+62 170+39 145+46 181+45
24 B-E 33+ 6 49+16 60+26 37+12 83+12 41+ 9 30+20 36+21 39+14 36+25
n 4 9 4 5 4 5 6 5 6 6
4 & 16 A 133+43 185+47 168+40 125+27 153+29 148+60 135+64 136+53 106+66 34+20
LOU FAT 4 & 16 B-E 45+31 38+ 6 38+11 23+ 4 31+14 28+ 4 25+11 33+16 31+15 22+ 9
HIGH FIBRE n 11 6 9 5 9 5 14 6 10 4
DIET 24 A 152+53 160+24 160+20 211+15 146+65 193+78 173+47 164+80 149+36 148+31
24 B-E 59+11 33+ 8 51+ 8 76+47 59+23 42+18 29+11 48+37 39+17 37+20
n 4 6 4 5 4 5 6 6 6 6
4 & 16 A 191+71 212+33 144+57 199+56 133+51 177+44 136+27 145+41 122+60 146+35
4 & 16 B-E 50+21 35+12 29+18 32+16 27+19 35+14 26+17 26+16 27+15 30+15
STANDARD n 16 6 13 4 9 5 12 6 12 6
DIET 24 A 115+61 146+51 207+51 156+52 146+33 142+39 119+21 105+41 138+45 163+65
B-E 32+14 60+30 32+17 42+14 37+27 43+21 24+12 28+19 37+20 44+16
n 6 6 4
-----------
5
-----s-l-------
4 5 6 5 6 6
K a ll ik re in  values expressed as nmolpNA.min .g tissue (Mean + SD) 
Segment A = Caecum; Segment B - E = D is ta l Colon segments; Time in weeks
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TABLE 16
COMPARISON OF THE PLACEBO GROUPS: p robab il it ies .
Tissue k a i l ik re in -1 ik e  amidase a c t iv i ty .
Comoarison p - value
Diet : High fa t  vs Low fa t 0.4190
Placebo groups vs no drug 0.7620
Time: 4 & 16 vs 24 weeks 0.1160
No carcinogen vs carcinogen 0.0500
Segment: A vs B - E 0.0000
These comparisons are only for the placebo groups - i . e .  
the sa line -trea ted  and ethanol-treated animals and the animals 
receiving no drugs.
The comparisons indicate that there is no systematic 
e f fe c t  of d ie t ,  treatment (saline , ethanol or no drug) or time on
the levels  of TKLA measured in the control animals.
The e f fe c t  of carcinogen is very marginal and is not 
considered s ign if ican t by th is  analysis. The e ffec t of segment is
c lear  and is discussed in the tex t .
For further analysis the placebo groups were merged for  
analysis with respect to d ie t and drug treatment.
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TABLE 17
KALLIKREIN ACTIVITY IN RAT COLON
The e ffe c ts  of d ie t  and drug treatm ent by segment of colon.
POOLED CONTROL APROTININ INDOMETHACIN
CARCINOGEN NO YES NO YES NO YES
DIET TIME SEGMENT
4 & 16 A 153+35 192+38 105+53 141+102 157+57 189+59
HIGH FAT 4 & 16 B-E 40+24 45+26 24+12 62+52 38+23 75+65
LOU FIBRE n 30 16 13 6 14 5
DIET 24 A 128+80 189+61 123+62 170+39 145+46 181+45
24 B-E 58+32 44+22 30+20 36+21 39+14 36+25
n 12 19 6 5 6 6
4 & 16 A 150+38 155+48 135+64 136+53 106+66 34+20
LOU FAT 4 & 16 B-E 38+27 30+12 25+11 33+16 31+15 22+ 9
HIGH FIBRE n 29 16 14 6 10 4
DIET 24 A 153+42 186+46 173+47 164+80 149+36 148+31
24 B-E 56+28 49+35 29+11 48+37 39+17 37+20
n 12 16 6 6 6 6
4 & 16 A 161+64 196+40 136+27 145+41 122+60 146+35
4 & 16 B-E 37+22 34+13 26+17 26+16 27+15 30+15
STANDARD n 38 15 12 6 12 6
DIET 24 A 150+57 148+42 119+21 105+41 138+45 163+65
B-E 33+18 49+24 24+12 28+19 37+20 44+16
n 14 16 6
-=-i-------------
5
— =-t----------
6 6
K a l l ik r e in  values expressed as nmolpNA.min .g tissue (Mean + SD) 
Segment A = Caecum; Segment B - E = D is ta l Colon segments; Time in  weeks
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TABLE 18
KALLIKREIN ACTIVITY IN THE RAT COLON 
The e f fe c t  of drug treatment
Pooled d ie ts  - high f a t ,  low f ib re  and low fa t ,  high f ib re .  
Pooled placebo groups
POOLED CONTROL APROTININ INDOMETHACIN
CARCINOGEN NO YES NO YES_______ NO YES
TIME SEGMENT
4 & 16 A
4 & 16 B-E
24 A
24 B-E
152±38 173±49 
39+20 38±15 
59 32
140+70 188±57 
58±21 46±24 
24 35
116±58 139+78 
25+ 6 48+37 
27 12
139+68 167+62 
30± 5 43±29 
12 11
132±65 113+85 
35+12 49+44 
24 9
147±39 164+40 
39±10 37±13 
12 12
K a ll ik re in  values are in nmolpNA.min *.g * 
Time expressed in weeks.
Segment A = Caecum
Segment B - E = Distal colonic segments
-  1 2 0  -
TABLE 19a
PROSTAGLANDIN CONTENT OF THE RAT COLON.
DIET: high f a t ,  low f ib r e  d ie t
COLON SEGMENT: 
CARCINOGEN
CAECUM 
NO YES
55+19 ..........
120+44 122+53 
34+11 107+54
103+15 ..........
42+37 73+16
71+20 107+36
56+13 ..........
69+13 80+26
48+ 8 106+70
104+22 ..........
  202+102
65 86+14
76+17 ..........
58+ 4 112+34
PROX. COLON 
NO YES
51+29...... ..........
252+114 138+91 
38+16 143+94
163+77 ..........
158+37 68+ 6
166+53 153+67
77+29...... ..........
98+64 71+18
54+30 128+77
112+59 ..........
  200+19
56 84+26
93+19 ..........
94+ 2 131+37
MID COLON 
NO YES
96+46 .........
313+196 184+91 
128+92 203+102
172+77 .........
279+76 142+56 
137+52 230+172
111+70 .........
106+76 156+52 
64+40 168+67
159+56 .........
  298+34
192 151+33
148+33 .........
96+32 277+87
DIST. COLON 
NO YES
101+36 ..........
316+192 294+238 
116+24 173+48
198+48 ..........
520+459 106+28 
230+114 232+69
99+34 ..........
154+26 142+23 
111+90 146+74
172+63 ..........
  328+156
108 128+35
173+64 ..........
98+18 315+67
RECTUM n
NO YES NO YES
108+41  3 -
225+95 124+44 6 4 
184+52 186+55 4 9
170+67   7 -
366+392 74+66 4 2 
209+70 163+65 6 6
115+51  8 -
143+58 146+34 2 4 
129+61 194+54 6 -
173+87   4 -
  248+24 - 2
175 140+59 1 5
145+20   4 -
78+ 7 224+39 2 5
DRUG TIME
NIL 4
16
24
APROTININ 4 
16 
24
INDOMETHACIN 4 
16 
24
SALINE
VEHICLE
ETHANOL
VEHICLE
4
16
24
4
16
24
Values shown are  mean + standard devia tion
-1
P rostg landin  content expressed as ng.g PGE  ^
Time expressed as weeks
-  1 2 1  -
TABLE 19b
PROSTAGLANDIN CONTENT OF THE RAT COLON.
DIET: low f a t ,  high f ib r e  d ie t .
COLON SEGMENT: CAECUM PROX. COLON MID COLON DIST. COLON
CARCINOGEN : NO YES NO YES NO YES NO YES
DRUG_________TIME
NIL 4 66+ 8   37+15   130+44   178+63 ..........
16 119+18 132+51 116+38 88+57 233+97 199+117 256+146 223+67
24 55 74+20 71 127+67 222 150+58 79 199+40
APRO TININ 4 73+16   86+61   147+28   137+34 --------
16   110+ 8   98+32 ..................  122+13  167+65
24   209+112   157+50 ..................  202+20  245+57
INDOMETHACIN 4 102+56   98+22   161+14   176+64.........
16 110+14 110+30 133+58 124+43 200+54 188+36 228+78 168+76
24 68+37 59+17 52+29 96+46 62+16 115+35 81+51 134+29
SALINE 4 90+17   84+28   206+121   201+83... .....
VEHICLE 16   297+173   232+74 ..................  411+108 . 471+107
24 70+24 157+52 121+48 137+67 182+83 278+123 128+30 376+178
ETHANOL 4 77+28   92+59   171+90   170+38........
VEHICLE 16 ....................................................................................................................................
24 46+14 110+ 8 78+27 262+163 117+24 220+42 135+62 193+30
RECTUM n
NO YES NO YES
182+16  3 -
196+68 171+73 6 3 
125 222+53 1 6
145+54   8 -
  128+ 5 - 2
  282+26 - 4
179+92   4 -
206+79 166+55 6 4 
137+47 140+78 3 4
221+103 .........  4 -
  466+45 - 4
128+37 238+54 4 4
154+43   4 -
140+41 200+34 4 2
Values shown are  mean + standard dev ia tion
-1
P rostg landin  content expressed as ng.g PGE  ^
Time expressed as weeks
-  1 2 2  -
TABLE 19c
PROSTAGLANDIN CONTENT OF THE RAT COLON.
DIET: standard labora tory  d ie t .
COLON SEGMENT: 
CARCINOGEN
CAECUM 
NO YES
PROX. COLON 
NO YES
MID COLON 
NO  YES
DIST. COLON 
NO YES
RECTUM 
NO YES
n
NO YES
DRUG TIME
NIL 4
16
24
66+32
62+37
76+12 57+15
70+45 ........... 132+94 ..........  130+90 ............  134+96   9 -
104+87 ........... 266+168 .............  218+190 .... 107+69   6 -
74+57 45+14 162+59 78+19 187+84 102+41 167+40 107+41 6 6
APROTININ 4
16
24
66+26   85+43 ..........
  70+17 ............  100+23
79+30 107+55 101+34 105+38 156+44 185+90 162+69 193+93 151+62 199+67 6 5
96+37   133+75   133+32   6 -
  147+19   171+35   142+25 - 2
INDOMETHACIN 4 48+19 ...........  53+30 ...........  70+52   68+38 ............  88+48   6 *
16 95+54 78+19 110+58 88+44 151+53 166+14 154+53 183+51 153+43 150+47 6 4
24 56+21 86+47 79+29 90+45 153+48 124+76 175+83 123+80 159+55 152+99 6 3
SALINE
VEHICLE
ETHANOL
VEHICLE
4
16
4
16
171+68 151+70 216+70 424+237 296+105
24 142+38 85+43 210+101 98+19 326+199 214+38 297+49 188+44 223+35 158+30 4 4
110+27 162+96 192+55 200+75 274+67
24 141+28 78+17 143+27 93+37 257+111 153+22 242+42 141+48 260+72 189+49 4 5
Values shown are  mean + standard dev ia tion
-1
P rostg landin  content expressed as ng.g PGE  ^
Time expressed as weeks
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TABLE 20
PROSTAGLANDIN CONTENT OF THE RAT COLON
The e ffe c ts  o f d ie t  and drug treatm ent by segment of colon.
CARCINOGEN
NO DRUG 
NO YES
SALINE
NO
VEHICLE
YES
ETHANOL
NO
VEHICLE
YES
APROTININ 
NO YES
INDOMETHACIN 
NO YES
DIET TIME SEGMENT
4 & 16 A 98+48 122+53 104+22 202+102 76+17 113+34 73+16 63+17 80+26
HIGH FAT 4 & 16 B-E 214+138 185+109 154+62 268+37 140+16 234+196 97+46 108+50 129+46
LOU FIBRE n 9 4 4 2 4 11 2 10 4
DIET 24 A 34+11 107+54 65 86+14 58+ 3 112+34 71+20 107+36 48+ 8 106+70
24 B-E 116+39 176+67 133 133+35 92+14 237+40 171+88 195+104 89+63 159+68
n 4 9 1 5 2 5 6 6 5 6
4 & 16 A 101+30 132+51 90+17 297+173 77+27 73+16 110+ 8 106+33 110+30
LOU FAT 4 & 16 B-E 177+74 170+61 178+67 395+15 146+51 128+51 129+39 180+76 161+55
HIGH FIBRE n 9 3 4 4 4 8 2 10 4
DIET 24 A 55 74+20 70+24 157+52 45+14 110+ 8 209+112 68+37 39+18
24 B-E 124 174+22 140+37 257+95 117+22 219+14 222+61 83+47 121+49
n 1 6 4 4 4 2 4 3 4
4 & 16 A 66+32 171+68 110+27 66+26 70+17 72+46 78+19
4 & 16 B-E 141+115 272+166 207+79 112+51 140+34 106+59
147+52
STANDARD n 15 6 4 6 2 12
4
DIET 24 A 76+12 57+15 142+38 75+44 141+28 78+17 79+30 107+55
56+21 74+45
24 B-E 148+73 83+38 267+115 162+57 225+80 144+51 142+56 170+79
141+65 97+59
n 6 6
------- -
4 5 4 5 6 5 6
6
Prostaglandin content expressed as ng.g PGE  ^ (Mean+SD)
Segment A = Caecum; Segment B - E = D is ta l Colon segments; Time in weeks
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TABLE 21
COMPARISON OF THE PLACEBO GROUPS: probabilit ies.
Tissue PGE2.
Comparison___________ p - value
Diet : High fa t  vs Low fa t 0.2439
Placebo groups vs no drug 0.0668
Time: 4 & 16 vs 24 weeks 0.0000
No carcinogen vs carcinogen 0.0000
Segment: A vs B - E 0.0000
These comparisons are only for the placebo groups - i . e .
the sa l in e -trea ted  and ethanol-treated animals and the animals
receiving no drugs.
The comparisons indicate that there is no systematic 
e f fe c t  of d ie t  or treatment (saline, ethanol or no drug) on the
leve ls  of PGE2 measured in the control animals.
There are c lear effects of time, carcinogen 
adm inistration and segment on the PGE2 levels measured and for 
fu r th e r  analysis the placebo groups w il l  be merged with respect 
to d ie t  and drug treatment but considered separately for other 
comparisons.
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TABLE 22
PROSTAGLANDIN CONTENT OF THE RAT COLOM
The e ffe c ts  o f d ie t  and drug treatm ent by segment of colon.
POOLED CONTROL APROTININ INDOMETHACIN
CARCINOGEN NO YES_______ NO YES________ NO YES
DIET TIME SEGMENT
4 & 16 A 93+35 149+62 113+34 73+16 63+17 80+26
HIGH FAT 4 & 16 B-E 179+119 186+83 234+196 97+46 108+50 129+46
LOW FIBRE n 17 6 11 2 10 4
DIET 24 A 48+15 103+39 71+20 107+36 48+ 8 106+70
24 B-E 113+59 179+83 171+88 195+104 89+63 159+68
n 7 19 6 6 5 6
4 & 16 A 93+26 239+128 73+16 110+ 8 106+33 110+30
LOU FAT 4 & 16 B-E 170+90 186+83 128+51 129+39 180+76 161+55
HIGH FIBRE n 17 7 8 2 10 4
DIET 24 A 59+18 108+45 209+112 68+37 39+18
24 B-E 129+50 209+99 222+61 83+47 121+49
n 9 10 4 3 4
4 & 16 A 97+58 540+257 66+26 70+17 72+46 78+19
4 & 16 B-E 182+134 584+265 112+51 140+34 106+59 147+52
STANDARD n 25 2 6 2 12 4
DIET 24 A 114+38 69+26 79+30 107+55 56+21 74+45
24 B-E 203+99 126+58 142+56 170+79 141+65 97+59
n 14 16
------ =-i—
6 5 6 6
Prostaglandin  content expressed as ng.g PGE  ^ (Mean+S.D.)
Segment A = Caecum; Segment B - E = D is ta l Colon segments; Time in weeks
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TABLE 23
PROSTAGLANDIN CONTENT OF THE RAT COION.
The e ffe c t  of drug treatment
Pooled d ie ts  - high f a t ,  low f ib re  and low fa t ,  high fib re .  
Pooled placebo groups
POOLED CONTROL APROTININ INDOMETHACIN
CARCINOGEN NO YES NO YES NO YES
TIME SEGMENT
4 & 16 A 94+32 191+125 98±34 92±24 83+36 95±31
4 & 16 B-E 176+88 259±117 188±124 113±19 141±57 145±31
n 34 13 19 4 20 8
24 A 52+20 105+44 71±20 148±87 56+23 87+59
24 B-E 121±30 191±66 171±51 206+54 87±36 144+46
n 16 31 6 10 8 10
Prostaglandin content expressed as ng.g PGE2 
Time expressed in weeks.
Segment A = Caecum
Segment B - E = Distal colonic segments
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TABLE 24a
r.RYPT CELL PRODUCTION RATES 
High f a t ,  low f ib re  d ie t
C O L O N  S E G M E N T  
DRUG CARCINOGEN TIME CAECUM MID COLON DIST. COLON RECTUM
NO 4 0.248±0.023 0.250±0.074 0.100±0.071 0.195+0.041
16 0 . 191±0.024 0.238+0.053 0.128+0.010 0.159±0.037
NONE 24 0.221+0.038 0.326+0.034 0.203±0.033 0.134+0.015
YES 16 0 . 233±0.017 0.475±0.087 0.445±0.080 0.102±0.037
24 0.323±0.037 0.176±0.044 0.128±0.041 0.123±0.009
NO 4 0.174+0.035 0.152±0.039 0.251+0.064 0 .179±0.124
16 0.12 9±0.019 0 .191±0.029 0.335±0.031 0.290+0.041
APROTININ 24 0.081±0.071 0.033±0.024 0.145+0.073 0.300+0.062
YES 16 0.131+0.036 0.087+0.024 0.247+0.102 0.232+0.061
24 0 . 143±0.033 0.267±0.076 0.359+0.124 0.261±0.064
NO 4 o . 277±0.115 - ............ ........ 0 .097±0.057 0.089+0.072
16 0 . 203±0.145 0.145+0.121 0.136+0.021 0.209+0.094
INDOMETHACIN 24 0.149+0.032 -0.049+0.036 0.160+0.067 0.031±0.046
YES 16 ....................................................................................................
24 0 . 184±0.039 0.108+0.048 0.246±0.036 0.068+0.051
Values show the slope of the l in e  of regression + standard error.
The slope represents the crypt cell production rate in cells.min .crypt .
Time in weeks
- 128 -
TABLE 24b
CRYPT CELL PRODUCTION RATFS
Low fa t  , high f ib re  d ie t  
DRUG CARCINOGEN TIME
C
CAECUM
0 L 0 N S 
MID COLON
E G M E 
DIST. COLON
N T 
RECTUM
NO 4
16 0 . 107±0.031 0.057+0.026 0 .145±0.073 0.264±0.033
NONE 24 0.255+0.065 0.105+0.046 0 . 193±0.013 0.278±0.080
YES 16 0 . 185±0.049 0.193+0.060 0.529±0.059 0.204±0.052
24 0.155+0.028 0.050+0.018 0.129+0.028 0.092±0.024
NO 4 0.218±0.026 0.039+0.087 0 . 191±0.038 0.128+0.068
16 0 . 177±0.055 0 .137±0.023 0 . 158±0.032 0 . 165±0.028
APROTININ 24 0 . 177±0.022 0.090+0.030 0.016+0.033 0 .091±0.017
YES 16 0 . 163±0.054 0.065+0.063 0.176+0.054 0.238±0.048
24 0 .121±0.042 0.098+0.050 0 . 137±0.038 0 . 161±0.028
NO 4 0 . 136±0.067 0.089+0.031 0.082±0.015 0.137+0.035
16 0.185+0.030 0.117+0.020 0.101+0.025 0.074+0.046
INDOMETHACIN 24 0 .1 13±0.022 0 . 151±0.012 0.130+0.031 0 .148±0.062
YES 16 0 . 159±0.078 0.006+0.055 0.299±0.080 0.133+0.108
24 0 .217±0.045 0.212+0.024 0 . 143±0.049 0 .098±0.038
Values show the slope of the line  of regression ± standard error.
The slope represents the crypt cell production rate in cells.min .crypt 
Time in weeks
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TABLE 24c
CRYPT CELL PRODUCTION RATFS
Standard laboratory d ie t  
DRUG CARCINOGEN TIME
C
CAECUM
0 L 0 N S 
MID COLON
E G M E 
DIST. COLON
N T 
RECTUM
NO 4 0.150+0.071 0 . 137±0.022 0.078+0.050 0.049+0.014
16 0.194+0.039 0 . 136±0.031 0.117+0.040 0.115±0.039
NONE 24 0.212±0.066 0.256+0.043 0.260+0.061 0.141+0.031
YES 16 0 . 187±0.055 0.300+0.061 0.279+0.034 0.092±0.022
24 0 . 142±0.055 0 .158±0.039 0.148+0.034 0 .155±0.035
NO 4 0.213+0.062 0 .125±0.034 0.255+0.041 0.366+0.092
16 0.063±0.021 ■-0.017+0.062 0.026+0.012 0.131±0.051
APROTININ 24 0 . 136±0.034 0.062+0.015 0.072+0.017 0 . 153±0.032
YES 16 0.284+0.030 0 .173±0.019 0.182+0.056 0 .221±0.016
24 0.097±0.043 0 . 170±0.048 0.164+0.039 0.158+0.056
NO 4 0 . 186±0.066 0.230+0.029 0.176+0.037 0.080±0.034
16 0.056±0.048 0.080+0.062 0.143+0.093 0 .299±0.168
INDOMETHACIN 24 0.090±0.040 0.063+0.035 0.116+0.017 0.041±0.017
YES 16 0.010+0.049 0.006±0.012 0.183+0.099 0.097±0.054
24 0.098±0.062 0.077±0.024 0.165+0.056 0.158+0.020
Values show the slope of the l ine  of regression ± standard error.
The slope represents the crypt cell production rate in cell s.min .crypt 
Time in weeks
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TABLE 25a
RAT FAECAL CONSTITUENTS 
Animals not receiving carcinogen
High fa t ,  Low fa t ,  Standard
______________________ Low f ib re  d iet High f ib re  d iet d iet
NEUTRAL STEROIDS
Coprostanol 
Cholesterol 
Total plant sterols
1.38+0.74 
2.57+0.84 
5.90±1.82
0.80+1.60
0.73+0.54
2.08+1.08
0.50+0.17 
1.04+0.29 
4.47±1.03
TOTAL STEROLS 9.85+2.65* 3.61+3.02 6. 02± 1.39
LONG CHAIN FATTY ACIDS
Palm itic  acid 
Unsaturated F.A. 
Stearic  acid
12.73+3.15 
10.71+3.74 
12.42±2.89
0.79+0.43
1. 02+1.02
0.69±0.27
0.85+0.23 
1.85+1.26 
0.43+0.15
TOTAL FATTY ACIDS 35.86+8.41* 2.49+1.51 3 . 13±1.43
FREE BILE ACIDS
Lithocholic  acid 
Deoxycholic acid 
Chenodeoxycholic acid 
Hyodeoxycholic acid 
Muricholic acids
0.30+0.07 
2.04+0.74 
0. 20+0.10 
0.49+0.27 
1.07±1.00
0.22+0.13
0.67+0.47
0.14+0.13
0.38+0.24
0.20+0.29
0.22+0.09
1.37+0.90
0.17+0.11
1.16+1.11
1.07±0.87
TOTAL BILE ACIDS 4.59+2.62+ 1.58+1.12 4.09+2.35
n = 13 11 13
Notes
1 .Values shown are expressed in mg.g  ^ of dry faeces (mean + SD).
2 . Totals may not equal the sum of the preceding components since 
the to ta l  value was calculated from the individual points.
3 . Unsaturated F.A. = l in o le ic ,  l ino len ic  and oleic acids.
4 . *  = greater than other d ie ts , p<0.005.
+ = greater than low fa t ,  high f ib re  d ie t ,  p<0.005
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TABLE 25b
RAT FAECAL CONSTITUENTS
Animals receiving carcinogen
High fa t ,  
Low f ib re  d iet
Low fa t ,
Hi ah f ib re  d iet
Standard
d iet
NEUTRAL STEROIDS
Coprostanol 
Cholesterol 
Total plant sterols
1.40+0.53 
2.92+0.62 
4.78±1.10
0.23+0.06 
0.50+0.06 
1.55+0.66
0.87+0.25 
0.87+0.56 
2.59±1.85
TOTAL STEROLS 9.00+1.65* 2.28+0.73 4.33+2.64
LONG CHAIN FATTY ACIDS
Palmitic acid 
Unsaturated F.A. 
Stearic  acid
13.71+4.81
14.09+5.43
12.60+4.33
0.54+0.45 
0.62+0.37 
0.77±1.01
1.24+0.63
1.77+1.49
1.73±0.32
TOTAL FATTY ACIDS 40.41±14.22* 1 .93±1.48 4.74+2.29
FREE BILE ACIDS
Lithocholic acid 0.25+0.09 
Deoxycholic acid 1.68±0.79 
Chenodeoxycholic acid 0.19+0.07 
Hyodeoxycholic acid 0.80+0.48 
Muricholic acids 1.26+1.14
0.16+0.04
0.49+0.23
0.06+0.02
0.37+0.21
0.29+0.20
0.23+0.10 
0.79+0.52 
0.15+0.07 
0.37+0.40 
0.22±1.18
TOTAL BILE ACIDS 4.77±2.45* 1.39+0.36 1 .72±2.05
n 10 10 9
Notes
1 .Values shown are expressed in mg.g * of dry faeces (mean + SD).
2 . Totals may not equal the sum of the preceding components since 
the to ta l value was calculated from the individual points.
3 . Unsaturated F.A. = l in o le ic ,  l ino len ic  and o le ic  acids.
4. *  = greater than other d iets , p<0.005.
+ = greater than low fa t ,  high f ib re  d ie t ,  p<0.05
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TABLE 26
DIET/DRUG
GROUP ANIMAL NO
TUMOURS IN 
. SITE OF
RATS
LESION HISTOLOGY
GROUP 50 84/274 colon - 16cm tubular adenoma
duodenum adenocarcinoma
STANDARD 84/275 colon - 14cm adenocarcinoma
DIET 84/279 colon - 11cm adenocarcinoma
colon - 16cm tubulovillous
adenoma
NO DRUGS 84/280 colon - Ocm adenocarcinoma
84/281 colon - 16cm tubular adenoma
24 WEEKS 84/282 colon - 18cm tubular adenoma
ileum adenocarcinoma
84/284 colon - 15cm tubular adenoma
colon - 16cm tubular adenoma
84/285 colon - 18cm adenocarcinoma
GROUP 53
STANDARD
DIET
APROTININ 
24 WEEKS
84/306
84/309
84/312
84/313
84/316
84/317
colon - 12cm 
colon - 20cm
ileum 
colon - 
colon - 
colon - 
colon - 
colon - 
jejunum 
colon - 
colon - 
colon -
10cm
17cm
12cm
24cm
25cm
10cm
15cm
20cm
tubular adenoma 
tubulovillous  
adenoma 
adenocarcinoma 
tubular adenoma 
tubular adenoma 
tubular adenoma 
tubular adenoma 
dysplastic focus 
adenocarcinoma 
adenocarcinoma 
adenocarcinoma 
adenocarcinoma
GROUP 56 84/338 colon - 10cm adenocarcinoma
84/343 colon - 10cm adenocarcinoma
STANDARD ileum adenocarcinoma
DIET 84/348 colon - 20cm adenocarcinoma
84/349 colon - 10cm adenocarcinoma
INDOMETHACIN
24 WEEKS
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TABLE 26 (continued)
TUMOURS IN RATS
DIET/DRUG
GROUP__________ ANIMAL NO. SITE OF LESION HISTOLOGY
GROUP 58
STANDARD
DIET
84/354
84/356
colon - 
ileum 
colon -
13cm
18cm
tubular adenoma
adenocarcinoma
adenocarcinoma
SALINE VEHICLE 
24 WEEKS
GROUP 60 NO TUMOURS
STANDARD
DIET
ETHANOL VEHICLE 
24 WEEKS
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TABLE 26 (continued)
DIET/DRUG
GROUP
TUMOURS IN 
ANIMAL NO. SITF OF
RATS
LESION HISTOLOGY
GROUP 63 84/379 colon - 8cm tubular adenoma
84/902 colon - Ocm adenocarcinoma
HIGH FAT 84/903 colon - Ocm adenocarcinoma
LOW FIBRE colon - 10cm adenocarcinoma
DIET 84/904 colon - 10cm adenocarcinoma
NO DRUGS
24 WEEKS
GROUP 66 84/405 colon - 15cm villous  adenoma
84/407 colon - 11cm adenocarcinoma
HIGH FAT colon - 16cm tubular adenoma
LOW FIBRE 84/411 colon - 6cm tubular adenoma
DIET 84/412 colon - 13cm tubular adenoma
84/414 colon - 10cm adenocarcinoma
APROTININ
24 WEEKS
GROUP 69 84/437 colon - 11cm adenocarcinoma
84/439 colon - 10cm adenocarcinoma
HIGH FAT 84/441 colon - 10cm adenocarcinoma
LOW FIBRE 84/443 colon - 11cm adenocarcinoma
DIET
INDOMETHACIN
24 WEEKS
GROUP 71 84/451 colon - Ocm adenocarcinoma
colon - 8cm adenocarcinoma
HIGH FAT 84/453 colon - 13cm adenocarcinoma
LOW FIBRE 84/454 colon - 16cm tubular adenoma
DIET 84/455 colon - 8cm adenocarcinoma
SALINE VEHICLE
24 WEEKS
GROUP 73 NO TUMOURS
HIGH FAT
LOW FIBRE
DIET
ETHANOL VEHICLE
24 WEEKS
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TABLE 26 (continued)
TUMOURS IN RATS
DIET/DRUG
GROUP ANIMAL NO. SITE OF LESION HISTOLOGY
GROUP 76 84/474 colon - 11cm adenocarcinoma
84/476 colon - 20cm adenocarcinoma
LOW FAT duodenum tubulovillous
adenoma
HIGH FIBRE 84/478 colon - 16cm villous  adenoma
DIET 84/911 colon - 17cm tubular adenoma
84/912 colon - Ocm adenocarcinoma
NO DRUGS
24 WEEKS
GROUP 79 84/506 colon - 17cm adenocarcinoma
84/511 colon - 18cm tubulovillous
adenoma
LOW FAT 
HIGH FIBRE 
DIET
APROTININ 
24 WEEKS
GROUP 82 NO TUMOURS
LOW FAT
HIGH FIBRE DIET
INDOMETHACIN 
24 WEEKS
GROUP 84 84/550 colon - 15cm adenocarcinoma
84/551 colon - 9cm adenocarcinoma
LOW FAT
HIGH FIBRE DIET
SALINE VEHICLE 
24 WEEKS
GROUP 86 NO TUMOURS
LOW FAT 
HIGH FIBRE 
DIET
ETHANOL VEHICLE 
24 WEEKS
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TABLE 27
TUMOURS IN RATS 
THE DISTRIBUTION OF ANIMALS WITH TUMOURS.
DRUG HIGH FAT, LOW FAT, STANDARD
TREATMENT LOW FIBRE DIET HIGH FIBRE DIET DIET
NONE 4 (9) 5 (9) 8 ( 12)
APROTININ 5 (10) 2 ( 12) 6 ( 11)
INDOMETHACIN 4 (12) 0 ( 12) 4 (12)
SALINE VEHICLE 4 (5) 2 (5) 2 (5)
ETHANOL VEHICLE 0 (5) 0 (5) 0 (5)
TOTAL FOR DIET 17 (41) 9 (43) 20 (45)
Figures show the number of animals with tumours
Figures in brackets indicate the number of animals in the group
For high fa t ,  low«fibre d iet versus low fa t ,  high f ib re  d ie t:
X = 4.140, p < 0.05
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TABLE 28
TUMOURS IN RATS 
THE DISTRIBUTION OF TUMOURS IN ANIMALS.
DRUG HIGH FAT, LOW FAT, STANDARD
TREATMENT_______ LOW FIBRE DIET HIGH FIBRE DIET DIET
NONE 5 (4) 6 (5) 12 (8)
APROTININ 6 (5) 2 (2) 12 (6)
INDOMETHACIN 4 (4) 0 5 (4)
SALINE VEHICLE 5 (4) 2 (2) 3 (2)
ETHANOL VEHICLE O O O  
TOTAL TUMOURS 20 (17) 10 (9) 32 (20)
Figures represent the to ta l number of tumours in each group 
Figures in brackets represent the number of animals with 
tumours.
TABLE 29
TISSUE KALLIKREIN-LIKE AMIDASE ACTIVITY 
AND PGEZ CONTENT 
IN ANIMALS WITH AND WITHOUT COLONIC TUMOURS.
Colonic tissue ka il ik re in -1 ik e  amidase a c t iv ity
COLON SEGMENT ANIMALS WITH TUMOURS ANIMALS WITHOUT TUMOURS
Caecum (A) 165 ± 51 (33) 169 ± 58 (52)
D istal colon (B-E) 42 ± 24 (33) 45 ± 28 (52)
Colonic PGE^  content
COLON SEGMENT ANIMALS WITH TUMOURS ANIMALS WITHOUT TUMOURS
Caecum (A) 99 ± 70 (33) 94 ± 45 (44)
Distal colon (B-E) 164 ± 101 (33) 166 ± 73 (44)
TKLA expressed as nmol pNA.mg ^.min
PGE2 expressed as mg.g *
Values are mean ± S.D. (n)
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TABLE 30
PLASMA INDOMETHACIN IN RATS
SAMPLE NUMBER________ INDOMETHACIN CONCENTRATION
1 1.0
2 0.8
3 1.0
4 1.0
5 4.2
6 0.5
7 0.4
8 0.6
9 0.6
10 0.8
11 0.9
12 1.1
13 0.6
14 0.6
Indomethacin concentrations shown in meg.ml 1 of plasma. 
Mean concentration is 1.00 ± 0.9mcg.ml 
Each sample came from a d iffe ren t animal.
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F I G U R E S
FIGURE 1
THE SYNTHESIS OF PROSTAGLANDINS.
The chart shows the synthesis of the major 
prostaglandins from arachidonic acid by 
cyclo-oxygenase. The source of the fa t ty  acids is  
shown and the pathway of formation of the 
leukotrienes is indicated.
Indomethacin blocks the a c t iv i t y  of 
cyclo-oxygenase.
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Synthesis of Prostaglandins
Linoleic acid cc-Linoleic acid
Eicosapentaenoic acid ^  3-series Prostaglandins
5-series Leukotrienes
Dihomo-y-Linolenic acid
\
1-series Prostaglandins 
3-series Leukotrienes
Arachidonic acid
COOH
LipoxygenaseCyclo-oxygenase
P G I:
PGF
PGD
2 a
0
HO
0
PGG 5 - Hydroperoxy-
eicosatetraenoic acid
P G H - T X A - T X B 2 4 -  series Leukoti ienes
PGE
COOH
HO OH
( Catabolism)
13,14-Dihydro-PGE2
FIGURE 2
EXPERIMENTAL PLAN
Animals were entered into the study at 
about 10 weeks of age. At th is  time, having been 
weaned on th e ir  standard laboratory d ie t ,  they 
commenced e ith e r  of the specialised d iets  or 
continued with th e ir  standard d ie t .  Any drug 
treatment was also commenced at th is  point.
Weekly in jections of azoxymethane began at 
the fourth week and were given fo r  twelve 
consecutive weeks.
Groups of animals were sacrif iced  fo r  
study at 4, 16 and 24 weeks a f te r  entry into the 
experiment.
(see pages 51-56 fo r  more d e ta i ls )
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FIGURE 3
EXAMPLES OF CRYPT CELL MICRODISSECTIONS.
The upper f igure  shows crypts from the 
caecum; the lower f igure  shows crypts from the 
d is ta l colon. The greater length of the d is ta l  
crypts is evident. The metaphase figures appear as 
dense points of staining in the lower crypt, 
( indicated by arrowheads)
(o r ig ina l magnification xlOO)
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FIGURE 4
PROPORTIONS of NEUTRAL STEROIDS, FATTY ACIDS and 
BILE ACIDS in FAECES
Each of the faecal components is shown as 
a percentage of the to ta l neutral steroids, fa t ty  
acids or b i le  acids.
Each d ie t  is presented separately.
Abbreviations:
COP = coprostanol 
XOL = cholesterol
Palm, acid = palm itic  acid 
Lin. acids = l in o le ic ,  l in o le n ic  
and o le ic  acids
LCA = l i th o ch o lic  acid 
DCA = deoxycholic acid 
CDCA = chenodeoxycholic acid 
HDCA = hyodeoxycholic acid 
Murichol = muricholates
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FIGURE 5
EXAMPLES OF COLONIC TUMOURS
The two figures opposite show the 
macroscopic appearance of the colonic tumours 
induced in the ra t  colon a f te r  treatment with 
azoxymethane.
The upper f igure  shows a sessile tumour of 
the d is ta l  colon and the lower f igure  shows a 
polypoid tumour at the caecal pole.
(scale in lower f igure  is  1cm)
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FIGURE 6
This f igure  i l lu s t r a te s  the abdominal 
viscera from an animal with carcinomatosis. The 
primary tumour is shown at *  and has been opened. 
M ultip le  peritoneal and mesenteric tumour deposits 
are evident. Liver metastases were also present, 
(not shown)
This appearance was exceptional at the 
stage examined (24 weeks) and was only seen in 
animals on the high f a t ,  low f ib re  d ie t .
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FIGURE 7
DISTRIBUTION OF TUMOURS IN THE COLON
Each tumour which developed in the animals 
was recorded and is i l lu s t ra te d  in th is  diagram.
At the time of s a c r if ic e  the distance of the 
tumour from the ileo-caecal junction junction was 
recorded and expressed as a percentage of the 
to ta l  length of the colon. The s ite  of the tumour 
was then plotted onto th is  diagram by proportion.
The more proximal location of tumours from 
aniamls on the high f a t ,  low f ib re  d ie t  is 
apparent when compared with those on the other two 
d ie ts .
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Distribution of Colon Tumours in the Rat
o #o
Duodenum O *  
Jejunum 
Deum
•  High fat, Low fibre diet
*  Low fat, High fibre diet 
O Standard laboratory dietooo
D I S C U S S I ON
There is l i t t l e  doubt that the development of colorectal 
cancer whether experimental or natura lly  occurring is 
conveniently and correctly regarded as a multi step process. 
(Maskens, 1976, 1978 & 1981) In the animal model i t  appears that 
colonic carcinogenesis is a two-step process. The f i r s t  step 
involves in i t ia t io n  of the tumour by administration of the 
carcinogen. The second step involves the promotion of the tumour 
by m u ltip lication  of the transformed c e l ls .  This study is an 
examination of tumour promotion - the study of agents which are 
not of themselves carcinogenic but which aid the development of a 
tumour. In the ra t model used in th is  study the in i t i a t o r  is 
c le a r ly  defined and the moment of i ts  exposure known. This 
contrasts with the situation in the human where neither the 
i n i t ia t in g  agent nor the time of i ts  exposure are known.
The principles governing current thinking in colorectal 
carcinogenesis may be conveniently summarised : " A p a rt ic u la r  
substrate is acted on by bacteria in the bowel to produce a 
carcinogenic product. Diet is important in determining the 
concentration of the substrate and w il l  also a ffe c t  the 
composition of the bacterial f lo ra .  Thus cholesterol and b i le  
acids may be acted on by colonic bacteria to produce carcinogens 
that act lo ca lly  - or may be absorbed to act elsewhere. Bowel 
t ra n s i t  time, affected by f ib re ,  w il l  a f fec t  exposure to any 
active compounds produced." (Berry, 1988) These few sentences 
d is t i l  a great deal of the knowledge and work which has 
accumulated on colonic carcinogenesis and are remarkable by th e ir
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genera lity  rather than th e ir  brevity . The author leaves open the 
question of whether the "products" are in i t ia to r s  or promoters 
but i t  is recognised that the search for tumour in i t ia to r s  in the 
d ie t  fo r human colon cancer has been a barren f ie ld .
The current study has endeavoured to go beyond simple 
observation of d ietary influence on tumour induction and b i le  
acids to make some attempt to establish the mechanisms by which 
such a lte ra tions in colonic environment may a l te r  tumour 
promotion. The results obtained w il l  be discussed with regard to 
the levels of local mediators - autacoids - d is tr ibu ted  in the 
colon and to the bearing th is  may have on tumorigenesis in th is  
model and more generally.
TISSUE KALLIKREIN-LIKE AMIDASE ACTIVITY (TKLA)
The methodology used for the assay of TKLA is 
well-established and known to produce re l ia b le  resu lts . This was 
found in th is  study also with the coe ff ic ien t  of varia t ion  being 
around 2%. The only aberrant feature was the in a b i l i t y  to 
establish an optimum working pH. This has not been previously 
noted and a broad pH optimum of pH 8 - 9 is usually described 
(Claeson, Friberger, Knos et a l . ,  1978; Amundsen, Putter, Friberg 
et a l . ,  1979). Despite th is  the assay performed predictably in 
our hands in a l l  other ways and in part icu la r  showed inh ib it io n  
by protease inh ib itors  in a standard pattern with a c t iv i ty  being 
completely abolished by aprotinin but only p art ly  inh ib ited  by 
soybean trypsin in h ib ito r .  There is no record of in s ta b i l i t y  of 
the substrate S-2266 at a lka line  pH (Kabi - personal
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communication) and TRIS buffer has been s a t is fa c to r i ly  used in 
th is  pH range previously. The problem was not confined to colon 
as gastric  and small bowel tissues would not demonstrate an 
optimal pH e ith er .  Nonetheless using the suggested pH of 8.2  
provided results which were compatible with other workers in 
terms of a c t iv i ty  measured. (Al-Dahir & Z e i t l in ,  1983).
Therefore there was no reason to mistrust the assay and i ts  use 
here was e n t ire ly  identical with other documented workers. The 
most l ik e ly  explanation is that pH curve has a rather f l a t  peak 
and th is  obscures the optimal pH as assessed here. The sharp 
increase in measured a c t iv i ty  at high, non-physiological 
a lk a l in i t y  may not re f le c t  enzymic a c t iv i ty  on the substrate and 
may be a lka line  hydrolysis. The substrate, S-2266 is thought to 
be the most sensitive for the detection of human urinary  
k a l l ik re in  ( i t s  original use). (F ied ler, Gieger, Hirschauer et 
a l . ,  1978)
Tissue ka i l ik re in -1  ike amidase a c t iv i ty  (TKLA) in the colon
The pattern of k a i l ik re in -1 ik e  a c t iv i ty  along the colon 
has not been previously described in d e ta i l .  I t  has been 
appreciated that kinin-forming a c t iv i ty  varies along the 
gastrointestinal tra c t  and was higher in the caecum than in the 
proximal or d ista l colon which had sim ilar levels of a c t iv i ty .  
(Frankish & Z e i t l in ,  1980) The underlying b e l ie f  is that  
k a l l ik re in  d is tribu tion  as measured by th is  assay is a re f lec t io n  
of in tr in s ic  kinin-forming a c t iv i ty .  I t  seems that the tissue  
k a i l ik re in -1 ik e  amidase a c t iv i ty  of the caecum is considerably
- 150 -
higher than that of the rest of the colon. This presumably 
re f le c ts  the natural function of the caecum in water and 
e le c tro ly te  resorption but i t  must also be appreciated that the 
ra t  caecum is not analogous to the human and seems to have 
special, but as yet poorly defined functions. This study has 
assessed the a c t iv i ty  of the whole thickness of the colon and 
takes no account of the source of the a c t iv i ty  which may be in 
any of the layers of the bowel. I t  should not be from ex tr in s ic  
sources since the colon was perfused blood-free p r io r  to assay. 
Z e i t l in  and Smith (1973) showed in human colon that the kininogen 
(k a l l ik re in  substrate) was in the muscle of the colon and the 
k a l l ik re in  a c t iv i ty  was in the mucosa (a pattern which changed 
with inflammatory bowel disease). No comparable analysis exists  
in the ra t but for reasons to be discussed below i t  is tempting 
to consider th is  po s s ib il i ty  in the ra t also since other 
autacoids (PGE2, cAMP and cGMP) have a variable d is tr ib u tio n  
between mucosa and submucosa. I t  is possible to loca lise  
k a i l ik re in -1 ik e  a c t iv ity  histochemically (Kimura, Takagi, Igari  
et a l . ,  1982) using a peptide ester with simultaneous coupling to 
an azo dye and th is  may be a means to identify ing  the s i te  of 
k a l l ik re in  a c t iv i ty .
That there is a role for kinins in the colonic mucosa was 
c le a r ly  demonstrated by Al-Dhahir and Z e i t l in  (1982 & 1983) since 
the reversal of b ile  salt-induced mucosal damage was effected by 
the antiproteinase aprotinin and accompanied by a reduction in 
the a c t iv i ty  of the previously raised tissue kal 1 ik re in -1 ike
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amidase a c t iv i ty .
Frankish and Z e i t l in  (1980) described an e f fe c t  of d ie t  
on the colonic kinin-forming a c t iv i ty  with a f a l l  in the 
kinin-forming a c t iv i ty  in the caecum and a concomitant r ise  in 
the d is ta l colon with starvation or feeding a 5% glucose d ie t  for  
60 hours. However they point out that these results re lated to 
the "fullness" of the bowel rather than the d ie tary  content. In 
the current study no e ffec t of d ie t  was observed on the colonic 
tissue k a i l ik re in -1 ik e  amidase a c t iv i ty .  This is probably not 
surprising since the animals were allowed to consume th e ir  d ie t  
until  the time of sacrif ice  and the colons were invariab ly  
" fu l l " !  I t  might be argued that increasing the d ie tary  fa t  
content would increase the b ile  acid production which, on the 
basis of the work of Al-Dhahir & Z e i t l in  (1983) may have been 
expected to increase the tissue ka l1ik re in -1 ike  amidase 
a c t iv i ty .  While considerable changes in the concentrations of 
faecal b i le  acids were demonstrated the s ituation  is not 
analogous to d ire c t ly  perfusing the colon with high concentration 
b ile  acid solution.
I t  was not unexpected that there would be no change in 
the tissue k a i l ik re in -1 ik e  amidase a c t iv i ty  with time but changes 
in the ra t  colon with senescence are defined p a r t ic u la r ly  with 
re la t io n  to ce ll turnover (Holt & Yeh, 1988). Considerable e f fo r t  
was made to eliminate diurnal changes by sac rif ic in g  the animals 
at the same time of day on every occasion.
- 152 -
The Effect of Aprotinin
Aprotinin produced a f a l l  in the colonic tissue  
k a i l ik re in -1 ik e  amidase a c t iv i ty  (TKLA) which is explicable by 
i ts  antiprotease a c t iv i ty .  However, when i ts  a b i l i t y  to abolish 
TKLA in v i t ro  is taken into account then the observed reduction 
in a c t iv i ty  was actually quite small. This was underlined by the 
prompt s ign ifican t f a l l  seen in the p i lo t  experiment when 
aprotinin was given for a period of two weeks. I t  could be 
suggested that the dose given was inadequate but the dose used in 
th is  experiment was c learly  e f fec tive  in the short term and 
appeared to be the maximum safe dose which could be used for  
these animals. The LD^q has been documented at 2.5 x 10 
K ill.kg '*  for rats (F r i tz  & Wunderer, 1983) which is 100 times 
greater than the dose used here but the aim in th is  experiment 
was long-term survival. Protracted in jections at 5 times the 
f in a l  dose level used were associated with great morbidity and 
m orta lity .  A lte rnative ly , the dose could have been given more 
frequently to produce a prolonged suppression period but th is  
raises many practical d i f f ic u l t ie s .
Aprotinin forms a re la t iv e ly  stable complex with tissue  
k a l l ik re in  (F r i t z  & Wunderer, 1983) but i t  also in h ib its  other 
proteases. None of the animals showed any evidence of th is  - in 
p art ic u la r  there was no evidence of a haemorrhagic d iathesis.  
Aprotinin is metabolized in the ra t kidney microsomes and th is  
appears to be a f a i r l y  rapid process. Therefore the paucity of 
the aprotinin e ffec t could be attr ibuted to e ither:
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1. inadequate dosage
2. doses which were too infrequent
3. the a b i l i t y  of the animals to synthesise new enzyme to replace 
that which was inhib ited by the aprotinin
4. induced metabolism of aprotinin.
The th ird  of these p o s s ib il i t ie s  is perhaps the most 
in tr igu ing  and worthy of further assessment.
Neither carcinogen nor indomethacin had an e f fe c t  on 
TKLA. No interaction between TKLA and azoxymethane or 
indomethacin has been previously shown.
TISSUE PROSTAGLANDIN E.  fPGE^ ) .
The d is tribu tion  of PGE2 in the colon has never been 
examined in the detail described in th is  study (nor fo r any 
eicosanoid). The method used to estimate the colonic PGE^  follows  
accepted methodology and uses a well-established, validated assay 
using commercial reagents of predictable purity  and high q u a lity .  
In p art icu la r  the antibody showed l i t t l e  c ro ss -reac tiv ity  with 
other s im ilar eicosanoids. The levels of PGE2 in the tissue  
obtained by the methods used here produce results which are of 
very s im ilar  magnitude to other workers who have attempted to do 
the same. (Bennett & DelTacca, 1975; Karmali, Thaler & Cohen, 
1983, Bennett, Chariier & McDonald, 1976; Sharon, Ligumsky, 
Rachmilewitz et a l . ,  1978; Minoura, Takata, Sakaguchi et a l . ,  
1988) The results of A tta llah , Lee, Ambrus et a l . ,  (1984) in a 
varie ty  of normal and neoplastic tissues produce PGE2 contents on 
average one f i f t i e t h  of those quoted elsewhere. These results
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were obtained by e ither bioassay or radioimmunoassay following  
simple extraction or chromatographic separation.
The large v a r ia b i l i t y  of some of the results in th is  
study is d i f f i c u l t  to explain and is not simply a technical 
problem. The interassay variation was shown to be around the 20% 
level which is acceptable for th is  method. All samples were 
assayed in duplicate to minimise random error and the most 
extreme values were on occasion analysed a second time with no 
change in the resu lt .  Additionally the extreme values were 
obtained during assays which produced "normal" results in the 
same batch. This v a r ia b i l i t y  has been noted by other workers but 
is ra re ly  commented on. I t  would seem that the assay is giving a 
true re f lec tio n  of the PGE2 in the v ia l .  The method of 
preparation was designed to prevent undue formation of prostanoid 
and th is  was shown to be e ffe c tive .  The preparation used in th is  
study was probably more cautious than others as both low 
temperatures and indomethacin were used to prevent prostanoid 
production. The other studies cited use one or other method as a 
ru le .  By separating the homogenised sample immediately then loss 
of prostanoid content by metabolism or increase in the content by 
continued formation from i ts  precursors were both avoided. The 
experiments on overnight storage showed that the l a t t e r  s ituation  
could have been a problem for homogenates l e f t  fo r a s ig n if ican t  
amount of time before separation. Since the tissue was perfused 
blood-free then large variations in exogenous prostanoid from 
activated p la te le ts  or other blood components would be un like ly .
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I t  did appear that the aberrant values did a ffec t  the colon of 
the animal in a general way i . e .  a l l  segments examined had 
higher leve ls . These observations would a l l  tend to point to the 
observed "extreme" values being a true re f lec t io n  of the colonic 
PGE2 at the time of sac r if ice . I t  is possible that the trauma of 
s ac r if ice  may influence the f ina l values assayed. Granstrom 
(1978) captured the essence of th is  problem when he said " . . .  the 
accuracy of many radioimmunoassays unfortunately seems to be very 
low when they are applied to biologic material . . .  there are 
often enormous discrepancies between data obtained by th is  kind 
of methodology and those from the more specific  gas
chromatographic - mass spectrophotometric methods No source of
error seems to exist to explain sometimes unphysiologically high 
'PG l e v e l s ' . . .  the most l ik e ly  explanation is m is interpretation  
[o f the assay]."
Tissue PGE^  in the colon.
The d is tribution  of PGE2 along the colon with re la t iv e ly  
low levels  proximally and higher levels more d is ta l ly  has never 
been described. The significance of th is  is purely conjectural 
but in re la tion  to the the present study i t  is perhaps worthwhile 
re f le c t in g  that colonic tumours in th is  model tend to occur in 
the d is ta l colon and that th is  d is tribu tion  is the inverse of the 
colonic tissue k a l i ik re in -1 ik e  amidase a c t iv i ty .
There did not appear to be any s ign ifican t e f fe c t  of d ie t  
on the colonic content of PGE2 or i ts  d is tr ibu tio n  in the colon.
A considerable body of work describes colonic prostanoids, the
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effec ts  of tumorigenesis and the actions of a selection of 
reagents. There has been no work re la ting  the d ie t  to colonic 
prostanoid content until recently. Minoura and coworkers (1988) 
fed rats a d ie t  supplemented with e ither l in o le ic  acid or 
eicosapentaenoic acid (EPA) and demonstrated that the colonic 
PGEg content as measured by radioimmunoassay was s ig n if ic a n t ly  
lower in the animals on the EPA-augmented d ie t .  Hence the 
composition of the d ie t affected the colonic PGE2 content and the 
inh ib ito ry  e ffec t  of EPA was thought to represent in h ib it io n  of 
conversion of l in o le ic  acid to arachidonic acid. The high fa t  
d ie t  used in the current study had 2.5% l in o le ic  acid and 7.5% 
ole ic  acid (compared with 2.1% to ta l mixed fa t  fo r the low fa t  
d ie t )  and may therefore have been expected to show a s ig n if ican t  
a lte ra tio n  in the colonic PGE2 i f  a simple increase in substrate 
flow were a l l  that influenced the tissue levels of PGE2. While 
PGE2 is the most abundant prostanoid in the colon there is good 
evidence that the gastrointestinal tissues synthesise the whole 
spectrum of cyclo-oxygenase and lipoxygenase products. (Dreyling, 
Hoppe, Peskar et a l . ,  1986; Craven, Saito & DeRubertis, 1983) I t  
is therefore quite possible that assay of one component is a 
very blunt instrument and only a panoramic analysis would reveal 
the true extent of the changes occurring with d ie tary  a l te ra t io n .  
Colonic PGE2 and Indomethacin.
The e ffec t  of indomethacin was reasonably unambiguous and 
produced a s ign ifican t reduction in colonic content of PGE2 as 
would be expected from i ts  inh ib it ion  of cyclo-oxygenase. I t  was
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in teresting  that administration of the carcinogen resulted in a 
r is e  in the PGE2 content for two reasons. F i rs t ly ,  th is  r ise  was 
occurring in colonic tissue which did not necessarily have tumour 
formation evident and secondly i t  was not re a l ly  apparent until  
the 24 week stage. I t  may be said therefore, that the raised PGE2 
content did not occur during the phase of tumour in i t ia t io n  and 
was only evident a f te r  the phase of tumour promotion. This change 
was not simply localised to areas of frank neoplastic change but 
was in fact a f ie ld  change affecting apparently normal mucosa. 
Additionally , the raised levels of PGE2 induced by the carcinogen 
were reduced by the administration of indomethacin.
Inh ib it ion  of colonic PGE2 production by indomethacin has 
been demonstrated by several workers. (Boughton-Smith, et a l . ,  
1983; Craven, Saito et a l . ,  1983; Rampton et a l . ,  1981;) While 
elevated levels of prostaglandin production have been c lea r ly  
associated with tumours of the colon (Bennett et a l . ,  1977) and 
elsewhere (Bennett et a l . ,  1975; Roll and et a l . ,  1980; Karmali, 
Welt et a l . ,  1983; Smith et a l . ,  1983; A tta llah  et a l . ,  1984) an 
e f fe c t  of carcinogen administration such as described here has 
not been previously noted. In view of the observable changes 
which occur in the mucosa by h is to log ica l, histochemical and 
ultras tructura l assessment on the administration of a carcinogen 
or in the areas adjacent to a tumour (page 22) i t  is not 
surprising to find a widespread a lte ra tion  in PGE2 leve ls . This 
must lead to the reappraisal of those results which use "normal" 
tissue adjacent to a tumour as the control as th is  may be of
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i t s e l f  abnormal.
While i t  is tempting to a t tr ib u te  the beneficial effects  
of indomethacin on tumorigenesis to i ts  a b i l i t y  to in h ib it  
prostaglandin synthesis (Powles et a l . ,  1973; Humes et a l . ,  1974; 
Lynch et a l . ,  1979; Bockman, 1983; Pollard et a l . ,  1983; 
Kollmorgan et a l . ,  1983; Narisawa et a l . ,  1984) i t  must always be 
remembered that inh ib it ion  of one pathway necessarily a lte rs  
another and the role of other prostanoids and the leukotrienes  
remains to be established. The significance of the lipoxygenase 
pathway in inflammatory bowel disease only became apparent when 
the deleterious e ffec t of indomethacin was properly assessed. 
(Rampton & Sladen, 1981) Indeed, completely d if fe re n t  systems may 
be involved - indomethacin can in h ib it  the effects  of bradykinin 
which resu lt  in a r ise in cGMP in lung tissue. (Stoner, 
Manganiello & Vaughan, 1973)
Colonic PGEg -fu rther  considerations.
Another problem which confronts th is  type of research is 
to id e n t ify  the source of the metabolite under study. In th is  
study the whole thickness of the colonic wall has been used to 
measure the prostanoid levels - a manoeuvre which necessarily  
measures the prostanoid content of a myriad of d i f fe re n t  cell  
types including the one of in terest - the colonic e p ith e l ia l  
c e l l .  I t  has been shown that the v i r tu a l ly  a l l  colonic PGE2 is 
synthesised by the submucosa and that the e p ith e l ia l  ce lls  
possess 71% of the prostanoid degradative capacity of the colon. 
While the in tact colon produces mainly PGE2 the e p ith e l ia l  ce lls
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produce mainly PGF2a and only small quantities of PGE2• (Craven 
and DeRubertis, 1983; Dreyling et a l . ,  1986) Furthermore, i t  
appears that superfic ia l ep ith e l ia l  ce lls  produce more prostanoid 
and have a greater capacity to metabolise prostanoid than do the 
p ro l i fe ra t iv e  c e l ls .  These observations must be compared with the 
observations that colonic k a l l ik re in  a c t iv i ty  is lodged in the 
mucosa while i ts  substrate is in the muscle (vide supra). The 
overall view would suggest that there is a f lux  of autacoids 
which bathes the p ro l i fe ra t iv e  compartment of the colonic 
epithelium and are degraded elsewhere.
All of which poses yet another problem - what relevance 
has the measurement of an aggregate prostanoid tissue content of
a large area of tissue from a single moment in time? The true
answer probably is that i t  is the best which can be done. Some 
workers have tr ie d  to circumvent th is  problem by measuring the 
synthetic capacity of the colon given specified substrates (e .g .  
Boughton-Smith et a l . ,  1983) or simply to measure the release of 
prostanoid in tissue culture (e .g . Dreyling et a l . ,  1986). The 
curious finding is that while the algebra may a l te r ,  the net 
results  are much the same.
This study has demonstrated that the levels of PGE£ in
the ra t  colon depend on the s ite  of the colon where the sample is
made, are reduced by indomethacin and raised by the 
administration of the carcinogen azoxymethane. These changes 
are large ly  consistent with previous observations on prostanoids 
in carcinogenesis but i t  has not been possible to demonstrate an
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association with d ietary  change. The relevance of these changes 
to the development of colorectal tumours in th is  model w i l l  be 
discussed below.
CRYPT CELL PRODUCTION RATF
The metaphase arrest technique for the estimation of the 
crypt ce ll production rate is a satis factory  one especially  when 
used with crypt cell squash preparations as were used here. This 
eliminates the problem of cell size varia tion  and altered  
position with mitosis with estimates from histological sections 
and also avoids the necessity of having to calculate a crypt size 
in terms of cell population. Wright (Wright & Appleton, 1980; 
Wright, 1982) has compared stathmokinetic analysis with thymidine 
lab e ll in g  techniques and concludes that the metaphase arrest  
technique gives an estimate of a useful parameter, the cell b irth  
ra te .  This study has used th is  parameter alone to measure the 
crypt ce ll production rate which requires no derivation from the 
measured values and is therefore as accurate as any method for  
th is  purpose.
Despite f u l f i l l i n g  the necessary c r i t e r ia  la id  out by 
Wright th is  study fa iled  to demonstrate any s ig n if ican t e f fe c t  of 
s ite  of colon, d ie t  or carcinogen treatment on the crypt cell  
production ra te . The values obtained were of the same magnitude 
as Galloway (1986) and more recently by Savage et a l . (1988). In 
spite of the lack of e ffec t  of s i te ,  d ie t  and carcinogen both of 
the drugs given to the rats - aprotinin and indomethacin - 
appeared to resu lt in a generalised reduction in the crypt cell
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production ra te .
Previous work by a varie ty  of authors has presented 
evidence that administration of a carcinogen results in a series 
of changes in the crypt involving the p ro l i fe ra t iv e  compartment - 
p r in c ip a lly  a s h if t  in the s ite  of p ro l ife ra t io n  to the surface 
of the crypt with subsequent fa i lu re  of c e l lu la r  d i f fe re n t ia t io n  
and a general increase in cell p ro l i fe ra t io n .  (L ipkin , 1971, 
Maskens and Deschner, 1977; Deschner, 1982 & Wright, 1983) I t  has 
also been appreciated that the pattern of c e l lu la r  p ro l ife ra t io n  
d i f fe rs  from one area of colon to the next being generally slower 
in the d is ta l colon than elsewhere (Lipkin, 1971; Sunter, Wright 
& Appleton, 1978 and Sunter, Watson, Wright et a l . ,  1979) and i t  
is therefore important to compare l ik e  areas of the colon. 
Furthermore the proportion and s ite  of the p ro l i fe ra t in g  
component of the crypt also varies by region. (Sunter, Appleton, 
Wright et a l . ,  1978) With th is  degree of v a r ia b i l i t y ,  studying 
changes associated with tumour development becomes very involved. 
Wright (1983) suggests in discussing the rat-DMH model that the 
carcinogen produces progressive hyperplasia in the colon with 
increased p ro l i fe ra t iv e  rates and that out of that generalized  
hyperplasia evolves a slowly cycling transformed ce ll which gives 
r is e  to the tumour. This has no bearing on the p ro l ife ra t io n  
rate  of the induced tumour which may be increased over normal. 
Sunter (1984) proposes a s im ilar scenario. Tutton and Barkla 
(1976) measured cell p ro l ife ra t io n  in the descending colon of the 
ra t  following treatment with dimethyl hydrazine and found the cell
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cycle time to be reduced with an accompanying increase in 
p ro l ife ra t io n  in the carcinogen treated animals.
Deschner and coworkers (Deschner, Long, Hakissian et a l . ,
1983) showed in mice that the su scep tib il ity  to colonic tumour 
induction by dimethyl hydrazine was d ire c t ly  related to the rate  
of c e l lu la r  p ro l ife ra t io n  in the colonic crypt as assessed by 
thymidine labe lling  - a d is t inc tion  which was s t i l l  present a f te r  
administration of the carcinogen. Deschner and Maskens (1982) 
also showed characteris tic  changes in the lab e llin g  of the 
colonic crypts in patients and animals with tumours.
This sort of evidence makes i t  more d i f f i c u l t  to explain 
why th is  study was unable to discern any differences in the crypt 
ce ll  production rates between carcinogen and non-carcinogen 
treated animals since i t  would appear that th is  sort of 
transformation is easiest to detect. While the technique used is 
re l ia b le  and was correctly executed consideration must be given 
as to whether su ff ic ien t  animals were studied, s u f f ic ie n t  crypts 
counted in each preparation and whether m itotic  figures were 
correc tly  assessed. The experimental protocol ensured that the 
numbers of animals and crypts counted f e l l  within accepted 
guidelines. While the counting of m itotic  figures can vary 
s ig n if ic a n t ly  between individuals, when counted by one individual 
is very reproducible. (Own observations, unpublished.) All 
samples in th is  study were counted by one person.
By examining tissue which was not necessarily adjacent to 
tumours or in animals which had had carcinogen but had not
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developed tumours, then i t  is quite possible that s ign if ican t  
a lte ra tions  in the crypt cell production rate were overlooked. 
Indeed the spread of the results may suggest that the wide 
varia t ion  is due to sampling animals with widely varying crypt 
ce ll  production rates due to whatever cause and not ju s t  random 
var ia t io n .
With the fa i lu re  to demonstrate any e f fe c t  of carcinogen 
on the crypt cell production rate i t  is perhaps not surprising  
that no e f fe c t  of d ie t  could be discerned. The significance of 
the reduction by the drug therapy is therefore perhaps more 
s ta t is t ic a l  than practical as the levels of significance achieved 
are not high. I t  has to be borne in mind that aprotinin did 
reduce tumour incidence in one group and that no tumours were 
seen in the groups receiving indomethacin and ethanol. The 
altered crypt cell production rate may be a re f le c t io n  of these 
observations. A reduction in crypt ce ll  production rate  would be 
consistent with reduced kinin formation as might be produced by 
aprotin in . (Pisano, 1975) A reduction in crypt ce ll  production 
would not be consistent with previous observations on the effects  
of prostaglandins on cell turnover. (Tutton & Barkla, 1980b) 
However, i t  would be remarkable i f  such weak e ffects  showed 
through when dietary effects did not apparently e f fe c t  the crypt 
ce ll  production rate .
A recent study (Savage et a l . ,  1988) showed a s ig n if ican t  
a lte ra t io n  in tumorigenesis following small bowel resection but 
could only demonstrate an a lte ra tion  in the crypt ce ll  production
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ra te  a f te r  transection at the duodenum. This manoeuvre is already 
known to produce hyperplasia in the colon (Williamson & Rainey,
1984) and the fa i lu re  to demonstrate changes in the crypt cell  
production rate  in th is  s ituation highlights the problems of th is  
kind of study.
The study most s im ilar to the current one is that of 
Galloway (1986) in that i t  uses in the same animals, d iets and 
methodology. Even th is  study which examined the e f fe c t  of d ie t  on 
the crypt ce ll  production rate found the results d i f f i c u l t  to 
assimilate but arrived at the conclusion that in animals fed a 
tumour promoting d ie t the crypt cell production rate  was reduced 
- an e f fe c t  which was properly considered to allow " . . . i n i t i a t e d  
c e lls  to more readily  establish th e ir  carcinogenic advantage" 
which is reminiscent of the comments of Wright. However the 
d ie tary  effects on the crypt cell production rate were by no 
means c lear-cut and the problem of v a r ia b i l i t y  was noted.
Hence, while the current study does not immediately 
support conventional wisdom and is d i f f i c u l t  to understand and 
unify as no clear pattern emerges i t  is not invalidated and 
merely points to the depth of confusion which exists and to the 
necessity for careful evaluation of future work.
Control of e p ith e l ia l  turnover.
A remarkable varie ty  of agents have been shown to 
influence the p ro l i fe ra t iv e  a c t iv i ty  of the ra t  colon. Jacobs 
(1984) found that feeding bran to rats produced an increase in 
the p ro l i fe ra t iv e  a c t iv i ty  of the crypt. Deschner & Raicht (1979)
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and Deschner et a l . ,  (1981) showed that b i le  acids had a strong 
trophic e f fe c t  on colonic cell p ro l ife ra t io n  whether administered 
d ire c t ly  or in the d ie t .  Tutton and Barkla (1980a,b & c ; 1981 
& 1982) demonstrated the dependence of colonic e p ith e l ia l  cell  
p ro l ife ra t io n  on cAMP, prostanoids, neurotransmitters, 
glucocorticoids and androgens. Oscarson (1982) adds gastrin  and 
pro lactin  to th is  l i s t .
Eastwood (1977) has said that gastro intestina l e p ith e l ia l  
renewal is " . . . a  complex process which involves the in teraction  
of numerous ex trace llu la r  factors with the in tra c e l lu la r  control 
mechanisms fo r p ro l i fe ra t io n ,  migration and d if fe re n t ia t io n  " . 
Current research has barely described the events of e p ith e l ia l  
renewal l e t  alone deal with the controlling factors. Yet 
something is known of these controlling processes as has been 
outlined above.
Moreover i t  can be shown that some of these contro lling  
mechanisms are influenced by carcinogens. DeRubertis and Craven 
(1977 & 1980) have shown that carcinogens can activate  cyclic  
nucleotide metabolism to e f fe c t iv e ly  increase the cGMP:cAMP ra t io  
which is associated with enhanced cell growth and loss of contact 
in h ib it io n  - a characteris tic  of transformed c e l ls .  Further 
studies (Craven, Saito et a l . ,  1983) showed that PGE£ would 
decrease thymidine uptake in v i tro  and increase the cAMP levels;  
indomethacin produced the converse resu lt when given in vivo but 
in v i t ro  did not a l te r  thymidine uptake. This indicated that  
in h ib it io n  of colonic prostaglandin synthesis and the concurrent
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reduction in mucosal cAMP were in s u ff ic ie n t  alone to stimulate  
mucosal DNA synthesis. The net e ffe c t  of prostaglandin was to 
in h ib i t  p ro l i fe ra t iv e  a c t iv i ty .
Tutton and Barkla (1980b & c) also found that colonic 
ce ll  p ro l i fe ra t io n  was reduced by cAMP but could demonstrate no 
e f fe c t  of a prostaglandin analogue or indomethacin on colonic 
crypt turnover. Curiously, the prostaglandin analogue increased 
je junal ce ll  p ro l ife ra t io n  but inhib ited the p ro l i fe ra t io n  of 
adenocarcinomas. On the other hand indomethacin has also been 
shown to in h ib it  the growth of some cell lines in v i t r o .  (Bayer & 
Beaven, 1979) The inh ib it ion  seems to occur at the G1 phase of  
the ce ll  cycle which may imply an e ffec t on the synthesis of RNA 
or proteins. (Johnson & Wolberg, 1971)
To th is  l i s t  of controlling factors must be added the 
expanding f ie ld  of growth factors. Growth of normal ce lls  is 
la rg e ly  controlled by the interp lay between several polypeptide 
hormones and hormone-like growth factors that are present in 
t issue f lu id .  Malignant ce lls  do not seem to be subject to the 
same controls. (Sporn & Todaro, 1986) The factors may be produced 
by the ce l ls  themselves and the control exerted in an autocrine 
fashion. The presence of such growth factors has been 
demonstrated in human colonic cancer cell l in e s . (Coffey, Shipley 
& Moses, 1986) In the context of the current study i t  should be 
pointed out that bradykinin is a small peptide which may well 
have the properties of a growth factor and ce rta in ly  functions in 
an autocrine fashion as do the prostanoids. The recent
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demonstration of the control of human colonic cancer cell l in e  
growth by peptide hormones lends more weight to the study of 
agents such as the kinins. (Smith & Solomon, 1988)
This digression into the mechanisms of control of 
c e l lu la r  growth and d if fe re n t ia t io n  has been an attempt to re la te  
the findings of the current work to established knowledge. I t  is 
abundantly c lear from a l l  which has preceded that the 
understanding of the c e l lu la r  growth and d i f fe re n t ia t io n  is 
embryonic and the current work underlines the v o la t i le  nature of 
the results  which can be obtained. The essential problem with 
much of th is  kind of work is separating cause and e f fe c t .  As 
regards c e l lu la r  p ro l ife ra t io n  i t  must be asked when is a cell  
which is p ro l i fe ra t in g  abnormally neoplastic? Since neoplastic  
change is a disease of the genes then i t  is eas ily  understood 
that the genetic change must occur long before any a lte ra t io n  in 
the detectable changes in c e l lu la r  p ro l ife ra t io n  - at least a 
whole colonic crypt needs to be repopulated for a change in the 
crypt ce ll production rate to be noticed. S im ila r ly ,  i f  the 
changes in the surrounding autacoids are being assessed then are 
these changes the resu lt  of tumour development or are they simply 
epiphenomena which have no d irect role in the tumour development? 
Or are they causative and what causes them? The answers to these 
questions are not simple and w il l  be returned to la te r .
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FAECAL BILE ACIDS
The results of the study on the faecal b i le  acids 
d is t in c t ly  showed that the faecal b i le  acid concentration 
depended s ig n if ic a n t ly  on the d ie t the animals consumed. The high 
f a t ,  low f ib re  d ie t resulted in higher levels of to ta l faecal 
b i le  acids, to ta l neutral sterols and to ta l long chain fa t ty  
acids than in the animals on the low fa t ,  high f ib re  d ie t .  
Moreover, the pattern of the b i le  acids was a lte red . The r ise  in 
the faecal b ile  acids was p r inc ipa lly  due to a r ise  in the levels  
of deoxycholate and muricholate. The rise  in the sterols and
fa t ty  acids was due to a r ise in a l l  components. I t  is
in teresting to note that the fa t ty  acids present did not simply
re f le c t  the dietary input and must therefore imply that these are
derived by metabolism.
Diet and Faecal Bile Acids.
The e ffec t of d ietary fa t  on faecal b i le  acids in the 
experimental animal has been studied at some length with f a i r l y  
consistent results s im ilar to those in th is  study. (Reddy et a l . 
1974; Reddy et a l . ,  1984; Reddy et a l . ,  1986; Sakaguchi et a l . ,  
1986; Galloway et a l . 1986). These results confirm the orig inal  
hypothesis of H i l l  and colleagues ( H i l l ,  1983) who made th e ir  
deductions from epidemiological and human studies. Some workers 
have shown that the actual changes produced depend on the type of 
d ietary  fa t  used with polyunsaturated fats  having the most 
pronounced effects on the faecal b i le  acids and s tero ls . (Reddy 
et a l . ,  1984; Sakaguchi et a l . ,  1986) Some authors have suggested
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that administration of a carcinogen is su ff ic ie n t  to a l te r  the 
faecal b i le  acid p ro f i le  but there is no good evidence of that in 
th is  study. (Reddy et a l . ,  1974; Nigro et a l , 1974)
The e ffe c t  of f ib re  on the faecal components has been 
much less-well assessed. Brydon et a l . (1980) suggested that a 
d ie t  low in f ib re  resulted in increased levels of cholate, 
chenodeoxycholate and muricholate in the ra t  colon which would 
accord with the present study and corroborate the findings in 
humans. (Aries et a l . ,  1971; Cummings et a l . ,  1979). The work of 
Galloway et a l . (1986) examined combinations of high and low fa t  
and f ib re  and found that the faecal b ile  acid levels were best 
correlated with the f ib re  level of the d ie t - a low f ib re  d ie t  
resulted in higher levels of b ile  acids. However, as Galloway 
correc tly  points out the faecal b i le  acid p ro f iles  of the ra t  are 
considerably d iffe ren t to those of man - the principal products 
are muricholate and hyodeoxycholate (Brydon et a l . ,  1980) - and 
th is  makes i t  impossible..to draw analogies between the ra t  
model and human colonic carcinogenesis." The f in a l  pattern of 
tumour induction in that series of experiments re flec ted  the 
faecal b i le  acid concentrations and that is true here also. 
However, i t  must be said that the tumour incidence in the animals 
receiving th e ir  standard laboratory d ie t  was as high as that in 
the animals on the sp ec if ica lly  high fa t ,  low f ib re  d ie t .  The 
faecal b i le  acid composition of standard d ie t  animals did not 
resemble the high fa t  group at a l l  except in the levels  of faecal 
deoxycholate and muricholate which appeared s im ila r .  The animals
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on th e ir  standard d ie t  also had a higher level of polyunsaturated 
fa t ty  acids than those on the low fa t  d ie t  but the level in no 
way matched that of the the high fa t  group. While the groups are 
not s t r ic t ly  comparable th is  may imply that the combination of 
fa t  and f ib re  produces a maximum e ffec t at a specific  
concentration. More simply, the relationships between f a t ,  f ib re  
and tumour incidence are non-linear and may be inter-dependent.
I t  may also be deduced that some other component of the faeces is 
in fact the important agent. The faeces are mutagenic by 
themselves and may contain any number of active or p o te n t ia l ly  
active substances. (V en itt ,  1982; Thompson, 1983 & 1984)
Bile  Acids and Tumour Development.
The promoting e ffec t of b i le  acids on experimental ra t  
tumorigenesis has been shown several times with convincing 
resu lts . (Narisawa et a l . ,  1974; Reddy et a l . ,  1977 & 1979; 
Cohen, Raicht, Deschner et a l . ,  1980). The promotional properties  
have been p r inc ipa lly  attr ibuted to the secondary b i le  acids 
although the primary ones are also e f fe c t iv e .  A recent study 
using in testina l resection as a means of stimulating  
tumorigenesis did not demonstrate a relationship with the b i le  
acid levels , (Savage et a l . 1988) but an e a r l ie r  study in the 
same vein did show the expected a ltera tions in the b i le  acids 
(Koga et a l . ,  1982).
The role of b ile  acids in the scheme of carcinogenesis in 
man is to act as substrates for the faecal microbes to form 
e ith e r  carcinogenic or promotional agents. In the animal model
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they can only act as promoters since the carcinogen is defined.
As to how the b i le  acids perform th is  promotion is not 
established. This work has found no d irect interaction between 
b i le  acids and the endogenous mediators bradykinin and 
prostaglandin E2 as assessed by the drug-based experiments Bile  
acids may act d ire c t ly  on the ep ith e l ia l  ce ll  to cause promotion 
and the occurrence of b i le  acid receptors in tumours may support 
th is  idea (Summerton et a l . ,  1983) but i t  has been pointed out 
that receptor induction may also be an indecisive epiphenomenon. 
(Berry, 1988) I t  seems more l ik e ly  that there is at least one 
fu rther  l in k  in the chain. Recent evidence has added a new 
dimension to th is .  The induction of ornithine decarboxylase in 
the mouse skin by the tumour promoter 12-0-tetradecanoylphorbol 
acetate seems to be mediated by the prostaglandins (Verma, 
Ashendel & Boutwell, 1980). In the ra t colon, azoxymethane and 
b ile  acids w il l  stimulate the a c t iv i ty  of ornith ine decarboxylase 
- the hallmark of promotion - and th is  also seems to mediated by 
prostaglandins. (Takano, Matsushima, Erturk et a l . ,  1981; 
Narisawa, Hosaka & Niwa, 1985; Luk, Hamilton, Yang et a l . ,  1986). 
I t  has been appreciated for years that b ile  acids can stimulate  
the a c t iv i ty  of phosphol ipase A2 which is necessary to l ib e ra te  
arachidonic acid for prostanoid formation. (Creutzfeld &
Schmidt, 1970) Raised levels of phospholipase A2 have been 
demonstrated in tumours (Rillema, Osmialowski & Linebaugh, 1980). 
Bradykinin can be shown to stimulate c e l lu la r  production of 
prostanoid by governing one or more phospholipases. (B e ll ,
Baenziger & M ajerus,1980; Hofman & Majerus, 1982; Nielson, 
Bukhave, Ahnfelt-Ronne et a l . ,  1988) Hence both of the mediators 
studied here may yet have a role in b i le  acid-associated tumour 
promotion which th is  study has not demonstrated.
DIET AND TUMOUR INDUCTION.
The overall tumour induction rate in th is  model was 
somewhat lower than is usually seen in comparable studies. 
Galloway (1986) noted th is  also. The dose of carcinogen was 
c e r ta in ly  adequate by any standard and the time interval 
sa tis fa c to ry  at 6 months. S usceptib il ity  to the carcinogen is 
recognised to vary between and within species (e .g . Deschner et 
a l . ,  1983) and i t  may be that the breed of ra t  used here (Albino 
Swiss) is  more res is tan t to the carcinogen than the species most 
commonly used (Sprague-Dawley, Wistar & Fisher F344). Since 
tumours did develop there can be no doubting the potency of the 
carcinogen and the tumour y ie ld  would probably have increased i f  
the animals had been l e f t  for another month.
The defined diets  produced the expected dichotomy in 
tumour induction with the high fa t ,  low f ib re  d ie t  producing more 
animals with tumours. This accords with the work of Galloway et 
a l . (1986). Quite unexpectedly, an equivalent number of the 
animals on th e i r  usual laboratory d ie t  developed tumours when 
given the carcinogen. While i t  is appreciated that these diets  
are not s t r i c t l y  comparable th is  observation does serve to 
i l l u s t r a t e  tha t consideration of aetio logical factors should 
perhaps be more wide-ranging. The standard laboratory d iet
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d i f fe r s  in many ways from the defined diets and opens up the 
p o s s ib i l i t ie s  that one or more of these differences may be 
responsible fo r  i ts  tumour promoting p o ten tia l.  As has been 
described above in the examination of the b i le  acid results i t  
does seem possible that the "fina l common path" of the 
promotional event may be through the b ile  acids since the p ro f i le  
in these animals resembles the high fa t ,  low f ib re  d ie t .
I t  has also become apparent with further research that 
not only the quantity but the qua lity  of the d ietary  fa t  is of 
importance. I t  would seem that polyunsaturated fats  have a 
greater carcinogenic potential than saturated fats  (Sakaguchi et 
a l . ,  1984 & 1986; Reddy et a l . 1984; Minoura et a l , 1988) an 
e f fe c t  which is not confined to colonic tumours. (Hopkins & West, 
1976; H i l ly a rd  & Abraham, 1979) Not every study has been able to 
make th is  d is t in c t io n  (Reddy et a l . ,  1976a & 1977) and the 
diffe rence  may be more subtle with altered d is tribu tion  of 
tumours or more aggressive histology. (Nauss et a l . ,  1983 & 
Lockniskar et a l . ,  1985) The fa t ty  acid composition of the 
standard laboratory d ie t  is not available but animals consuming 
th is  d ie t  had a re la t iv e  excess of faecal polyunsaturated fa ts .
In th is  study i t  is in teresting  to note that the tumours were 
d i f fe r e n t ly  d is tr ibu ted  in the colon for each of the d ietary  
groups and tha t while the high fa t ,  low f ib re  d ie t  produced more, 
proximal tumours the low f a t ,  high f ib re  d ie t produced tumours 
which were usually more d is ta l ly  located. Histological variation  
was not a prominent feature . This is s im ilar to Nauss et a l . ,
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(1983) and bears comparison with the work of Koga et a l . ,  (1982) 
who found that resection of small bowel led to more tumours in 
the " le f t "  colon associated with higher b i le  acid concentrations 
where the b i le  acids would accumulate. Presumably th is  is true in 
the high f ib r e  d ie t  in th is  study and the s h if t  to the "right" in 
the high fa t  d ie t  re f le c ts  higher concentrations of b ile  acids 
entering the colon. The standard d ie t produced tumours in a 
d is tr ib u t io n  more resembling the low fa t ,  high f ib re  d ie t and 
th is  would suggest that the e ffec t  of the d iet is more subtle 
than i t  f i r s t  appears. The dose of carcinogen also determines the 
f in a l  tumour d is tr ib u t io n  with high doses producing more d ista l  
lesions. (Ward et a l . ,  1973; LaMont & O'Gorman, 1978)
The e f fe c t  of d ie tary  f ib re  is much less predictable as 
has already been outlined (page 15). Most frequently dietary  
f ib re  has been associated with a protective e ffec t  and that was 
seen here since the lowest tumour incidence occurred in the group 
with the high f ib re  content. By analogy with Galloway's study i t  
would appear from th is  study that d ietary f ib re  accords with the 
tumour r is k  be tte r  than the d ietary  fa t  assuming that the 
re la t io n s h ip  between these variables ( r is k ,  fa t  and f ib re  
content) is l in e a r .  One explanation for the disparate results  
seen by some workers may be the fact that there is an "ideal" fa t  
and f ib r e  combination which promotes tumorigenesis better than 
one or other fac to r  alone. Most studies have examined only the 
e f fe c t  o f one variab le  on tumour development and only studies 
such as those of Wilson et a l . (1977), Trudel et a l . ,  (1983) and
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Galloway et a l . ,  (1986) go any distance towards examining both 
variab les simultaneously.
Another source of confusion in studies on dietary f ib re  
is  the d e f in it io n  of the f ib re  i t s e l f .  The term dietary f ib re  
covers a multitude of chemicals and is probably best defined as 
"the sum of l ig n in  and non-alpha glucanpolysaccharides" 
(Southgate, 1982). From a practical standpoint th is  is equivalent 
to l ig n in ,  ce llu lose  and a varie ty  of other polysaccharides. 
Studies into  the e f fe c t  of d ietary f ib re  have to se tt le  for  
e ith e r  adding one or two defined components of th is  mixture to 
the d ie t  in known quantity or giving a mixture (e.g . bran) of 
e s s e n t ia l ly  unknown and variable composition. The f ib re  in the 
d ie t  o f th is  study comprises almost en t ire ly  of l ign in  and 
c e llu lo se .
D ietary f ib re  can have one or more of a varie ty  of 
e ffe c ts  on the colon. I t  w i l l  increase faecal weight and 
defaecation frequency while reducing tra n s it  time, d ilu t ing  the 
in te s t in a l  contents and reducing the faecal pH (Kritchevsky,
1986) but these e ffec ts  depend on the type of f ib re  (Hillman, 
Peters, Fisher et a l . ,  1983) and cellulose may be the most 
potent. Fibre w i l l  also adsorb organic and inorganic substrates 
and may increase microbial growth (Kritchevsky, 1986; Cummings 
& Branch, 1982) but the a c t iv i ty  of some microbial enzymes such 
as #-glucuronidases, fi-glycosidases and mucinases may be 
decreased. (Shiau et a l . ,  1983; Prizont 1984) Dietary f ib re  is 
also associated with decreased dehydroxyl ation of b ile  acids and
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the production of short chain fa t ty  acids by cellulose  
fermentation. (Cummings, 1982 & 1984) Short chain fa t ty  acids can 
have e f fe c ts  on ce ll  structure and p ro life ra t io n  which are 
thought to be protective both d ire c t ly  and by th e ir  a b i l i t y  to 
reduce colonic pH. (Cummings et a l . ,  1982; Kim, Tsao, Morita et 
a l . ,  1982; Samuelson, Nelson & Nyhus, 1985; Kritchevsky, 1985)
The binding of b i le  acids per se does not seem to be beneficial 
(Kritchevsky, 1986) and the d ilu tiona l e ffec t of f ib re  is less 
convincing as a a protective mechanism. (Calvert, K lurfeld ,  
Subramaniam et a l . ,  1987) I t  would appear that effects on the 
colonic mucins, t ra n s i t  time, colonic bulk or the e ffec t  of f ib re  
on energy a v a i la b i l i t y  may be more important than the obvious 
ones. Kritchevsky (1986) concludes that "There is no consistent 
thread of evidence through e ith er  human or experimental data 
which would confer an unequivocally protective role on f ib re  in 
general or on some specific  f ib re  component in p a rt ic u la r ."  
Dietary f a t ,  faecal b i le  acids, prostanoids and tumours.
By comparison, the mechanism of action of d ietary fa t  is 
thought to be reasonably well understood since there appears to 
be a more d ire c t  l in e  from fats  to b ile  acids to tumours.
However, there is growing evidence that the e ffe c t  may not be as 
straightforward as o r ig in a l ly  visualised.
A d ire c t  ca lo r ic  e f fe c t  of fa t  on tumour promotion has 
never been adequately demonstrated but i t  has to be noted from 
th is  study that the animals receiving a high fa t ,  low f ib re  d iet  
did have a s ig n if ic a n t ly  greater ca loric  intake than the animals
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on the low f a t ,  high f ib re  d ie t  when given carcinogen. When no 
carcinogen was given the caloric  intakes of these two groups were 
ind is tingu ishable . The differences in the growth patterns of the 
two groups re f lec te d  the differences in ca loric  intake and i t  was 
obvious tha t the animals on the high fa t  d ie t  to lerated the 
carcinogenic in su lt  better  than those on the low fa t  d ie t .  I t  is 
d i f f i c u l t  to determine i f  the observed changes in caloric  intake 
which occurred were the indicators of impending tumour 
development or the resu lt  of the animals developing tumours.
Several studies have noted that dietary fats  can modulate 
the immune response in an inh ib itory  fashion and that  
polyunsaturated fa ts  are more e ffec tive  than saturated ones. 
(Hopkins & West, 1976; Bansal, Rhoads & Bansal, 1978; Kollmorgan, 
Sansing, Lehman et a l . ,  1979; Erickson, McNeill, Gershwin et a l . ,  
1980; V i ta le  and Broitman, 1981) I t  is widely appreciated that 
immunosuppression f a c i l i t a te s  the development and metastasis of 
tumours and some observations in humans give support to the 
experimental s itua tion  by showing alterations in l ip id  profiles  
in malignancy and increased invasiveness of tumours with
immunosuppressive manoeuvres. (Wood, Habib, Thomson et a l . ,  1985;
Blumberg, Agarwal & Chuang, 1985) As to how the dietary l ip ids
may influence the corporate immunity is not understood but i t
seems l i k e ly  tha t they w i l l  a l te r  the composition and f lu id i ty  of 
ce ll  membrane, a l te r  the levels of the ubiquitous cAMP, a l te r  
macrophage function and cholesterol synthesis. (V ita le  & 
Broitman, 1981) With respect to the colonic cancer model one
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group of authors has demonstrated that the r is k  of the animal 
developing a colonic tumour is d ire c t ly  related to the re la t ive  
proportions of polyunsaturated fats  present (the Hartz ra t io )  the 
princ ipa l determinant of th is  ra t io  being arachidonic acid 
(Sakaguchi et a l . ,  1984). When dealing with changes in 
polyunsaturated fa ts  in the context of the current study i t  is 
d i f f i c u l t  not to be led to immediately consider whether the 
prostanoids may be involved. There is good evidence that they may 
also mediate the immune response and seem on the whole to in h ib it  
both T and B ce l l  a c t iv i ty  although th is  is by no means uniform. 
(Pelus & Strausser, 1977; Harvey, Allegra, Demers et a l . ,  1977; 
Goodwin & Webb, 1980; Goldyne & Stobo, 1981; Mertin & Stackpole, 
1981) I t  is c lear that prostanoids do not in i t ia te  immune 
responses but modulate a response in it ia te d  elsewhere and this  
modulation may vary depending on the cell type and i ts  stage of 
d i f fe r e n t ia t io n  or ac tiva t ion . (Goldyne et a l . ,  1981) The 
evidence of prostanoid involvement in immunoinhibition and the 
other evidence of th e ir  involvement in tumours and tumour 
promotion necessarily implies that an inh ib ito r  of prostanoid 
production such as indomethacin would most l ik e ly  have a 
benefic ia l e f fe c t  e f fe c t  on tumour development. This was not seen 
in th is  study although the protective e ffect of indomethacin has 
been shown elsewhere. (Humes et a l . ,  1974; Lynch et a l . ,  1979; 
Pollard et a l . ,  1981a & b; Narisawa et a l . ,  1981; Bennett et a l . ,  
1982; Carter et a l . ,  1983; Kollmorgan et a l . ,  1983; Pollard et 
a l . ,  1983; Metzger, Meier, Uhlschmid et a l . ,  1984) Indomethacin
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was given in the drinking water in a dose comparable to the other 
studies and no previous study has demonstrated the presence of 
indomethacin in the serum of the animals at the time of sacrifice  
in leve ls  which are thought to be therapeutic. (Hucker et a l . ,  
1966)
I f  the results  obtained for tumour induction in the 
animals receiving standard d ie t  were unexpected then the results  
fo r  animals given ethanol were s ta r t l in g  since not one animal 
showed any sort of neoplasm. This observation is completely 
without precedent since a l l  the previous evidence suggests that 
ethanol in high doses w il l  enhance tumour development - 
predominantly in the rectum. (Se itz , Czygan, Waldherr et a l . ,  
1984; Hamilton, Hyland, McAvinchey et a l . ,  1987) and may do this  
by enhancing the crypt ce ll  turnover in the rectum. (Simanowski, 
S e itz ,  Baier et a l . ,  1986) Others who gave the ethanol as a 
control medium (as in th is  study) demonstrated no effect on 
tumour incidence (Lynch et a l . ,  1978, Carter et a l . ,  1983). This 
immediately draws c r i t i c a l  attention to the other works 
suggesting indomethacin was protective.
Humes et a l . ,  (1974) administered indomethacin by 
subcutaneous in jec tio n  on alternate  days in a short-term model. 
Lynch et a l . ,  (1978) administered indomethacin in drinking water 
with ethanol as a solvent which appears to have been properly 
con tro lled . However the dose of indomethacin used (120mcg/day at 
maximum) was ra ther small. Pollard and Luckert (1981a & b) 
calculated tha t they gave th e ir  rats 3 mg/kg in a day via
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drinking water but did not use ethanol and only changed the water 
every three days which suggests that the rats may have been 
receiving l i t t l e  or any drug of consequence since the s ta b i l i ty  
of th e i r  solution was not demonstrated and indomethacin is 
v i r t u a l l y  insoluble in water. Their study in 1983 was conducted 
on s im ila r  l in e s .  Bennett et a l . ,  (1982) gave the drug as a syrup 
but only in a short term system. The studies of Narisawa et 
a l - , (1 9 8 1 ) ,  Carter et a l . ,  (1983), and Kollmorgan et a l . ,  (1983) 
are more convincing demonstrations of the inh ib itory capacity of 
indomethacin on tumour development but the la t te r  two of these 
perta in  to ra t  mammary tumorigenesis. I t  is pertinent to note 
tha t the Kollmorgan group calculated the f ina l dosage of 
indomethacin to be 2.5 - 3.0mg/kg.day which is exactly the dose 
used in th is  study. The study by Metzger et a l . (1984) is 
in te re s tin g  in that a protective e ffect of indomethacin is 
demonstrated (a t  a low dose of 200 - 500 meg.kg'*.d"*) on colonic 
carcinogenesis but another cyclo-oxygenase inh ib ito r - 
meclofenamate - was without e f fe c t .  As in some other studies, the 
indomethacin was dissolved in water d irec t ly  and th is  must raise 
doubts as to the de livery  to the animal. The discrepancy between 
the two drugs may underline th is  and pose the probability  that a 
non-specific  e f fe c t  has occurred. In d irect contrast, Danzi, 
Ferulano, Abate et a l ; , (1984) could demonstrate no protective  
e f fe c t  o f indomethacin on tumour development and suggested that 
i t  might even enhance the progression of the disease. However 
th is  study is not analogous to the current study since the drug
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was not administered un ti l  a f te r  tumours were proven to be 
present at an exploratory laparotomy.
I t  could therefore be argued that the evidence for  
indomethacin protection is much less than i t  f i r s t  appears since 
some of the studies are poorly controlled and give no indication  
of the dose of indomethacin used. Only the study of Narisawa et 
a l . ,  (1984) resembles the current research and was inconclusive 
also.
I t  has been shown that ethanol can influence the 
production o f prostanoids by a mechanism which is not clear but 
which may involve prostanoids other than those examined here. 
(Manku, Oka & Horrobin, 1979) I t  is therefore possible that the 
apparent in h ib ito ry  e f fe c t  of ethanol on tumour production is 
mediated by prostanoids.
The evidence link ing  prostanoids and neoplasia has 
already been presented, (page 42) I t  is worthwhile recalling that 
a considerable body of evidence has positive ly  identif ied  the 
prostanoids as being in tim ate ly  involved with classical tumour 
promotion in other systems and that they may also be a part of 
tumour in i t i a t io n  by acting as co-oxygenators. Moreover they have 
roles in c e l lu la r  communication and d if fe re n t ia t io n .  (Dro ller,  
1981; Honn, Bockman & Marnett, 1981; Levine, 1981; Karmali, 1983; 
Fischer, 1985; Trosko, Aylsworth, Jone et a l . ,  1985) To this must 
be added the concept of cytoprotection and th e ir  a b i l i t y  to a lte r  
mucus thickness. (B ickel, 1981; M il le r  & Jacobson, 1979; Robert, 
1981) Despite th is  a true ".. .causal relationship between
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arachidonic acid transformation and cancer has yet to be 
demonstrated." (Karmali, 1981)
Aprotinin and tumours.
Aprotinin produced a mild protective e ffect on tumour 
development in the animals receiving the low fa t ,  high fib re  diet 
and th is  would be consistent with work already reviewed showing 
an in h ib ito ry  capacity of aprotinin on tumour development. The 
hypothesis under study has suggested that th is  might be due to 
i t s  a b i l i t y  to in h ib i t  bradykinin formation as assessed by 
measurement of the tissue k a l l ik r e in - l ik e  amidase a c t iv ity  in the 
colon. This was undoubtedly reduced by aprotinin in a small way 
but not in a pattern which could be related d irec t ly  to 
carcinogenesis. However i t  is interesting that the effect was 
apparent when the tumour incidence was generally low. This may 
imply tha t  local kinin a c t iv i ty  is only one in fluentia l factor 
and that i t s  e f fe c t  can be completely swamped by other factors 
such as d ie ta ry  fa t  or f ib re .  The spectrum of a c t iv ity  of 
aprotin in  is so broad that i t  is not thought to act by just one 
channel. Other mechanisms of inh ib it ion  have been suggested - 
in h ib it io n  o f macrophage lysosomal enzymes (Thomson, Tweedie, 
Pugh-Humphreys et a l . ,  1978) a lterations in the cell surface 
(Latner & Sherbet, 1979) metabolism of "Metastatic factors" 
(Stein-Werblowsky, 1980) and improvement of host immunity. (F r itz  
& Wunderer, 1983) I t  is c lear that whatever mechanism is involved 
then a great deal of further work is required to fu l ly  assess the 
ro le  o f aprotin in  in tumour development.
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GENERAL DISCUSSION AND CONCLUSIONS.
I t  is  a great but not insurmountable step from the 
experimental animal to man. The inconstant nature of the results  
seen in th is  study - both within the study and in comparison with 
others - only serves to remind that generalised deductions from 
th is  kind o f work are in t r in s ic a l ly  flawed no matter the care 
taken. None the less, i f  the results are taken as pointers rather 
than destinations then i t  may be suggested that the study within  
these pages gives support to the hypothesis linking d ie t and 
cancer of the colorectum. In very general terms i t  would appear 
tha t d ie ta ry  fa t  increases the r isk  of tumour development while 
d ie ta ry  f ib re  protects against i t .  The relationship between these 
two components and th e ir  interaction is uncertain and i t  has been 
suggested, on the basis of the results obtained in animals on 
th e i r  standard d ie t ,  that these two components may not produce a 
d ir e c t ly  l in e a r  re lationship  with r isk  and that there may be an 
"ideal"  combination which promotes the development of 
experimental colonic tumours best. The place of other dietary  
components has also been considered although no information is 
ava ilab le  on th is .
Taken fu rthe r  the study supports, by association, the 
ro le  of faecal b i le  acids in the promotion of th is  tumour. The 
o rig in a l aim of the study was to seek expectantly into the place 
of the autacoids in th is  scheme by selecting two which seemed on 
a p r io r i  grounds to be of some importance. These results are much 
more problematical and the role of the kinins and the prostanoids
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is  by no means established. Nor is i t  refuted. While the present 
study has not demonstrated a role for kinins and prostanoids in 
experimental colonic tumours th is  may not necessarily re f lec t  the 
events occurring at or in the colonic epithelium. As has been 
already suggested, any detectable changes which available  
methodology can recognise may at best be the sum of a myriad of 
undetectable a lte ra tio n s  occurring at the c e l lu la r  leve l. Failure 
to demonstrate a substantial role for these autacoids may not 
necessarily mean they are inactive in carcinogenesis. The 
pointers are tha t kinins and prostanoids both have a place but 
the problem l ie s  in defining and measuring that place. Both of 
these substances are by th e ir  nature rather intangible in the 
body and much has been said in the preceding dialogue about the 
problems of measurement and the relevance of such measurement to 
the questions under study. In the f ina l analysis, until such 
times as we can place ourselves at the heart of the cell during 
i ts  l i f e  we may never properly understand what controls i t .  The 
re a l is a t io n  tha t cancer " . .  is at heart a genetic disease." 
(Bishop, 1986) and the re lentless assault on the gene may be the 
f i r s t  step in that understanding.
The relevance of th is  study to human disease must be the 
f in a l  consideration. The colorectal cancer animal model has been 
un iversa lly  acclaimed as a good representation of human tumours 
and th e i r  con tro lling  factors. This is true only within the 
confines o f the experiment being conducted and i t  is clear that 
too many workers take a rather l i t e r a l  interpretation of the
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animal model. A b r ie f  consideration of the technical aspects 
reveals one very fundamental difference - in the ra t ,  the primary 
carcinogen is known; in the human i t  is not. Furthermore, 
observations which suggest that ra t  colonic tumours may be 
aris ing  p r in c ip a l ly  from areas of specialised epithelium over 
lymphoid aggregates and that there may be two separate neoplastic 
processes at work only serve to highlight the differences.
(Nauss, Locniskar, Pavlina et a l . ,  1984) I f  human colorectal 
cancer is a two-stage process then i t  might reasonably be asked 
when the in i t ia t io n  process occurs. I t  is d i f f i c u l t  to see a 
human s itu a tio n  whereby a single, unique exposure to a carcinogen 
w il l  occur which has never previously occurred and which w il l  
never recur. On the other hand i t  may not be necessary to have an 
i n i t i a t o r ;  considering the m illions of cell divisions which occur 
d a i ly  then a spontaneous error could easily be promoted. Most 
errors may be inconsequential; many w il l  not survive or w ill  be 
corrected. One may be promoted and be unique by resisting a ll  of 
man's in b u i l t  safeguards by a legion of mechanisms of which 
changes in autacoids may only be one facet. The logical extension 
of that would be that a high rate of ep ithe lia l turnover would 
generate more errors and thereby more tumours; more important may 
be the a b i l i t y  of the ce ll to res is t mobilisation and express its  
carcinogenic advantage to the fu l l  in a more slowly cycling cell 
population. While i t  is re la t iv e ly  easy to develop concepts of 
large bowel tumorigenesis none of the hypotheses can adequately 
explain the most impressive observation of a l l  - that adjacent
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small bowel is highly res istant to tumour development in any 
s itu a t io n .  Surely, an answer to th is  conundrum would shed more 
l ig h t  on tumour development elsewhere.
When Doll and Peto published th e ir  a r t ic le  on the causes 
of cancer in 1981 they cited f ive  broad headings by which the 
d ie t  may influence the development of a tumour. Thus the d iet may 
provide the carcinogen d ire c t ly ,  may provide for the production 
of carcinogen w ithin the body, may a lte r  the activation or 
in ac t iv a tio n  of the carcinogen, affect the promotion of cells  or 
simply increase r is k  by obesity. This study has examined only one 
small facet of that range of p o s s ib il it ie s  in a purely 
experimental s ituation  and has demonstrated that the d iet does 
influence the s u s cep t ib il i ty  to tumour development in the colon 
and tha t  the e f fe c t  of the d ie t  may be mediated by the actions of 
local hormones such as the kinins or prostanoids but these 
e ffe c ts  are d i f f i c u l t  to quantify. This is borne out by the many 
other studies with s im ilar  results . In spite of th is wealth of 
knowledge i t  is s t i l l  true that " . . th e  science of d ie t  and cancer 
is  immature." (Doll & Peto, 1981)
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A P P E N D I C E S
APPENDIX 1
COMPOSITION OF THE DIETS.
CONSTITUENT
OXO ID
BREEDING
DIET
HIGH FAT 
LOW FIBRE 
DIET
LOW FAT 
HIGH FIBRE 
DIET
CRUDE FAT 4.0% 25.2% 2.1%
CRUDE PROTEIN 22.9% 14.9% 14.8%
CRUDE FIBRE 3.56% 2.1% 26.9%
ASH N/K 4.1% 7.5%
NITROGEN FREE EXTRACTIVES N/K 43.9% 38.7%
DIGESTIBLE CRUDE FAT N/K 22.6% 1.6%
DIGESTIBLE CRUDE PROTEIN N/K 13.6% 13.4%
TOTAL DIETARY FIBRE N/K 6.7% 35.5%
STARCH N/K 35.5% 25.8%
SUGARS N/K 3.2% 3.7%
GROSS ENERGY N/K 20.3 MJ/kg 14.7 MJ/kg
DIGESTIBLE ENERGY N/K 17.9 MJ/kg 8.2 MJ/kg
METABOLIZABLE ENERGY 12.0 MJ/kg 16.1 MJ/kg 7.4 MJ/kg
VITAMIN A 50000 i .u . 6000 i .u . 6000 i .u .
VITAMIN Do 3000 i .u . 1000 i .u . 1000 i .u .
VITAMIN EJ 60.0 mg 50.0 mg 50.0 mg
VITAMIN B, 6.0 mg 5.0 mg 5.0 mg
VITAMIN Bo 10.0 mg 5.0 mg 5.0 mg
VITAMIN Bo 5.0 mg 5.0 mg 5.0 mg
VITAMIN B° 35.0 meg 5.0 meg 5.0 meg
MENADIONE LC N/K 5.0 mg 5.0 mg
FOLIC ACID 1.0 mg 0.5 mg 0.5 mg
NICOTINIC ACID 10.0 meg 10.0 mg 10.0 mg
CALCIUM PANTOTHENATE N/K 10.0 mg 10.0 mg
CHOLINE CHLORIDE 1500.0 mg 400.0 mg 400.0 mg
LYSINE 1250.0 mg 2000.0 mg 2000.0 mg
METHIONINE 470.0 mg 1500.0 mg 1500.0 mg
CALCIUM 810.0 mg 4700.0 mg 2000.0 mg
PHOSPHORUS 650.0 mg 3500.0 mg 4000.0 mg
SODIUM CHLORIDE 230.0 mg 5000.0 mg 5000.0 mg
MAGNESIUM 180.0 mg 1000.0 mg 1000.0 mg
IRON 10.0 mg 20.0 mg 20.0 mg
COPPER 25.1 mg 7.0 mg 7.0 mg
MANGANESE 102.6 mg 20.0 mg 20.0 mg
ZINC 95.5 mg 10.0 mg 10.0 mg
COBALT 3.0 mg 0.3 mg 0.3 mg
IODINE 1.5 mg 0.5 mg 0.5 mg
[ Unless otherwise specified, a l l  values are for 1 kg of d ie t . ]
[ For d e f in it io n s  see notes on page 190]
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APPENDIX 1 (con tinued )
COMPOSITION OF THE DIETS.
Fattv  acid composition of High fa t ,  low f ib re  d ie t .
FATTY ACID_______ CHEMICAL COMPOSITION % COMPOSITION 0
Laurie acid CH3 (CH2) jqCOOH 0.1
M yris t ic  acid CH3 (CH2)^COOH 0.9
Palm itic  acid CH3 (CH2) j4COOH 5.2
Stearic  acid CH3 (CH2)^COOH 3.6
L ino le ic  acid CH3 ( CH2) 4CH=CHCH2CH=CH(CH2) 7C00H 2.6
Linolenic acid CH3 (CH2CH=CH)3 (CH2) 7C00H 0.4
Oleic acid CH3 (CH2) 7CH=CH(CH2) 7C00H 7.5
Palm ito le ic  acid ch3 ( ch2) 5CH*CH(CH2) 7cooh 0.3
M yris to le ic  acid CH3 (CH2) 3CH=CH(CH2) 7COOH 0.01
Clupanodonic acid ch3 (CH2) 3 (ch=chch2) 5( ch2) 2cooh 0.03
Arachidonic acid CH3 (CH2) 4 ( CH=CHCH2) 4 (CH2) 2cooh 0.2
DIET
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NOTES
1 .Crude fa t  is the material extracted with petroleum-ether under 
continuous reflux-Soxhlet Extraction
2 . Crude protein is the to ta l nitrogen content determined by 
Kjeldahl m ultip lied  by the factor 6.25 to convert to protein  
concentration
3 . Crude f ib re  (essentia lly  cellulose and l ig n in )  is the residue 
l e f t  a f te r  treatment with boiling d i lu te  acid and a lk a l i .
4 .Ash is the residue l e f t  a f te r  incineration at 500°C.
5 .Nitrogen Free Extractives (essentia lly  crude carbohydrate) is 
the d ifference of the sum of the percentages of moisture, f a t ,  
protein , f ib re  and ash from 100%
6 . Digestible values are found by experiment and free  
d ig e s t ib i l i t y  factors are used to indicate the amount of 
d igestib le  nutr ient. Usually obtained from pigs or poultry.
7. Total d ietary  f ib re  includes pectins and hemicelluloses which 
are soluble in the crude f ib re  assay and are therefore included 
in the N.F.E. value.
8. Starches and sugars are obtained by analysis.
9. Gross energy is the energy derived from bomb calorimetry and 
reasonably is the sum of the gross energies of the f a t ,  protein, 
f ib re  and carbohydrate contents of the d ie t .  Metabolizable energy 
is taken as 90% of d igestib le  energy.
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THE USE OF AZQXYMETHANE.
Azoxymethane was purchased from Ashe Stevens Inc.
D e tro it ,  USA in aliquots of 10 grams. This was made into a stock 
solution of 0.2g/ml with saline and stored at 4°C.
An aliquot of the stock solution was dilu ted  prior to use 
to give a solution of azoxymethane in saline of lOmg/ml. The 
animals were injected subcutaneously in the scapular area with a 
dose of lOmg/kg. This dose was repeated at weekly in tervals  for  
12 weeks. The f i r s t  dose of carcinogen was given at the fourth 
week of the experiment.
Animals receiving the carcinogen were kept separate from 
those which were not receiving i t .  While th e ir  d ie t ,  water and 
drugs came from a common source, at no time did the carcinogen 
treated animals and non-carcinogen treated animals mix. All 
animal waste was disposed of separately.
The use and storage of the carcinogen conformed to the 
guidlines la id  out in the memorandum "Working with Carcinogens - 
Code of Practice." (University of Glasgow, 1981)
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APPENDIX 3
ASSAY OF TISSUE KALLIKREIN-LIKE AMIPASE ACTIVITY. 
PREPARATION
1. Prepare TRIS (Sigma, Poole) buffer 0.2M, pH 8.2 with SBTI 
250mcg/ml (Sigma)
2. Prepare sodium lauryl sulphate 20% (BDH, Analar grade)
3. Prepare acetic acid 50% (BDH)
4. Water bath at 37°C
METHOD
1. Thaw tissue extract
2. Place 500mcl TRIS buffer in tubes and incubate for 10 minutes 
in water bath
3. Add 400mcl of extract
4. Mix and incubate for 5 minutes
5. Add lOOmcl of substrate (S -2266, Kabi Diagnostica) and 
incubate at 37°C for 45 minutes.
6. Add lOOmcl of acetic acid to stop the reaction
7. Centrifuge for 15 minutes to remove sediment (2000g)
8. Take 900mcl of supernatent and place in fresh incubation via l
9. Add lOOmcl of sodium lauryl sulphate
10.Mix and allow to stand for 5 minutes
11.Measure optical density on spectrophotometer at 405nm, s l i t  
width 0.3mm with d is t i l le d  water as the blank
All samples assayed in duplicate.
Assay blanks are prepared in the same way but the steps are: 
1 ,6 ,2 ,3 ,4 ,5 ,7 ,8 ,9 ,1 0 ,1 1 .
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CALCULATION OF THE TISSUE KALLIKREIN-LIKE AMIPASE ACTIVITY OF
RAT COLON.
Absorbance at 405nm 
Extinction coeff ic ien t  
Volume of incubate before centrifuging (ml)
Volume of supernatent taken (ml)
Volume of f ina l solution for assay (ml)
Wet weight of tissue (g)
Volume of water used to homogenise (ml)
Dilution of extract before assay expressed as:
volume of concentrate 
volume of f ina l solution
t  = Time of incubation
Vp = Volume of extract used
VE contains V£ x W/VH g of tissue  
( I f  th is  is diluted before assay then V£ contains VE x W/VH x D 
grams of tissue)
A c t iv i ty  is produced by th is  tissue and is assessed by formation 
of pNA. The concentration of pNA is measured in the f in a l  
solution Vp. This pNA is e n t ire ly  derived from the supernatent 
taken - V$ . Therefore the concentration of the pNA in the 
orig ina l incubate was :
Vp/Vs x A/e (m mol of pNA)
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Let A =
e =
D =
APPENDIX 4 (continued)
The orig ina l solution had a volume Vy,  and therefore the number 
of moles of pNA produced by incubation was:
_3
Vp/V<j x A/e x Vy x 10 (since vol is in ml) 
This a c t iv i ty  is produced in time t  by the tissue extract and 
therefore the rate of production of pNA per gram of tissue per 
minute is
_3-------------------  1------------
Vp/Vs x A/e x VT x 10 J x 1 / t  x (V£ x W/VH x D)
This reduces to
VF x A x VT x VH x 10 '3
Vs x e x t  x VE x W x D mol pNA.g-l.min-1.
For the usual values of Vy = 1.1
Vs -  0.9
Vp = 1.0 
Vp = 0.4  
e = 10343.367
th is  becomes :
295.41208 x (A x VH)/(W x D x t )  nmolpNA.g-1.min-1.
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APPENDIX 5
$-2266
DATA SHEET AS PREPARED BY KABI DIAGNQSTICA. STOCKHOLM. SWEDEN.
S-2266 is a chromogenic substrate for glandular 
k a i l ik re in s .
Chemical Name : H -D -V a ly l-L -leucyl-L -arg in ine-p -n itroan ilide
dihydrochloride.
Formula : H-D-Val-Leu-Arg-NH-@-N02 '2HC1
Molecular Wt. : 579.6
P rinc ip le  : H-D-Val-Leu-Arg-pNA ?D?OT§> H-D-Val-Leu-Arg-OH
+
p-NA
The method for the determination of a c t iv i ty  is 
based on the difference in the optical density 
(absorbance) between the pNA formed and the 
original substrate. The rate of pNA formation is 
proportional to the enzymatic a c t iv i ty .
S-2266 is supplied in v ia ls  containing 25mg of substrate and was 
made up in 28.8ml of fresh d is t i l le d  water to give a solution of
l.Smmol.l"1, This was stored in aliquots of 1ml at -40°C until  
use.
The data supplied with the reagent suggests that i t  is stable in 
solution fo r at least 2 months at temperatures of 2 - 8°C. All of 
the experiments here used the diluted substrate well within that  
time.
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APPENDIX 6
RADIOIMMUNOASSAY FOR PGE-
The individual steps for the assay are shown below.
1. Place 4ml of ethyl acetate into 18 tubes which w il l  be used 
fo r  the standard curve and evaporate to dryness in the vacuum 
oven at 37°C
2. Thaw a l l  samples and mix.
3. Take at least two aliquots (250mcl) from each sample and place 
in extraction tubes.
EXTRACTION
*3
4. Add 50mcl of H-PGE2 (0.02mcl/ml) to each sample tube and to 
two of four blank tubes (internal standard for the estimation 
of recovery). Add 50mcl of phosphosaline buffer to the two 
remaining blanks.
5. Place 50 mcl of 3H-PGE  ^ (0.02mcCi/ml) in each of four 
s c in t i l la t io n  via l inserts and add 5ml of s c in t i l la n t  to each. 
(Total counts for the estimation of recovery).
6. Add sodium c i t ra te  buffer to a ll  tubes (h a lf  the volume 
already present in each tube = 150mcl) and mix. Prostanoids 
w il l  be non-ionised at mildly acidic pH.
7. Add 2ml ethyl acetate to each tube and mix (Multivortex  
shaker) fo r 5 minutes.
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8. Allow organic and inorganic phases to s e tt le .  Freeze the 
inorganic layer by placing in dry ice/acetone up to interface. 
Decant the ethyl acetate into assay tubes.
9. Place assay tubes in the vacuum oven and evaporate to dryness 
at 37°C.
10. Allow the samples to thaw and repeat steps 7, 8 and 9. 
STANDARD CURVE
11. Set up standard curve using the tubes which had 4ml of ethyl 
acetate evaporated from them. Prepare in duplicate tubes for  
T, B, 0, (empty) and then 3, 10, 30, 100, 300 and 1000 pg of 
prostanoid by p ipetting the appropriate stock solution into  
the tubes. Evaporate to dryness in the vacuum oven.
RECONSTITUTION
12. Add phosphosaline buffer to a ll  tubes - 200mcl to the 
standards and 250mcl to the samples. Mix.
13. Remove 50mcl from each sample tube and place in a 
s c in t i l la t io n  v ia l insert . Add 5ml of s c in t i l la n t  (Biofluor)  
to the in se rt .  (For estimation of recovery).
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INCUBATION
14. Add 50mcl of ^H-PGE2 (0.2mcCi/ml) to each tube and mix.
15. Add 50mcl of anti-PGE2 antibody solution to a ll  tubes except 
T and B. Add 50mcl of phosphosal ine buffer to T and B.
16. Incubate overnight at 4°C.
SEPARATION
17. Add 50mcl of ge la tin  to every tube. Mix.
18. Add 200mcl of Dextran-coated charcoal suspension to a ll  tubes 
except T. Add 200mcl of phosphosaline buffer to T. Mix.
19. A fte r  10 minutes centrifuge at lOOOg for 2 minutes.
20. Take 250mcl of supernatant from each tube and place in a 
s c in t i l la t io n  v ia l insert. Add 5ml of s c in t i l la n t .
21. Count a l l  recovery and assay v ia ls  on s c in t i l la t io n  counter.
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THEORY.
The samples are assayed in duplicate. After ac id ification  
they are extracted twice with ethyl acetate and the recovery
o
measured by use of the tracer dose of H-PGE2 (0.02mcCi/ml) .
A fte r  reconstitu tion  in phosphosaline buffer the antibody and the
t r i t i a t e d  prostanoid are added for the incubation to proceed. The 
3
bound and unbound H-PGE2 are separated by using Dextran-charcoal
3
and a reasonable sample of the bound H-PGE2 measured by 
s c in t i l la t io n  counting. From the standards the s c in t i l la t io n  
counts are converted into pg of PGE2 in the original sample.
The blanks: T measures the to ta l a c t iv ity  of the t r i t ia t e d
solution used for the assay and was in the order of 
4000 cpm. (mean 4362+1060)
B was used to give an estimate of the non-specific
binding by the charcoal in the assay. This
non-specific binding was expressed as B/T x 100% and 
was less than 3%.
The '0 '  tube gave an estimate of the in i t i a l  binding 
of the assay and was expressed as " O ' / T  x 100%. This
was in the order of 25 - 38%.
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The IC50 fo r the reaction was the amount of PGE2 to 
reduce the 'O' value by 50% and ranged from 40 - 
140pg (mean 74 ± 41pg) depending on the total 
a c t iv i ty  of the ^H-PGE2
The detection l im i t  was defined as the amount of PGE2 
which would reduce the '0 '  value by by 10% and ranged 
from 5 - 15 pg. (mean 9 + 5pg)
Standard Curve F it t in g
The standard curve has the form Y = [K3/(X + K2)] - K1
and was f i t t e d  by an i te ra t iv e  programme on an Apple computer.
In th is  case Y = the cpm and X the amount of PGE2 in pg.
-  2 0 0  -
APPENDIX 6 (con tinued)
Calculation
Let P  ^ = pg of PGE2 measured by RIA
P = pg of PGE^  in the original sample 
R = the recovery (%)
Vj; = volume of extract assayed (mcl)
= weight of tissue in sample assayed (mg)
W = weight of original colon sample (mg)
= volume of PSB used to homogenise the tissue (ml)
The amount of PGE2 measured in the assay derives from 
200mcl of reconstituted sample which represents 4/5 of the tota l  
sample therefore :
the amount of PGE0 in the original sample = 5 x PM x 100 = P 
1 4 R
This PGE2 derived from V£ mcl of extract which contains W£ mg of
tissue.
Wr = VF x W since the sample was diluted
E 1 Vu x 10 tenfold before assay.
H
Therefore the [PGE,] o f the original sample extract
= P/WE = (5 /4  x PM x 100/R ) / (V e x W/(VH x 10))
1250 x PM x V„
= H H ng.g 1
V£ x R x W
K3
In th is  case P^  = _______  - ^2
(C + Kj) where C = cpm
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SOLUTIONS FOR PROSTAGLANDIN ASSAY
Sodium C it ra te  Buffer 0.15M pH 4.0 
Solution 1 27.5ml
Solution 2 22.5ml
D is t i l l e d  water to 100 ml
Solution 1 = C i t r ic  acid CgHgO^l^O 21g (BDH Chemicals.
Poole)
Sodium hydroxide 1M 200ml (BDH)
D is t i l le d  water to 1000ml
Solution 2 = Hydrochloric acid 0.1M (BDH)
(A ll  reagents were Analar grade)
Phosphosaline Buffer 0.15M pH 7.4
Solution A 10.12ml
Solution B 2.37ml
Sodium chloride 2.25g (BDH)
Gelatin  0.25g (BDH)
Thiomersal 0.012g (BDH)
D is t i l le d  water to 250 ml
Solution A = 0.2M Na2HP04 = 28.3g/l 
Solution B = 0.2M NaH2P04 = 31.3g/l
(A ll reagents were Analar grade)
-  2 0 2  -
APPENDIX 6 (con tinued)
SOLUTIONS FOR PROSTAGLANDIN ASSAY (continued)
G elatin  Solution
Gelatin  250mg (BDH Chemicals)
Phosphosaline buffer 25ml
Dextran-coated Charcoal Suspension
Charcoal (activa ted) 500mg (Sigma Chemical Co. Ltd., Poole)
Dextran T70 50mg (Sigma)
Phosphosaline buffer to 50ml
(so lution  used on ice with continuous s t ir r in g )
S c in t i l la t io n  Counting
S c in t i l la t io n  counting was carried out on a Packard 
T r i-c a rb  460C using a tr i t iu m  programme. The counting time was 5 
minutes fo r  each sample. This included the automatic caluation 
of a quench index parameter by analysis of the spectral index of 
the sample.
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REAGENTS FOR PROSTAGLANDIN RADIOIMMUNOASSAY 
Manufacturers' data
ANTISERA TO PGE^  ( In s t i tu t  Pasteur, 3,Bd Raymond Poincare, BP3) 
Orig in: rabb it  Immunogen: PGE2-BSA
Presentation: lyophilised (Reconstituted in phospholsaline 
b u ffe r ,  5.5ml per v ia l )
Binding parameters: Reconstituted antiserum binds 45% of lOpg of 
3H-PGE2
S e n s i t iv i ty  = 8 - 20pg (IC^g) A f f in i ty :  K = 8.2 x 10*® M *
Cross - r e a c t iv i ty :  PGA .^.................. ,0.04% PGA2..................... 0.30%
PGBj...................<0.01% PGB2................... <0.01%
PGDj...................<0.01% PGD2................... <0.01%
PGEj................... 10.70% PGE2 ................. 100.00%
DH- PGE1...............0.01% DH- PGE2...............2.1%
15K-PGEj.............0.16% 15K-PGE2 ........... 13.2%
ISKjDH-PGEj . ..0.03% 15K,DH-PGE2. ..0.6%
PGFj   0.01% PGF2 ................... 0.11%
DH-PGFj ......... .......  DH-PGF2 ......... <0.01%
15K-PGFj  <0.01% 15K-PGF2 ------- <0.01%
15K,DH-PGFj .<0.01% 15K,DH-PGF2 .<0.01%
19-OH-PGEj...<0.01% 19-0H-PGE2 . . . . ------
6K-PGFj   <0 .01% 19-0H-PGF2 . . . 0 . 0 1 9 %
t x b 2  <0 .01%
6 , 15K-PGE2  0 .01%
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TRI TI A ILD P.GE2 (Amersham International pic, Amersham HP7 9LL) 
Structure: [ 5 ,6 ,8 , l l ,1 2 ,1 4 ,1 5 (n )  - 3H]PGE„
Specific  A c t iv i ty :  160Ci/mmol, 438mCi/mg 
MW = 352 ( = 363 at th is  specific a c t iv ity )
Radioactive concentration: O.lmCi/ml 
Radiochemical purity  (HPLC) : 94.8%
Storage: At -20°C; decomposition not greater than 3%/month for 2 
months but may accelerate thereafter typical of 
t r i t i a t e d  compounds.
Supplied in ethanol:water mixture containing 25mcCi in 
250mcl of solution.
Stock solution: 50mcl of supplied solution has 4.95ml of ethanol
added to give a solution of lmcCi/ml. (stored at -20°C) 
Working solution: 1.4ml of stock solution (=1.4mcCi) has solvent 
evaporated and the 3H-PGE2 reconstituted in 7ml of 
phosphosaline buffer (0.2mcCi/ml) .  A further 1 in 10 
d ilu t io n  is made to give a 0.02mcCi/ml solution for the 
estimation of recovery.
PGE2 Standards
PGE2 was obtained from Upjohn Co., Kalamazoo. A stock 
solution of lng/ml was prepared in ethanol and stored at 4 C. In 
the assay varying volumes of the standard solution were assayed 
to create the standard curve for the assay (3 - 1000 mcl of 
solution = 3 - 1000 ng of PGE2)
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PREPARATION OF COLONIC TISSUE FOR STATHMOKINETIC ANA1YSTS.
1. Fix in Carnoy's solution 4 hours. (Drury & Wallington, 1980)
2. Transfer to 70% ethanol for storage.
3. Rehydrate through 70%, 50% & 30% ethanols - 10 mins each.
4. Immerse in N HC1 at 60°C for controlled hydrolysis. (10 mins)
5. Stain with S c h if f 's  reagent (Sigma, Poole) for 1 hour.
6. Dehydrate in sequential alcohols; store in absolute alcohol.
7. Suspend tissue in a drop of 5% acetic acid on a microscope 
s l id e .
8. S tr ip  o f f  mucosa using dissecting microscope.
9. Microdissect mucosal crypts using needles/blade to tease
apart.
10. Resuspend in a drop of 5% acetic acid.
11. Squash preparation with a coverslip.
12. Soak in methylated s p i r i t  to free coverslip with preparation
attached.
13. Dip coverslip in xy lo l.
14. Mount on a clean slide with clear polyester resin (Araldite)
with clamp to maintain squash.
15. Count metaphase figures in ten crypts.
16. Plot metaphase count with time to calculate regression l in e .
Method a f te r  Ferguson et a l . ,  1977 & Cooke et a l . ,  1984
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MEASUREMENT OF FAECAL BILE ACTDS-
Faecal b i le  acids were identif ied  and quantified by the 
method of Owen, Thompson and H i l l .  (1985)
Samples of the freeze-dried rat faeces were subjected to 
continuous extraction in a Soxhlet apparatus using organic 
solvents. I n i t i a l  extraction with petroleum ether yielded a 
'neu tra l f ra c t io n '  comprising mainly cholesterol, coprostanol, 
coprostanone, plant sterols and up to 10% free b ile  acids 
espec ia lly  1ithocholic acid. Subsequent extraction with methanol 
and chloroform (1:1 v/v) yielded an extract containing free bile  
acids and th e i r  conjugates and sulphates. This was fractionated  
using a l ip o p h i l ic  anion exchanger (diethylamino-hydroxypropyl 
Sephadex LH-20) and the steroids then identif ied  by computerised 
g as -l iq u id  chromatography - mass spectrometry.
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THE DETERMINATION OF INDOMETHACIN IN PLASMA 
BY SPECTROFLUORIMETRY
(Hucker et a l . ,  1966)
Method
1. To a stoppered tes t  tube add 1.0ml plasma
1.0ml c i t ra te  buffer 
0.5ml water
5.0ml n-heptane/iso-amyl
alcohol
2. Extract by mechanical shaking - 15mins.
3. Centrifuge at 2000 rpm
4. Transfer heptane phase (supernatant, 4ml) to a separate tube.
5. Add 5ml 0.1M sodium hydroxide.
6 . Extract by mechanical shaking - 15mins.
7. Centrifuge at 2000 rpm
8 . Aspirate organic phase
9. Place aqueous phase in a quartz cuvette
10 .Measure fluorescence - excitation 295nm
- emission 385nm
- s l i t  8nm
Solutions
C it ra te  buffer pH 5.0
n-heptane 3% v/v iso-amyl alcohol (Sigma, Poole)
0.1M Sodium Hydroxide.
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Principle
Indomethacin is extracted into heptane. I t  is then 
deacylated by sodium hydroxide to a fluorescent product which is 
measured. The amount of indomethacin in the plasma is calculated 
from known standards assayed at the same time. The relationship  
between the fluorescence and the indomethacin concentration is 
known to be l in e a r .
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